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Summary 
Background 
Magnetic resonance imaging (MRI) is an essential component of medical care: 
it plays a vital role not only in diagnosis of diseases and injuries, but also in 
the monitoring of disease progression and treatment success. Currently, how-
ever, the appropriateness of diagnostic imaging is increasingly debated. In a 
recent publication of 26 low-value medical procedures, 12 involved medical 
imaging among several categories: diagnostic, preventive and preoperative test-
ing [1]. With more than 100 MRI exams yearly per 1,000 population, Austria 
is leading in MRI utilisation in comparison to other OECD countries. A use-
ful investigation is one in which the result – positive or negative – will con-
tribute to diagnosis and will alter patient management. Inappropriate use 
may lead to costs without increasing diagnostic yields: not only the cost of 
the exams itself, but also ensuing treatment or follow-up costs, increase in 
waiting times and additional costs if patients are on sick leave [2]. Our aim 
was therefore to identify recommendations against the use of MRI and inter-
ventions to decrease inappropriate imaging relevant to the Austrian context. 
 
Methods 
We approached this topic from several sides. First, we screened databases 
for recommendations against the use of MRI in specified indications and 
compared to the Austrian referral guideline „Orientierungshilfe Radiologie”. 
Second, we performed a literature review to identify which tools and strate-
gies are used for utilisation management of MRI and their reported effects 
from pilot studies and third, we conducted interviews with relevant Austrian 
stakeholders, in which we explored their perspectives on current and possi-
ble future measures to steer appropriate use of MRI in Austria. 
 
Results  
Our screening of recommendations against the use of MRI identified several 
indications where recommendations differed from current referral guidelines 
in Austria. Current steering instruments of imaging utilisation are the cen-
tralised planning of MRI equipment, a cap on expenses, which is not coupled 
to performance criteria and a pre-authorisation system in which 99% of re-
ferrals are authorised. Our interviewees supported the introduction of edu-
cational measures for referrers and patients; the expansion of decision sup-
port and the facilitation of communication exchange. Current pre-authorisa-
tion is not perceived as a measure driving appropriate use. 
 
Conclusion 
The Austrian referral guidelines are widely accepted – we would advocate for 
an elaboration of these guidelines to allow referrers to better differentiate 
appropriate and inappropriate indications. Referrers should receive training 
and tools to consult patients on risks of inappropriate imaging. Radiologists 
should be more involved in decision making: as a minimum through consult-
ing service lines or by integration of their expertise in alternative pre-authori-
sation models. 
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Zusammenfassung 
Hintergrund und Problemstellung 
Die Magnetresonanztomographie (MRT), ein bildgebendes Schnittbildverfah-
ren zur Darstellung von Struktur und Funktion der Gewebe und Organe im 
Körper, ist ein wesentlicher Bestandteil medizinischer Versorgung: sie spielt 
nicht nur in der Diagnostik von Erkrankungen und Verletzungen, sondern 
auch im Monitoring von Krankheitsverlauf und Therapieerfolg eine entschei-
dende Rolle. Entstanden in den 1970er Jahren, entwickelte sich die MRT in 
den letzten Jahren kontinuierlich und mit zunehmender Geschwindigkeit 
technisch weiter. Als Konsequenz nehmen die Anwendungsgebiete der MRT 
laufend zu und umfassen derzeit Screening, Erstdiagnose, Follow-up und 
Staging sowie Monitoring. Verschiedene Spezialanwendungen wie die funk-
tionelle MRT (fMRT), MR Angiographie (MRA) und MR Spektroskopie 
(MRS) bieten weitere Funktionalität und erweitern damit den Anwendungs-
bereich zusätzlich. 
Die MRT hat im Vergleich zu anderen bildgebenden Verfahren, wie etwa der 
CT oder dem Röntgen, eine Reihe an Vorteilen: 
 Bei der MRT wird, anders als bei der CT oder dem Röntgen, keine 
ionisierende Strahlung, sondern ein starkes Magnetfeld eingesetzt.  
 Stoffwechselvorgänge und Funktion von Geweben und Organen kön-
nen, zusätzlich zur Anatomie, dargestellt werden. Durch einen höhe-
ren Weichteil-Kontrast (im Vergleich zur CT und dem Ultraschall) 
weist die MRT zudem eine höhere Sensitivität gegenüber Erkrankun-
gen auf. 
 Tomographische Bilder können in jeder Ebene erstellt werden, ohne 
dass der/die PatientIn bewegt werden muss. 
 Zwei- und drei-dimensionale Bilder können produziert werden. 
In der Darstellung von Knochenstrukturen (ausgenommen entzündlicher Er-
krankungen oder Tumore in den Knochen), dem Respirationstrakt und der 
Kalkablagerung in Geweben ist die MRT der CT allerdings unterlegen. Auch 
die Untersuchung sich bewegender Organe (z. B. Lunge, Herz) oder von Akut-
patientInnen (aufgrund von Lagerung und Dauer der Untersuchung) ist ein-
geschränkt.  
Als mögliche Risiken und Kontraindikationen der MRT sind zu nennen: 
 Die Gabe von Kontrastmitteln: Nebenwirkungen von Kontrastmitteln 
können in Form von Magenbeschwerden, Übelkeit und Kopfschmerz, 
Ausschlägen und Hautirritationen und, in sehr seltenen Fällen, als 
Nephrogene systemische Fibrose (NSF) auftreten. Nebenwirkungen 
sind jedoch generell selten. 
 Verbrennungen durch falsche Lagerung. 
 Implantate (Stents, Prothesen) und aktive Implantate (z. B. Herzschritt-
macher), wenn sie nicht explizit gekennzeichnet sind, sind Kontrain-
dikationen. Ferromagnetische Gegenstände (z. B. Münzen), die in das 
Magnetfeld geraten, stellen Risiken dar. 
 Klaustrophobie und Übergewicht der PatientInnen stellen relative 
Kontraindikationen dar. 
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In Österreich waren im Jahr 2013 insgesamt 153 MRT-Geräte im Einsatz, 
Österreich liegt mit dieser Gerätezahl über dem OECD Durchschnitt (18,7 
Geräte pro 1 Million EinwohnerInnen). Unabhängig vom Setting stiegen in 
Österreich die Gesamtzahlen an MRT-Untersuchungen zwischen 2009 und 
2012 um 3,3 % an, weniger als die Hälfte der Untersuchungen wurden in Spi-
tälern erbracht. Mit mehr als 100 jährlichen MRT-Untersuchungen pro 1.000 
EinwohnerInnen führt Österreich die Statistik der OECD Länder deutlich 
an, was auf einen möglicherweise übermäßigen und unangemessenen Ein-
satz der Technologie hindeutet. Diese Zahl bezieht sich auf Untersuchungs-
zahlen pro PatientIn pro Tag, wobei eine unbekannte Zahl der Untersuchun-
gen mit dem Faktor 1,9 multipliziert wird. Mehr als ein Drittel der stationär 
erbrachten MRTs waren 2012 Kopf- und Hals-Untersuchungen, am zweit-
häufigsten wurde die Wirbelsäule untersucht. Im Jahr 2012 wurden 243,9 
Millionen Euro für bildgebende Diagnostik ausgegeben, was rund 0, 8 % der 
gesamten Gesundheitsausgaben ausmacht. 
Derzeit wird die Angemessenheit bildgebender Verfahren in Diagnostik und 
Screening zunehmend diskutiert. Eine angemessene Untersuchung führt zu 
einer Diagnose und einer Veränderung der Therapie(planung). Unangemes-
sene und/oder übermäßige Verwendung kann dagegen zu Kosten führen, ohne 
dass klinische Ergebnisse erzielt werden: nicht nur Kosten, die direkt mit der 
Untersuchung zusammenhängen, sondern auch Folgekosten, die durch The-
rapie und Follow-up entstehen, durch steigende Wartezeiten und vermehrte 
Krankenstandstage. Zudem können für die/den PatientIn negative Konse-
quenzen wie unnötige Tests und Behandlungen, Stigmatisierung und Angst 
entstehen. 
Das in der internationalen Literatur beschriebene Ausmaß an unangemes-
senen Untersuchungen durch bildgebende Verfahren variiert stark und hängt 
von verschiedenen Faktoren ab: der Untersuchungsmethode, bestimmten In-
dikationen, der zuweisenden medizinischen Fachrichtung, dem Setting (intra- 
oder extramural) sowie von den Kriterien, durch die Angemessenheit be-
stimmt wird. 
 
Ziel und Forschungsfragen 
Ziel des vorliegenden Berichts ist die Identifikation von Strategien und Maß-
nahmen, um den unangemessenen Einsatz der MRT in Österreich zu redu-
zieren. Zudem werden explizite Empfehlungen gegen den Einsatz der MRT 
für bestimmte Indikationen identifiziert. 
Folgende Forschungsfragen wurden untersucht: 
1. Welche Kriterien definieren Angemessenheit bzw. Unangemessenheit von 
MRT in Diagnostik und Screening? 
2. Welche expliziten Empfehlungen gegen den Einsatz von MRT unter be-
stimmten Voraussetzungen und für bestimmte Indikationen gibt es?  
3. Welche Instrumente und Steuerungsmechanismen werden zur Bewältigung 
der unangemessenen Anwendung der MRT empfohlen? Gibt es wissen-
schaftliche Nachweise für die Effektivität dieser Instrumente und Mecha-
nismen? 
4. Wie wird die MRT derzeit in Österreich genutzt: welche Kriterien und 
Mechanismen werden eingesetzt, um den Einsatz existierender MRT-Ge-
räte zu steuern? 
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Methoden 
Im vorliegenden Bericht wurden drei Methoden-Ansätze verfolgt. Zunächst 
wurden öffentlich verfügbare internationale Empfehlungen gegen den Ein-
satz der MRT für bestimmte Indikationen analysiert und mit der österrei-
chischen „Orientierungshilfe Radiologie“ verglichen. Eine Literatursuche 
wurde durchgeführt, um Strategien und Instrumente zu identifizieren, die 
für das Nutzenmanagement („utilisation management“) von MRT eingesetzt 
werden. Gleichzeitig wurden dokumentierte Erfolge im Rahmen von Pilot-
projekten identifiziert. Anschließend wurden Interviews mit österreichischen 
Stakeholdern geführt, in welchen deren Meinung zu derzeitigen und mögli-
chen zukünftigen Steuerungsmaßnahmen für einen angemessenen Einsatz 
der MRT im österreichischen Kontext erfragt wurde. 
 
Ergebnisse 
Definition von Angemessenheit und Unangemessenheit der MRT 
Generell wird die Angemessenheit eines Tests oder einer Behandlung defi-
niert durch Nutzen, Risiko, vorhandene Ressourcen und individuelle Cha-
rakteristika von PatientInnen. Grundsätzlich gilt eine Untersuchung als an-
gemessen, wenn der erwartete Gesundheitsnutzen die zu erwartenden nega-
tiven Folgen übersteigt.  
Der unangemessene Gebrauch von Gesundheitstechnologien kann unter-
schiedliche Ausprägungen und Ursachen haben und beinhaltet sowohl deren 
falschen als auch übermäßigen Gebrauch. Einige der Hauptgründe für un-
angemessenen Einsatz sind: 
 unnötige Wiederholung von Untersuchungen 
 Untersuchungen die nicht zu einer Änderung im  
PatientInnenmanagement führen 
 zu häufige Untersuchungen 
 falsche Untersuchungen 
 fehlende klinische Information und das Fehlen von relevanten  
Fragestellungen 
 übermäßige Untersuchung („over-investigation“) 
Ein anderer Aspekt, der im Zusammenhang mit der MRT und anderen bild-
gebenden Verfahren diskutiert wird, ist „Overdiagnosis“. Diese tritt auf, wenn 
bei asymptomatischen Personen eine Erkrankung diagnostiziert wird, die bei 
ihnen weder zu Symptomen noch zu einem frühzeitigen Tod führen wird. 
Eigentlich gesunde Personen werden demnach als krank klassifiziert. Folgen 
können neben unnötigen Tests und Behandlungen auch Angst und Stigmati-
sierung sowie die Verschwendung limitierter Ressourcen sein. Zugrunde lie-
gende Ursachen sind technologischer Fortschritt, kulturelle Normen, kom-
merzielle Interessen, gesetzliche Anreize und erweiterte Krankheitsdefinitio-
nen. 
 
Empfehlungen gegen den Einsatz der MRT 
Immer mehr internationale Programme und Initiativen entstehen, die den 
unangemessenen Einsatz von Gesundheitstechnologien eindämmen wollen, 
indem konkrete Empfehlungen formuliert werden, die sich sowohl an Ärz-
tInnen und andere Gesundheitsberufe als auch an PatientInnen/Konsumen-
tInnen richten.  
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Im vorliegenden Bericht wurden die Empfehlungen sechs internationaler, 
öffentlich zugänglicher Programme analysiert: 
 Choosing Wisely® Kampagne (USA) 
 Choosing Wisely Canada Kampagne (Kanada) 
 NICE ‘Do not do’ Datenbank und NICE ‘referral advice’ Datenbank 
(Vereinigtes Königreich) 
 Appropriateness Criteria® des College of Radiology (USA) 
 CAR Referral Guidelines (Kanada) 
 ACCF Appropriate Use Criteria (USA) 
Insgesamt wurden 253 Empfehlungen identifiziert, von denen ein Großteil 
von den Appropriateness Criteria® des College of Radiology stammt. Die 
Empfehlungen wurden nach betroffenem Körperteil klassifiziert und anhand 
unterschiedlicher Charakteristika analysiert (siehe Kapitel 4.2). 
Folgende Erkenntnisse wurden erzielt: 
 Die meisten Empfehlungen gegen den Einsatz der MRT (21 %) be-
ziehen sich auf Kopf- Untersuchungen (inkl. Schädel und Gehirn). 
 69 % der Empfehlungen raten von einem Einsatz der MRT als Me-
thode zur Erstdiagnose ab (z. B. vor einer Ultraschall- oder Röntgen-
untersuchung). 
 Das Fachgebiet, auf das sich der Großteil (27 %) der Empfehlungen 
bezieht, ist die Onkologie. 
 Aufgrund von Unterschieden in der Anzahl an Empfehlungen und der 
unterschiedlich detaillierten Beschreibung der Krankheitsbilder, ist die 
Anzahl an programm-übergreifenden Empfehlungen gering. Die um-
fassendste Übereinstimmung, auch mit der Orientierungshilfe Radio-
logie, gab es für die Diagnose von unkomplizierten Rückenschmerzen 
(keine MRT ohne „Red Flags“). 
 Wo ein direkter Vergleich möglich war, stimmten die internationalen 
Empfehlungen gegen den Einsatz der MRT zum Großteil mit jenen 
der Orientierungshilfe überein. Gründe für differierende Empfehlun-
gen (13 Abweichungen wurden identifiziert) sind möglicherweise Zie-
le und Methoden der Empfehlungsentwicklung, widersprüchliche Evi-
denz, variierende Kriterien und das Detailniveau der Beschreibung 
von Krankheitsbildern und Interventionen. Die Orientierungshilfe be-
inhaltet eine wesentlich gröbere und weniger differenzierte Klassifi-
kation und Beschreibung (z. B. in Bezug auf die Verwendung von Kon-
trastmitteln) der verschiedenen Krankheitsbilder und Interventionen 
als viele der internationalen Empfehlungen. Zudem sind nicht alle 
Situationen, die von den Empfehlungen beschrieben werden, in der 
Orientierungshilfe enthalten. Insgesamt wurde für rund 60 analysierte 
Empfehlungen eine direkte Entsprechung in der Orientierungshilfe 
identifiziert. 
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Evidenzbasierte Guidelines definieren die Angemessenheit von bildgebenden 
Verfahren für bestimmte Krankheitsbilder. Unterschiedliche Faktoren – so-
wohl auf Seiten der ÄrztInnen als auch der PatientInnen – können der Um-
setzung dieser Guidelines im Weg stehen und somit den unangemessenen 
Einsatz bildgebender Verfahren befördern. 
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Interventionen gegen den unangemessenen Einsatz bildgebender Verfahren 
wurden durch eine Literatursuche identifiziert und durch die Erkenntnisse 
aus den Stakeholder-Interviews ergänzt. Viele unterschiedliche Interventio-
nen können eingesetzt werden, um den angemessenen Einsatz bildgebender 
Verfahren zu steigern. Nach der Taxonomie der Cochrane Effective Practice 
and Organisation of Care (EPOC)-Arbeitsgruppe, können solche Interven-
tionen in vier Kategorien eingeteilt werden, wobei jeweils unterschieden wird, 
ob ÄrztInnen oder PatientInnen Ziel der Intervention sind: 
Bildungsmaßnahmen 
 Entwicklung und Verbreitung von Richtlinien für die ZuweiserInnen, 
basierend auf Evidenz und Konsensprozessen. 
 Entwicklung von „Decision support tools” (Entscheidungshilfen) wie 
diagnostischen Pfaden, klinischen Entscheidungsregeln und eventuell 
elektronischen Entscheidungshilfen. 
 Verbreitung von Spitalsdaten zum Einsatz bildgebender Verfahren, ge-
meinsam mit Guidelines, um die öffentliche Wahrnehmung von über-
mäßigem Gebrauch zu steigern. 
 Training mit fingierten PatientInnen, um ZuweiserInnen Übung zu 
geben, den wachsenden Forderungen der PatientInnen gegenüber zu 
treten. 
Regulatorische und finanzielle Maßnahmen 
 „Pay-for-performance”-Modelle, basierend auf robusten Messgrößen 
und Instrumenten für Leistungserbringung. 
 Gedeckelte Bezahlungsmodelle mit fixen Zahlungen pro PatientIn, 
unabhängig von der Anzahl an Behandlungen. 
 Zusatzzahlungen der PatientInnen.  
 Zulassung von AnbieterInnen bildgebender Verfahren, um  
Selbstzuweisungen zu limitieren. 
 Streichung von nachgewiesen ineffektiven Leistungen aus dem  
Leistungskatalog. 
 Formelle Bewilligung geplanter Technologien/Verfahren durch die 
Versicherungen. 
Organisatorische und strukturelle Maßnahmen 
 Revidierung der Berufsrollen: „Gatekeeper”-Funktion der praktischen 
ÄrztInnen, sowie ExpertInnen- und BeraterInnenrolle der RadiologIn-
nen.  
 Schaffung multi-disziplinärer Teams, um die Expertise von Zuweise-
rIn und RadiologIn zu kombinieren und den Einsatz bildgebender 
Verfahren in Spitälern zu koordinieren. 
 „Point-of-care”-Beteiligung der RadiologInnen durch Telefonberatung 
(Hotlines) oder „radiology benefits manager“ (externe BeraterInnen). 
 Standardisierte digitale Zuweisungen, um die Vollständigkeit der Zu-
weisungsinformation zu gewährleisten, eventuell gemeinsam mit elek-
tronischem „Decision support“. 
 Qualitätssteigerung durch Monitoring der Nutzung bildgebender Ver-
fahren, gemeinsam mit entweder öffentlicher Berichterstattung oder 
mit zielgerichteten Ausbildungsbesuchen bei ZuweiserInnen mit un-
gewöhnlichen Zuweisungsmustern. 
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In einigen ausgewählten Projekten konnten durch Bildungsmaßnahmen, 
Entscheidungshilfen („Decision support tools“) oder fixe Zahlungsmodelle 
nachweislich Erfolge in der Reduktion unangemessener Untersuchungen 
mit bildgebenden Verfahren erzielt werden. Generell ist die Erfolgsaussicht 
auf eine Veränderung der derzeit herrschenden Kultur größer, wenn mehre-
re Maßnahmen als „Paket“ eingesetzt werden. 
Folgende Erkenntnisse wurden aus der Befragung österreichischer Stakeholder 
gewonnen: 
 Derzeitige Arbeitsabläufe erlauben keine Einbindung der Expertise der 
RadiologInnen in den Entscheidungsfindungsprozess. 
 Es gibt einen Bedarf an Fortbildung und Training für ZuweiserInnen 
zum Thema angemessener Einsatz bildgebender Verfahren.  
 Derzeitige Entscheidungshilfen bestehen hauptsächlich aus der Öster-
reichischen „Orientierungshilfe Radiologie” und gelegentlichem, un-
regelmäßigem Austausch zwischen RadiologInnen und ZuweiserInnen. 
 Forderungen von PatientInnen werden als Ursache für unangemesse-
nen Gebrauch bildgebender Verfahren angesehen. 
 Standardisierter Informationsaustausch könnte zu einem verbesserten 
Nutzungsmanagement beitragen. 
 Externes Monitoring/“pay for performance” ist im derzeitigen Kosten-
erstattungs-Modell schwierig zu implementieren. 
 Die derzeitige Form der Vorab-Autorisierung durch den chefärztlichen 
Dienst ist unzureichend, um den unangemessenen Einsatz bildgeben-
der Verfahren zu reduzieren.  
 
Schlussfolgerung und Empfehlungen 
Der Großteil der identifizierten Empfehlungen gegen den Einsatz der MRT 
beziehen sich auf MRT als Methode zur Erstdiagnose: das lässt darauf schlie-
ßen, dass es von besonderer Bedeutung ist, PatientInnen, basierend auf gründ-
licher klinischer Untersuchung, streng auszuwählen, bevor sie zu einer MRT 
überwiesen werden. Sowohl die Literaturübersicht als auch die Interviews zei-
gen, dass die Bestimmung der Angemessenheit bildgebender Verfahren kom-
plex ist und Training, Expertise und Erfahrung verlangt, welches Zuweise-
rInnen oder jungen SpitalsärztInnen oftmals fehlt. Zusammen mit einer Pra-
xis der Defensivmedizin und steigenden PatientInnenforderungen kann das 
wesentlich zu einem übermäßigen Gebrauch bildgebender Diagnostik beitra-
gen. Die Interviews machen deutlich, dass die Orientierungshilfe Radiologie 
einen hohen Bekanntheitsgrad und eine große Akzeptanz in Österreich er-
reicht hat, während andere Programme und Initiativen entweder unbekannt 
sind oder als Grundlage von (negativen) Entscheidungen nicht akzeptiert wer-
den. Es scheint daher ratsam, die breite Akzeptanz der Orientierungshilfe zu 
nutzen und detaillierte Empfehlungen, auch gegen den Einsatz der MRT, in 
die Guideline aufzunehmen. 
Aufgrund der großen Zahl an MRT-Indikationen wäre es sinnvoll, Manage-
mentmaßnahmen auf ausgewählte Indikationen zu konzentrieren, anstatt glo-
bal Entscheidungshilfen einzusetzen. Die Auswahl dieser Ziel-Indikationen 
sollte auf nachgewiesen hohen Zahlen zum unangemessenen Nutzen, häufi-
gem Einsatz und hohen Kosten basieren. 
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Detailliertere Guidelines für ZuweiserInnen, die diese dazu ermutigen, dif-
ferenzierte Entscheidungen zur Angemessenheit von bildgebenden Verfahren 
zu treffen, sind ein wichtiges Element zur Steigerung der Angemessenheit. 
Die Ergebnisse der Literaturübersicht weisen jedoch darauf hin, dass Guide-
lines durch Bildungsmaßnahmen für ZuweiserInnen und PatientInnen er-
gänzt werden sollten. Die identifizierten Maßnahmen sind Entscheidungs-
hilfen für ZuweiserInnen, Training für den Dialog mit PatientInnen und öf-
fentliches Bewusstsein zu übermäßigem Gebrauch und verfügbaren Guide-
lines. Diese Ergebnisse decken sich auch mit den Ansichten der Österreichi-
schen Stakeholder, die ebenso einen Bedarf an Fortbildung und Training für 
ZuweiserInnen sehen. 
 
Wir empfehlen: 
 prospektive Studien zur Nutzung und Angemessenheit der MRT, unter 
Verwendung vorab spezifizierter Kriterien für Angemessenheit in aus-
gewählten Indikationen,  
 die Auswahl von Verfahren, basierend auf Daten zu hoher regionaler 
Variabilität in der MRT-Nutzung und basierend auf Indikationen, wel-
che häufig durchgeführt werden und hohe Kosten verursachen, für die 
die Einführung von Maßnahmen gerechtfertigt wäre, 
 das Pilotieren dieser Interventionen in „motivierten“ Spitälern sowie 
Monitoring, Evaluierung und Publikation der Ergebnisse, 
Ergänzt durch: 
 einen Konsensusprozess zu Angemessenheitskriterien und die Adap-
tion der „Orientierungshilfe Radiologie” für ausgewählte Indikationen, 
basierend auf Gebieten mit fehlendem Konsensus zwischen der Ori-
entierungshilfe und den internationalen Empfehlungen,  
 Entscheidungshilfen für ZuweiserInnen und PatientInnen und 
 öffentlicher Bewusstseinsbildung zu Overdiagnosis und übermäßigem 
Einsatz bildgebender Diagnostik. 
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1 Introduction 
Magnetic resonance imaging (MRI) is a tomographic imaging technique used 
to investigate the morphology and function of tissue and organs of the human 
body. Emerging in the 1970ies, MRI (also referred to as nuclear magnetic re-
sonance imaging [NMRI] or magnetic resonance tomography [MRT]) is tech-
nically advancing ever more rapidly, and is increasingly applied for a wide 
range of indications [3]. Faster imaging techniques allow a reduction of time 
needed to acquire image data [3, 4]. 
Currently, however, the appropriateness of diagnostic imaging is increasingly 
debated. In a recent publication on 26 low-value medical procedures, 12 in-
volved medical imaging among several categories: diagnostic, preventive and 
preoperative testing [1].  
Estimates of inappropriate imaging are reported to amount to up to 30%, or 
even up to 77% inappropriate use for certain applications [5]. The proportion 
of inappropriate imaging is however very variable and depends on different 
factors such as the imaging technique, specific indications, the medical spe-
cialty requesting the orders, inpatient vs. outpatient setting, and the appro-
priateness criteria used. In the following we aim to present this variability of 
estimates. 
Using the RAND1 methodology of generating appropriateness scores for med-
ical tests and procedures [6], Emery et al. prospectively defined appropriate-
ness of MRI outpatient requests and matched them to 2,000 outpatient req-
uisitions (1,000 for lumbar spine MRI and 1,000 for head MRI for headache). 
This Canadian study found 28.5% of lumbar spine MRI requests inappropri-
ate, and an additional 27.2% of uncertain value; inappropriateness of lum-
bar spine MRI was high across most indications [7]. In contrast, most MRI 
scans for headache (82.2%) were found appropriate in this study. An analy-
sis of computer tomography (CT) and MRI requests across indications in Brit-
ish Columbia (Canada) using a five-point rating scale for appropriateness 
based on Canadian Association of Radiologists (CAR) guidelines and a meta-
analysis of other guidelines found the rates of inappropriate imaging account-
ing to only 2% [8]. A survey of inappropriate use of MRI in a Finnish Uni-
versity Hospital using the European Commission (EC) referral guidelines, 
found 7% inappropriate examinations [9]. An Italian study on outpatient re-
quests found 22% of requested radiological examinations not indicated ac-
cording to Italian national guidelines [10]. In an analysis of outpatient refer-
rals for CT and MRI using on evidence-based appropriateness criteria from 
a radiology benefit management company 35% of referrals for MRI of the spine 
and 37% for MRI of the shoulder were considered inappropriate [11]. 
Analyses of imaging use for staging of low-risk prostate cancer based on hos-
pital [12] or SEER2-Medicare [13] databases revealed a significant overuse of 
pre-operative imaging, despite the non-recommendation according to current 
guidelines. Choi et al. also identified significant geographic variation in im-
aging use [13]. 
                                                             
1 Named after the RAND corporation, that developed them. 
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A different approach quantifies rates of overutilization by comparing the 
number of scans ordered following a thorough evaluation of clinical history, 
previous imaging and physical examination by a specialist to the numbers of 
MRI carried out if MRI is used routinely for pre-evaluation screening. For 
shoulder MRI, this led to an estimate of 90% over-utilisation [14]. Another 
study analysed foot or ankle scans performed prior referral to a foot and an-
kle specialist and found 87% of pre-referral scans unnecessary [15]. 
Total numbers of MRI examinations in Austria increased from 974,818 to 
1,006,673 between 2009 and 2012 (Table 2.3-2). With these numbers, Austria 
is amongst the OECD countries with the highest numbers of examinations 
per 1,000 population (Figure 2.3-6), indicating potential over-utilisation of 
MRI. The aim of this report was therefore to identify strategies and oppor-
tunities to decrease inappropriate use of MRI in Austria. 
 
 
The following research questions were addressed: 
1. Which criteria define ‚appropriateness/inappropriateness’ of MRI for  
diagnosis and screening? 
2. What recommendations exist regarding circumstances and indications  
in which MRI should explicitly not be used?  
3. Which instruments and regulatory mechanisms are recommended to tackle 
the problem of inappropriate imaging? What evidence is available on the 
effectiveness of those interventions on reducing inappropriate use of MRI? 
4. How is MRI currently being used in Austria: which criteria and mecha-
nisms are applied for controlling the utilisation of existing MRI scanners? 
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2 Background 
2.1 MRI: technology, advantages and disadvantages 
The basis of MRI is a resonance phenomenon: if an external magnetic field 
(formed by the MRI scanner) is applied, the magnetic moments of atomic 
nuclei are forced to align with the direction of this field. The strength of the 
magnetic field is measured in Tesla (T). Most commonly used MRI units are 
whole-body systems with magnetic field strengths of 1.5T or 3T [16]. 
The whole MRI system is managed and controlled by a computer system that 
also constructs, stores and analyses the final images. 
MRI offers some advantages compared to other imaging techniques: First, no 
ionising radiation is used for MRI in contrast to e.g. computed tomography 
or X-ray. Physiological reactions to the non-ionising radiation do not accu-
mulate over years as the effects of ionising radiation do [3]. Second, it has 
the ability to show metabolism and function in addition to anatomy and has 
a higher soft tissue contrast than computed tomography (CT) or ultrasound 
[3, 4], resulting in high sensitivity to disease [17]. Third, tomographic imag-
es of any plane can be provided without moving the patient. And forth, 2- and 
3-dimensional images can be produced [16]. 
As no ionising radiation is used, MR imaging is generally considered a safe 
procedure [18, 19] that may also be used in pregnant women and children. 
The safety of MRI during pregnancy, in particular during the first trimester, 
is, however, not entirely proven and should therefore be thoroughly consid-
ered [17]. 
Due to its technical characteristics, application areas for MRI range from 
screening (e.g., for ovarian cancer), initial diagnosis, follow-up and staging 
(e.g., of prostate cancer) to monitoring (=surveillance; e.g., for breast cancer 
recurrence).  
 Screening is meant to look for conditions in patients without having 
symptoms of the respective condition, either generally or limited to 
persons with known risk factors.  
 The initial diagnostic procedure is the first study performed to deter-
mine or exclude a specific disease in a person showing up with com-
plaints or symptoms.  
 A follow-up on the initial diagnostic procedure, i.e. a procedure per-
formed subsequently, may be eligible if initially received results are 
non-specific and require further investigation.  
 If the disease is already known but the severity and advancement is 
unclear, staging may help to plan further treatment and assess the state 
of the disease.  
 Monitoring (or surveillance) is meant to observe changes over time in 
patients already known to have or suspected to have a certain disease. 
Patients are monitored to either check treatment adequacy and/or 
monitor for progression in severity of chronic diseases. After treatment, 
patients are monitored for side effects or recurrence of the disease [20].  
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Several specialised applications, like functional MRI (fMRI), MR angiography 
(MRA) and MR spectroscopy (MRS) provide an enhanced scope of applica-
tion by offering added functionality and advantages compared to other tech-
nologies: 
 Functional MRI is a neuroimaging technique used for non-invasive 
indirect measurement of neural activity and for imaging of activated 
cortical areas. As brain stimulation is correlated with an increase of 
metabolic activity of the respective brain area, human brain activity 
can be imaged due to changes in blood flow and volume.  
 Magnetic resonance angiography (MRA) uses MRI methods in order 
to provide images of the blood vessel morphology [17]. In addition, 
MRA (in combination with MRI) is used to investigate blood volume 
flow, perfusion and velocity in the diagnosis of vascular diseases [16].  
 MR spectroscopy is based on the physical principles of proton nucle-
ar magnetic resonance spectroscopy. The technique is applied for the 
diagnosis of metabolic changes relating to developmental and patho-
logic neurological conditions [3]. 
MRI is inferior to CT scanning in picturing bony structures (because of the 
low water and fat content of bone tissue), the respiratory tract and calcifica-
tion of tissue (e.g., in patients with osteoporosis). Also, the examination of 
moving organs (e.g., the lungs, the heart or peristaltic movement) or acute 
patients (due to positioning and time issues) may be unfeasible. Due to in-
creased blood emergence in the affected area, bone diseases like inflamma-
tion or tumours are, however, better detected by MRI when compared to CT 
or X-ray [3]. 
Despite several advantages, some contra-indications, safety risks and poten-
tial adverse events – not only for the patient but also for staff and other per-
sons in vicinity of the magnetic field [21] – need to be considered. 
For several diagnostic questions, the intravenous application of a contrast 
agent is required to increase the sensitivity and specificity and, thus, the di-
agnostic accuracy of MRI. Although MRI contrast agents are reported to be 
rather safe, some adverse events (AEs) have been described in the literature 
due to their inherent toxicity [3]. The overall incidence of AEs for Gadolini-
um-based agents – the ones most commonly used in clinical practice – was re-
ported to be between 0.17% and 0.48% [22, 23] and 0.93% respectively [24]. 
In the two former studies, 2-5% of those were classified as being severe [22, 
23], whereas in the latter, none were [24]. Common non-allergic reactions in-
clude gastrointestinal disorders, nausea, headache and vomiting, whereas typ-
ical allergic reactions include hives and skin irritation. Rarely, life-threaten-
ing reactions such as chest tightness, respiratory distress and peri-orbital oe-
dema can occur [3, 22, 23]. A relationship between the intravenous admin-
istration of the Gadolinium-based contrast agent gadodiamide and the occur-
rence of nephrogenic systemic fibrosis (NSF), a severe but rare disease oc-
curring in patients with kidney dysfunction, has been described by the Food 
and Drug Administration (FDA) in 2010 [25].  
Ferromagnetic materials (e.g., coins, keys, etc.) entering the inhomogeneous 
magnetic field of an MRI scanner pose a great risk to the patient, as they can 
become deadly projectiles [3, 26]. This requires that all persons entering the 
examination area are thoroughly screened for metallic objects. 
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Implants (e.g., stents, prostheses) or other metallic objects (e.g., bullets) may 
be a contraindication to MRI scanning if they contain ferromagnetic parts, 
possibly damaging surrounding tissue, vessels and nerves and/or the device 
itself [3, 27]. However, patients with certain ferromagnetic implants may 
undergo MRI examination with low magnetic field strength if the implant is 
held in place by retentive forces, will not heat a lot and does not threaten 
surrounding vital structures [28]. 
Intrauterine contraceptive devices (IUD) are usually made of plastic, contain-
ing an active Copper element. These objects are considered safe for patients 
using MR scanners operating at 1.5 Tesla or less [29]. 
Active implants or life-support systems (e.g., pacemakers and cochlear im-
plants) are contraindications to MRI scanning if their safety is not explicitly 
stated. The magnetic field can change or derogate their function, lead to ex-
cessive heating or damage certain components in addition to risks already 
mentioned above [27, 28]. However, several MRI-compatible pacemakers have 
already been developed and are brought to the market increasingly. 
Severe burns at skin-to-skin contact zones can occur when the positioning of 
arms and legs of the patient creates a closed conductive loop. Additionally, 
contact with heated metallic objects (e.g., metal in clothing, coils) may cause 
burns to the patient [3, 27]. In several studies, temporary and dose-related ver-
tigo and nausea have been reported at field strengths higher than 2T [30, 31]. 
Claustrophobia and obesity are relative contraindications to MR imaging [17]. 
Table weight limits (~160kg-250kg depending on scanner type) and bore di-
ameters (~60 cm) of MRI scanners may limit the usability of MRI for the 
evaluation of obese patients [32, 33]. 
 
 
2.2 Evidence based imaging 
2.2.1 Clinical utility of diagnostic tests 
The utility of any diagnostic test depends on the ability of the assay to im-
prove clinical decision making and patient-relevant outcomes, as compared 
to the current test and treatment strategy. Patient-relevant outcomes are  
 reduction of mortality,  
 increased quality of life,  
 reduction of adverse events and  
 positive consequences resulting from the avoidance of further,  
potentially invasive tests or toxic therapies 
Clinical utility of diagnostic imaging is rarely supported by high levels of ev-
idence from randomised controlled trials (RCT) (Table 2.2-1). Instead most 
studies of diagnostic imaging focus on diagnostic accuracy. Diagnostic accu-
racy describes the correlation of test results with the results of a reference 
standard. The use of diagnostic accuracy estimates alone as surrogates for 
patient outcomes is, however, limited due to the following factors: 
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 A widespread misconception is that high sensitivity and high specifici-
ty of a test translates in high certainty about the presence or absence 
of a condition in case of a positive or negative result. The probability 
for a certain health status after testing (the so-called post-test probabil-
ity) is, however, dependent on the probability before testing (so-called 
pre-test probability). Even a very accurate test may add little to clini-
cal management decisions if the pre-test probability for the tested con-
dition is very low. Advanced imaging should therefore preferentially 
be used after evaluation of clinical history and physical examination 
by a specialist [14, 15]. 
 Diagnostic accuracy cannot be reliably estimated if no or only a poor 
reference standard is available and if not all study participants are 
tested with a reference standard. Only estimates from high quality di-
agnostic accuracy studies should be considered [34]. 
 Diagnostic accuracy parameters only describe the capacity of a diag-
nostic procedure to identify one defined medical condition. Outside 
this original purpose, however, advanced medical imaging may pro-
duce incidental findings at often high rates. For example, in neuro-
logically asymptomatic people, the crude prevalence of incidental find-
ings on brain MRI is 2.7% or 1 in 37 [26]. Incidental findings are prob-
lematic, if there are no treatment options, as their discovery may have 
other harmful consequences for the patient, including anxiety or other 
implications such as e.g. loss of life insurance. 
Table 2.2-1: Evidence hierarchies by research questions 
Evidence Level Clinical utility for diagnostic research questions Diagnostic Accuracy3 
High I Systematic reviews and RCTs with patient 
relevant outcomes 
Diagnostic accuracy study with  
 Independent blinded comparison 
 Valid reference standard 
 Consecutive patient sample 
 Defined clinical presentation 
Moderate II Studies on surrogate outcomes  
(Changes in patient management based on post-
test probability) 
Diagnostic Accuracy Study not 
meeting the criteria for level II; 
Diagnostic case-control study 
Low III Studies on diagnostic accuracy Diagnostic Accuracy Study with  
poor reference standard;  
Very low IV Studies on technical accuracy Study of diagnostic yield 
Source: ([35-37]) 
 
Currently, only 14 studies are registered at clinicaltrials.gov with the search 
terms „randomised controlled trial | Study type: Interventional Studies | In-
tervention: Magnetic resonance imaging” (search results). 
                                                             
3 This column only applies to reviews of diagnostic accuracy. For the evaluation of 
the impact of a diagnostic test on health outcomes, the “intervention” column should 
be used. 
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In summary, the appropriateness of an imaging test is defined not only by 
test performance characteristics for a clinical indication, but also of the po-
tential negative consequences of imaging, an understanding of the implicit 
impact on clinical decision making, and an explicit understanding of how the 
test results might lead to care that could improve the patient’s chances for 
better survival or improved health status [38]. 
 
2.2.2 Referral guideline development 
With the Council Directive 97/43/Euratom European and International Leg-
islation related to radiation protection requires effective justification of imag-
ing tests involving radiation based on evidence-based guidance. As a conse-
quence a process of developing imaging referral guidelines were initiated in 
all European Union (EU) member states, including Austria [39]. Due to the 
paucity of higher levels of evidence (Table 2.2-1), most guidelines base their 
recommendations on results from diagnostic accuracy studies and expert con-
sensus. The total number of available guidelines on radiology are seen as a po-
tential barrier for adoption and adherence, and proposed solutions include 
international cooperation to develop fewer, internationally agreed guidelines 
[40]. European referral guidelines are available, but are currently updated [41]. 
As part of the European Commission (EC) Imaging Referral Guidelines Pro-
ject, a workshop amongst 60 participants formulated recommendations for 
future development of radiology guidelines in Europe [40]: 
 Stronger measures should be taken by the EC and the European com-
petent authorities for making Guidelines available and used in all EU 
member states. 
 Evidence-based Guidelines with separate guidance for children should 
be issued or endorsed by a trusted European organisation. 
 Educational initiatives and electronic requesting in connection with 
clinical decision support (CDS) systems should be used to improve the 
implementation of Guidelines. 
 Monitoring of Guidelines implementation and use should be by clin-
ical audit, particularly external audit, but also by local/internal audit. 
 
Orientierungshilfe Radiologie  
(Austrian Orientation Guideline Radiology) 
The Austrian Radiology Guideline was developed in 2011 and was edited by 
Verband für Bildgebende Diagnostik Österreich (Association imaging diag-
nostics Austria), Bundesfachgruppe Radiologie der Österreichischen Ärzte-
kammer (Radiology expert group of the Austrian medical association), Öster-
reichische Röntgengesellschaft (Austrian Radiology Association) and Verband 
für medizinischen Strahlenschutz Österreich (Association of medical radia-
tion protection in Austria). It aims at supporting referring physicians, radio-
logists and other health care providers in making the right choices relating 
to the utilisation of diagnostic imaging procedures in clinical practice. In 
addition, it aims at forcing a unified imaging strategy throughout Austria to 
facilitate the best possible health care quality and the most reasonable re-
source allocation. 
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Various work groups conducted autonomous literature searches in Medline, 
the Cochrane Library, the National Institute for Health and Care Excellence 
(NICE) and radiology journals to identify relevant evidence serving as a basis 
for recommendations. In addition, the US-American ACR Appropriateness 
Criteria and recommendations from the Royal College of Radiologists (GB) 
were consulted. Formulated recommendations were reviewed by selected ra-
diologists and nuclear medical scientists in Austria. Scientific societies accred-
ited to the Austrian medical Association were consulted for comments [42]. 
Updates of the recommendations are planned for every 4 years, meaning that 
a new version is scheduled to be published in 2015. Recommendations are 
rated according to 5 categories [42]: 
 Indicated for initial diagnosis: should be applied primarily 
 Indicated for follow-up diagnosis 
 Indicated after observation: applies for clinical situations with symptoms 
that usually disappear after a certain period of time; utilisation is in-
dicated when symptoms persist 
 No routine indication: may be appropriate under certain  
circumstances 
 Not indicated: no benefit to be expected 
 
 
2.3 MRI in Austria 
2.3.1 Regulation, planning and reimbursement 
Medical equipment planning 
MRI-devices are – among other large medical devices – planned centrally 
within the so called Austrian structural plan for large medical equipment 
(„Österreichischer Strukturplan Gesundheit-Großgeräteplan” 2012) [43]: within 
this plan the number of MRI scanners for the in- and outpatient health care 
sectors is regulated on the national and regional level. Economic, supply- and 
quality-related factors are considered to calculate maximum amounts and 
future needs. For Austria, the nearest MRI unit needs to be in 60 minutes 
reach, the population-related reference value is 1 unit/70,000-90,000 [43].  
 
Regulations and reimbursement 
There are different modes of reimbursement for the inpatient MRI scans, for 
those performed in the ambulatory departments in hospitals, and in the out-
patient sector, resulting in varying decision making processes and responsi-
bilities (Figure 2.3-1). 
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Figure 2.3-1: Referral and reimbursement processes in Austria 
 
Hospitals, inpatient sector 
 Hospitals, inpatient sector: MRI-scans are reimbursed within the Aus-
trian hospital reimbursement system LKF/“Leistungsorientierte Kran-
kenanstaltenfinanzierung” [44], that covers services in DRG/diagnosis-
related-groups and – in cases of costly interventions such as MRI scans 
– additional tariffs are allocated for „individual medical procedures” 
(listed in the MEL/“Medizinische Einzelleistungen” benefit catalogue).  
 Until recently (2013), MRI scans performed in the ambulatory depart-
ments in hospitals were covered by the overall allocated lump sum budg-
et for those departments. Since 2014, an ambulant benefit cata-logue 
is being piloted (listed in the KAL/“Katalog ambulanter Leistungen” 
benefit catalogue) with the intention to cover the true costs of the am-
bulatory departments in hospitals. 
 MRI scans as „MELs” and as „KALs” are being documented in the 
hospitals’ standardised documentation system. MRI scans for inpa-
tient patients are ordered by hospital clinicians, performed by the ra-
diologists on duty and reimbursed within the LKF-system.  
 In the outpatient sector, MRI scans are provided by independent out-
patient clinics of radiology (imaging institutes in private practice). 
Costs for MRI are covered by social health insurance provided that 
the patient has been referred to the radiologist by a general practi-
tioner or a specialist, that the examination has been pre-authorised by 
a head physician of the health insurance and that it is carried out us-
ing an MRI scanner listed in the Austrian structural plan for large 
medical devices. The Viennese section of social health insurance has 
disestablished the process of pre-authorisation for MRI examinations 
by September 2014 [45].  
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 The social health insurances reimburse the institutes on a fee-for-service 
basis, but only up to a predefined cap of expenses, independent of the 
frequencies of the examinations. With the intention of budget consol-
idation, an agreement between social insurances and outpatient MRI 
institutes was in place from 2009 to 2013, which restricted the ex-pense 
development of the institutes to 0.5%. As of January 1st, 2014 a new 
reimbursement framework was negotiated, that includes a yearly raise 
of the expense limit, concordant with the increase of total health in-
surance contributions [46].  
 Average tariffs per scan reimbursed by social health insurances have de-
creased over the past years. MRI scans are reimbursed according to the 
so-called organ tariff: a pre-determined sum (roughly €150, [47, 48]) 
can be claimed once per day and per patient. For certain body areas 
(e.g. upper abdomen) the tariff can be multiplied by a factor of 1.9. 
 Privately paid tariffs are usually considerably higher and depend on 
the body part that is being scanned. 
The costs of an MRI scanner depends on various factors, including the field 
strength (usually ranging from 0.5T to 3T for clinical use), the type of mag-
net (e.g., permanent magnet, superconducting magnet) and the size/purpose 
of the scanner (e.g., suitable for whole body scans or only for extremity scans). 
Generally, costs range from about 120,000€ to about 1 million € [49]. 
In 2012, the overall expenditure on diagnostic imaging in Austria accounted 
for 243.9 million €, representing 0.8% of the total expenditure on health care 
[50, 51]. 
 
2.3.2 MRI utilisation in Austria 
In 2013, a total of 153 MRI scanners were in use in Austria (excl. 16 MRI 
scanners with field strength of <1 Tesla), of which 93 were located in hospi-
tals and 60 in the outpatient sector (Table 2.3-1). The numbers of MRI scan-
ners in hospitals and outpatient imaging institutes were identified from the 
Medical equipment plan for large devices of the Ministry of Health [52]. 
Table 2.3-1: Numbers and location of MRI scanners in Austria  
 Hospitals Outpatient sector Total 
Equipment 2011 86 71 157 
Equipment 2013 93 60 153 
(Source: [52]) 
 
Total numbers of MRI examinations (2009-2012) in the outpatient sector (out-
patient imaging institutes) reimbursed by the social health insurers were pro-
vided by the Main Association of the Social Insurances. Data excluded num-
bers of Versicherungsanstalt für Eisenbahnen und Bergbau (VAEB) and Sozial-
versicherungsanstalt der Bauern (SVB). Total numbers of inpatient MRI exam-
inations in public hospitals were provided by the Ministry of Health. Data on 
MRI examinations in hospitals, including ambulatory services provided by 
hospitals were retrieved from the OECD Health statistics [53]. The results 
are summarised in Table 2.3.-2 and Figure 2.3-2. 
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Table 2.3-2: Total numbers of MRI examinations in 3 sectors, average annual and overall percentage change, 2009-2012 
 
2009 2010 2011 2012 
Average annual 
percentage 
change 
Overall  
percentage change 
(2009-2012) 
In hospitals,  
inpatient sector*** 
248,274 253,426 262,132 264,000 2.2% 6.3% 
In hospitals, ambulatory 
department** 
172,223 146,077 160,884 166,223 -1.1% -3.5% 
In outpatient sector* 554,321 562,783 574,411 576,450 1.3% 4.0% 
Total 974,818 962,286 997,427 1,006,673 1.1% 3.3% 
(* Source: HVB, **Source: OECD; *** Source: BMG) 
 
Total numbers of MRI investigations in the hospitals, inpatient sector, in-
creased from 248,274 to 264,000 between 2009 and 2012 (+6.3%). In the am-
bulatory setting of hospitals, numbers decreased from 172,223 to 166,223 be-
tween 2009 and 2012 (-3.5%). In the outpatient sector, examinations increased 
from 554,818 to 587,842 (+4.0%). Overall, there was an increase of 31,833 
MRI examinations in Austria between 2009 and 2012 (+3.3%). Less than half 
of overall investigations are carried out in hospitals (Figure 2.3-2).  
 
Figure 2.3-2: Total numbers of MRI examinations in 3 sectors, 2009-2012 
Numbers of MRI examinations categorised to individual medical procedures 
(MEL) of the medical procedures catalogue were provided by the Ministry of 
Health. Similar data for the hospital ambulatory sector and the outpatient 
sector were not available. The results are summarised in Table 2.3-3 and 
percentage numbers are represented in Figure 2.3-3. 
In 2012, more than a third of the investigations in the inpatient sector are MRI 
of the head and neck (36%); a fifth are MRI of the spine (19%), followed by 
MRI of abdomen and pelvis (11%), MR-angiography of head and neck (11%) 
and functional MRI (8%) (Figure 2.3-3). 
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Figure 2.3-3: MRI Utilisation volumes by medical procedure (body part), 2012, Hospitals, inpatient sector. 
(Data source: BMG.* MR-guided organ biopsy; MR-guided preoperative tissue marking;  
MR-guided placement of therapeutic drainages.) 
Table 2.3-3: Total numbers, average annual and overall percentage change of MRI exams  
by individual medical procedure (body part), Hospitals, inpatient sector; 2009-2012 
Individual Medical Procedure 2009 2010 2011 2012 
Average 
annual 
percentage 
change 
Overall 
percentage 
change 
(2009-2012) 
ZA030 MRI – Head and Neck 90,182 89,395 94,530 96,183 2,2% 6,7% 
ZN260 MRI of the spine 46,727 47,639 49,715 49,696 2,1% 6,4% 
ZC030 MRI – Abdomen and Pelvis 29,561 30,165 30,138 29,740 0,2% 0,6% 
ZA040 MR-Angiography – Head and Neck 23,180 25,883 28,151 29,387 8,3% 26,8% 
ZN270 Functional MRI 18,052 19,885 19,902 20,566 4,5% 13,9% 
ZE030 MRI – lower limb 13,228 12,717 12,722 12,232 -2,6% -7,5% 
ZC040 MR-Angiography – Abdomen  
and Pelvis 
9,045 9,055 9,043 8,737 -1,1% -3,4% 
ZE040 MR-Angiography – lower limb 6,991 6,466 6,242 5,909 -5,4% -15,5% 
ZD030 MRI – upper limb 4,496 4,889 4,747 4,542 0,5% 1,0% 
ZB040 MRI – Thorax 3,877 4,338 3,920 4,266 3,7% 10,0% 
ZB060 Cardiac Imaging by MRI 1,577 1,824 1,846 1,743 3,8% 10,5% 
ZB050 MR-Angiography – Thorax 859 671 701 575 -11,8% -33,1% 
ZD040 MR-Angiography – upper limb 299 273 263 216 -10,1% -27,8% 
ZN040 Organ biopsy – MR-guided 108 154 144 139 10,9% 28,7% 
ZN080 Preoperative tissue marking – 
MR-guided 
57 60 47 66 8,0% 15,8% 
ZN110 Placement of therapeutic 
drainages – MR-guided 35 12 21 3 -25,5% -91,4% 
Total 248,274 253,426 262,132 264,000   
(Data source: BMG) 
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The five areas with highest volume also show in average positive change 
rates throughout 2009 to 2012 (Figure 2.3-4). Furthermore, MRI of the up-
per limb, MRI of the thorax and cardiac imaging represent small areas of 
utilisation, but with on average positive change rates from 2009 to 2012. 
MRI and MRA of the lower limb and MRA of abdomen and pelvis have on 
average negative change rates. MR guided drainage placement, biopsies and 
tissue marking, and MR angiography of thorax and upper limb are very 
marginal applications of MRI. 
 
Figure 2.3-4: Average annual change in MRI utilisation 2009-2012 by medical procedure (body part), Hospitals, 
inpatient sector. (Source: Own presentation, data: BMG) 
Austria is well above OECD average regarding the amount of MRI units per 
million population [54]: While the OECD average is 13.3 MRI units/million 
population (in 2011 or nearest year), 18.6 units/million population were reg-
istered for Austria in 2011 [43] (Figure 2.3-5). A limitation of this indicator 
is that the number of MRI units is not necessarily an accurate representation 
of the capacity to perform MRI examinations, as some of the units might be 
also dedicated research and not fully available for clinical investigations. 
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Figure 2.3-5: MRI units per Mio population in OECD countries (2011 or nearest year) 
(Source: OECD Health Statistics 2013, http://dx.doi.org/10.1787/health-
data-en. http://dx.doi.org/10.1787/888932917256. 1Equipement outside 
hospital not included, 2Only equipment eligible for public reimbursement. ) 
The second indicator for MRI utilisation is the number of MRI exams per 
1000 population. In 2011, the OECD average was 55.5 exams per 1,000 popu-
lation [54]. We retrieved the data on MRI utilisation in other OECD coun-
tries from OECD Health statistics [53]. Utilisation per 1,000 population in 
Austria was calculated based on population data from the OECD statistics 
[53]: in 2012, 119 MRI exams per 1,000 persons were reimbursed in hospital 
and outpatient settings. According to the OECD data set, Austria is among 
the countries with the highest frequencies of MRI exams per 1,000 popula-
tion, jointly contributed by the hospital (including ambulatory services pro-
vided by hospitals) and outpatient sector (outpatient imaging institutes) [53] 
(Figure 2.3-6). An exam is defined „as a medical imaging session to study 
one (or more than one) body part that yields one or more views for diagnos-
tic purposes” ([53]: Definitions, sources and methods). National jurisdictions 
might vary in the way the numbers of examinations are counted and thereby 
distort the comparison. In Austria, e.g., MRI and MRA in the same patient 
are counted separately and certain extensive examinations in one patient are 
recorded as 1.9 examinations.  
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Figure 2.3-6: Total MRI exams per 1000 population in OECD countries (2012 or nearest year) 
(Sources: Own presentation with data from OECD health statistics [53] * Nearest year 2011; ** Nearest year 
2009. Only countries were included where available data covered hospitals and outpatient setting.) 
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3 Methods 
This report seeks to answer the following research questions: 
1. Which criteria define ‚appropriateness/inappropriateness’ of MRI for  
diagnosis and screening? 
2. What recommendations exist regarding circumstances and indications in 
which MRI should explicitly not be used?  
3. Which instruments and regulatory mechanisms are recommended to tackle 
the problem of inappropriate imaging? What evidence is available on the 
effectiveness of those interventions on reducing inappropriate use of MRI? 
4. How is MRI currently being used in Austria: which criteria and mechanisms 
are applied for controlling the utilisation of existing MRI scanners? 
 
The following methods were applied. 
 
 
3.1 Criteria for appropriateness/inappropriateness 
in diagnosis and screening 
To identify criteria that define the appropriateness or inappropriateness of 
MRI in diagnosis and screening (1st research question), a hand search was per-
formed in relevant journals and on HTA websites in June 2014 [55-60]. In 
addition, articles that were identified to answer the 3rd research question (see 
chapter 3.3) and literature describing the programmes that were identified 
for answering the 2nd research question (see chapter 3.2) were consulted to 
address this question. Besides, definitions were derived from the Preventing 
Overdiagnosis Conference that was held in Oxford, UK, on the 15th to 17th Sep-
tember 2014.  
 
 
3.2 Systematic search for recommendations 
against the use of MRI 
To identify evidence-based recommendations regarding circumstances and 
indications in which MRI should explicitly not be used in clinical practice, 6 
publicly accessible and searchable resources have been systematically 
searched in May, June and August 2014 using the search terms magnetic 
resonance imaging, MRI, imaging, MRA, MR angiography and scan: 
 The Top 5 lists of the US-American Choosing Wisely® campaign 
 The Top 5 lists of the Choosing Wisely Canada campaign 
 The UK-based NICE ‘Do not do’ database and NICE referral advice 
database 
 The Appropriateness Criteria® of the US-American College  
of Radiology 
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 The CAR Referral Guidelines 
 The ACCF Appropriate Use Criteria 
These programmes have been identified by an unsystematic hand search on 
HTA websites, applying a snowball system.  
Inclusion criteria were:  
 public availability 
 up-to dateness of recommendations (≤8 years) 
 either German or English language 
 a published description of evidence-based methods used for  
compiling the recommendations, and  
 the inclusion/consideration of diagnostic procedures  
(i.e. at least 1 recommendation regarding MRI utilisation available). 
Table 3.2-1: Programmes, dates and amount of recommendations identified 
Programme Weblink Date 
Amount of 
recommendations 
identified 
Choosing Wisely® USA http://www.choosingwisely.org/ May 2014 29 
Choosing Wisely Canada http://www.choosingwiselycanada.org/ May 2014 8 
NICE ‘Do not do’ 
recommendations and 
Referral Advice databases 
http://www.nice.nhs.uk/usingguidance/donot
dorecommendations/index.jsp 
http://www.nice.nhs.uk/usingguidance/referra
ladvice/search.jsp 
May 2014 28 
The ACR Appropriateness 
Criteria® 
https://acsearch.acr.org/list June 2014 160 
The ACCF Appropriate Use 
Criteria 
http://www.cardiosource.org/Science-And-
Quality/Quality-Programs/Imaging-in-
FOCUS/ACC-Appropriate-Use-Criteria.aspx 
August 
2014 8 
The CAR Diagnostic 
Imaging Referral Guidelines 
http://www.car.ca/en/standards-
guidelines/guidelines.aspx 
August 
2014 
17 
 
In a next step, identified recommendations were included in the analysis ac-
cording to two independent reviewers (JM, AK). Inclusion criteria were: 
 MRI-related content: recommendations were excluded if they only re-
ferred to (imaging) techniques other than MRI. Recommendations 
were included, however, when imaging in general was addressed.  
 explicit recommendation against the use of MRI for certain indications 
or circumstances. 
Selected recommendations were analysed considering the intervention, pur-
pose and indication they describe, the medical specialty they are related to, 
and according to overlaps between the programs.  
In addition, recommendations were compared to the Austrian Orientation 
Guideline for Radiology. Since the OGR did not include protocol specifica-
tions, recommendations relating to specific MRI protocol (field strength, use 
of contrast agents) were not considered in the comparison. In the Austrian 
hospital and outpatient setting, various (international) guidelines are relevant 
and being used associated with MRI decision making (e.g., the guideline on 
unsystematische 
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MRI quality assurance by the German Radiology Society4 and various guide-
lines by the German Working Group of the Scientific Medical Societies5 [Ar-
beitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften]). 
The Austrian Orientation Guideline Radiology is, however, among the most 
common and widely-used. Therefore, it serves as the Austrian standard to be 
compared with identified recommendations. 
 
 
3.3 Literature review 
To identify factors leading to inappropriate imaging and proposed interven-
tions aiming at reducing inappropriate imaging by MRI, we performed a lit-
erature search in the following databases: 
 Cochrane (23.06.14, 133 Hits)  
 CRD (26.06.2013, 90 Hits) 
 Embase (19.06.14, 483 Hits) 
 Medline (23.06.2014, 598 Hits) 
using the following keywords: 
Imaging, MRI, magnetic resonance imaging, diagnostic imaging 
AND 
Overuse, overutilization, overdiagnosis 
Appropriate use, appropriateness 
Inappropriate use, unnecessary, inappropriateness 
Utilization management 
Appropriate use criteria, appropriateness criteria 
Decision support 
The database search was complemented by a hand search in the references of 
selected key articles [60-62] which yielded additional 15 references. 
Inclusion criteria: 
 Type of article: primary and secondary research, reviews,  
meeting reports 
 Topic: Interventions targeting appropriateness of MRI utilisation – 
(as listed in the Effective Practice and Organisation of Care (EPOC) 
Taxonomy); factors leading to inappropriate use of MRI 
 Language: English or German 
Exclusion criteria:  
 Type of article: conference abstracts, letters to the editor, etc. 
 Topic: indication-specific appropriateness criteria, only referring  
to imaging methods other than MRI 
The 1304 Hits of the database search were screened by title and abstract. 117 
articles were selected and ordered as full text, of which 57 were excluded. 
From the remaining 60 articles the authors selected relevant parts by quali-
tative aspects, categorised them to interventions based on the EPOC taxon-
omy and summarised them in the present report. 
                                                             
4 http://www.drg.de/de-DE/48/leitlinien 
5 http://www.awmf.org/en/clinical-practice-guidelines.html 
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Figure 3.3-1: Prisma tree 
 
3.4 Semi-structured interviews with 
stakeholders 
The authors were interested to contrast and align the results of the literature 
review with the opinions and experiences of Austrian stakeholders to assess 
the transferability of the results to factors and interventions to the Austrian 
context. 
The interviews were conducted between 09 Sept 2014 and 10 Oct 2014 using 
a semi-structured questionnaire, with wording adapted to the different stake-
holders.  
Topics addressed were: 
 Factors leading to increased imaging utilisation and/or need 
 demographic development, technological development, patient 
demand, referral demand 
 Situations leading to inappropriate imaging utilisation 
 repeated investigation, investigation too early, wrong investigation, 
investigations with a highly unlikely or irrelevant positive result, 
incomplete referral information 
 Instrumente/ProzesseInstruments/processes in place or conceivable 
to contain  
inappropriate imaging utilisation 
 Guidelines, disinvestment recommendations, decision support 
tools, information exchange, refusal of imaging requests,  
pre-authorisation, monitoring, education 
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We identified the stakeholder groups involved in decisions on appropriate 
imaging, either in day-to-day practice with the patients or in utilisation man-
agement. These we identified to be: 
 radiologists in outpatient setting 
 radiologists in hospital setting 
 health insurers 
 health governmental representatives (medical equipment planning) 
 referrers 
We contacted representatives by a template invitation e-mail, in which they 
were informed about the general aims of the project, the function in which 
they were contacted and the following description of the aim and topic of the 
interview: „a practice-oriented insight in steering and control mechanisms 
currently used as a basis for decision making and referral processes”. We con-
tinued sampling until we had at least one representative for each stakeholder 
group. In total 16 stakeholders were contacted. five did not reply, two pro-
posed a representative and one interview was cancelled due to conflicting 
schedule, leading to a final list of 10 interviewees (Table 3.4-1). 
Table 3.4-1: List of interview partners 
Interview partner Affiliation 
Wolfgang Hofer  Leading radiologic technologist at Diagnosezentrum Urania  
(Diagnostic Center Urania), Vienna 
Prim.Univ.-Prof.Dr. Gerhard 
Mostbeck 
Otto-Wagner Spital, Vienna 
Wilhelminenspital, Vienna 
Erw. Präsidium Österreichische Röntgengesellschaft 
Dr. Christian Euler  Österreichischer Hausärzteverband 
(Austrian association of general practitioners) 
Prim. Univ. Doz. Dr. Thomas Rand Bundesfachgruppe Radiologie der österreichischen Ärztekammer – BURA 
(Expert group on radiology at the Austrian medical association) 
Krankenhaus Hietzing, Vienna 
Präsidium Österreichische Röntgengesellschaft 
Dr. Eva Maria Kulcsar-Mecsery General practitioner 
Dr. Susanne Rabady Österreichische Gesellschaft für Allgemein- und Familienmedizin – ÖGAM 
(Austrian association of general and family medicine) 
Mag. Stephan Mildschuh Gesundheit Österreich GmbH – GÖG 
Dr. Friedrich Vorbeck Diagnosezentrum Donaustadt (Diagnostic center Donaustadt), Vienna 
Bundesfachgruppe Radiologie der österreichischen Ärztekammer – BURA 
(Expert group on radiology at the Austrian medical association) 
Präsidium Österreichische Röntgengesellschaft 
Dr. Gottfried Endel Hauptverband der Österreichischen Sozialversicherungsträger – HVB 
(Association of Austrian Social Insurance Institutions) 
Univ.-Prof. Dr. Hannes 
Deutschmann 
Universitätsklinik für Radiologie, LKH- Univ. Klinikum, Graz 
(Department of radiology, University hospital Graz) 
 
Transcripts of the interviews were produced during the interviews, the tran-
scripts were sent to the interviewees for approval. 
Content of the transcripts was coded according to the framework set in the 
topic list and grouped using MAXQDA Version 11. Main messages of grouped 
citations were then translated in English. 
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4 Results 
4.1 Appropriate and inappropriate use 
of advanced medical imaging  
4.1.1 Definitions, Causes and Effects 
Appropriateness 
According to the US-based Ambulatory Care Quality Alliance (AQA), the con-
cept of „appropriateness”, as applied to health care, balances risk and bene-
fit of a treatment, test, or procedure in the context of available resources for 
an individual patient with specific characteristics [63]. Basically, ‘appropri-
ateness’ may be defined as a condition of expected health benefits of a health 
technology outweighing its expected negative outcomes, assuming that effec-
tive technologies may become inappropriate when over- or misusing them. Of 
note, a valid metric of the appropriateness of medical imaging does not only 
take into consideration spending but also utilisation [64]. 
Defining the appropriateness of diagnostic imaging, in particular MRI, for 
individual indications and in general is complex as it may vary with patient 
characteristics (e.g., age and gender) as well as with the patients’ condition and 
symptoms [65]. In addition, the appropriate use of MRI is affected by struc-
tural conditions such as the availability of a technology [65] or qualified staff. 
Further influencing factors are the rapid development of imaging technolo-
gies [60] and increasing patient demand. Potential negative consequences of 
imaging include poor specificity with a high number of false positives, result-
ing in unnecessary further procedures [38]. For a sensible definition, the eval-
uation within well-defined clinical scenarios is required [2]. 
 
Inappropriate use:  
overuse/overutilisation, misuse and wasteful use 
The inappropriate use of a certain technology may also include its overuse or 
misuse [66] and is often referred to as being ‘wasteful’. ‘Overuse/overutilisa-
tion’ is defined as the use of a technology more often than is indicated [55], 
not improving patient outcome at the same time [67], whereas ‘misuse’ can be 
described as the use of a technology for purposes other than those for which 
it was originally intended in the absence of evidence that doing so is clinically 
effective and cost-effective (for example, scope creep) [55]. Moreover, ‘waste’ 
in healthcare is being described as the excessive use of an otherwise effective 
intervention [56]. According to the European Commission Report [58], the 
chief causes of the wasteful use of radiology are: 
 Repeating investigations which have already been done 
 Investigation when results are unlikely to affect patient management 
 Investigating too often 
 Doing the wrong investigation 
 Failing to provide appropriate clinical information and questions 
that the imaging investigation should answer 
 Over-investigating 
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The use of MRI is not necessarily either appropriate or inappropriate – there 
also are applications considered ‘equivocal’, located between the two sides of 
the continuum (e.g., indicated only under specific conditions), causing no dif-
ference in expected net health outcome for a certain clinical scenario [2].  
 
Overdiagnosis 
Another aspect that is frequently mentioned in the context of MRI utilisation 
(and the use of other diagnostic technologies) is overdiagnosis. Overdiagnosis 
occurs when people without symptoms are diagnosed with a disease that ul-
timately will not cause them to experience symptoms or early death [57, 68]. 
More broadly defined, overdiagnosis refers to the related problems of over-
medicalisation and subsequent overtreatment, diagnosis creep (…) and dis-
ease mongering, all processes helping to reclassify healthy people with mild 
problems or at low risk as sick [57, 69]. Overdiagnosis may cause harm in-
ducing unnecessary labelling, unneeded tests and treatment, and wasteful re-
source allocation. Factors entailing overdiagnosis are multifaceted, including 
technological evolvement, cultural beliefs, commercial and professional vested 
interests, legal incentives and widened disease definitions [57]. A recent def-
inition [70] describes overdiagnosis in cancer screening as the detection of 
cancers that, in the absence of screening, would not present symptomatically 
during one’s lifetime.  
 
 
4.2 Identification of recommendations 
against the utilisation of MRI 
4.2.1 Programmes and databases – methods and aims 
The inappropriate use of imaging techniques is increasingly recognised as a 
serious concern regarding health care quality, patient safety and health care 
costs [71]. There is an ever-increasing amount of evidence on appropriate (and 
inappropriate) imaging utilisation, being translated into recommendations by 
a number of initiatives and programmes aiming at optimising quality and 
minimising waste to reduce the harm that results from unneeded examina-
tions. As both physicians (general practitioners and specialists) and patients 
continuously need to assess the appropriateness of imaging procedures by 
making choices in routine practice, such recommendations can help identify 
and implement best practice care. The goals and methods of the programmes 
analysed for this report are described below. More detailed information about 
the Choosing Wisely® campaign USA and the NICE ‘Do not do’ Recommen-
dations and Referral Advice Databases can be found in a previous report [72]. 
 
The Choosing Wisely® campaign USA 
The initiative was launched in 2009 by the National Physicians Alliance (NPA) 
and was further developed in 2012 when 9 specialty societies created lists of 
‘Five things physicians and patients should question’, listing 5 evidence-based 
recommendations against the use of frequently applied procedures they con-
sidered inappropriate [73, 74]. Currently, more than 50 societies have joined 
the initiative which is under the patronage of the American Board of Internal 
Medicine (ABIM) Foundation. 
es gibt auch MRT-
Anwendungen, die 
weder angemessen noch 
unangemessen sind 
Overdiagnosis kann zu 
negativen Konsequenzen 
wie unnötigen 
Behandlungen und 
Tests, Stigmatisierung 
und Angst führen 
 
eigentlich gesunde 
Personen werden als 
krank klassifiziert 
 
zugrunde liegende 
Faktoren sind komplex  
unangemessener Einsatz 
bildgebender Verfahren 
hat negative Folgen auf 
Qualität, Sicherheit und 
Gesundheitsausgaben 
 
die Anzahl an 
verfügbaren 
Empfehlungen für 
ÄrztInnen und 
PatientInnen steigt an 
die Initiative wurde 
2009 gestartet und  
2012 weiterentwickelt 
 
mehr als 50 teilnehmende 
Fachgesellschaften 
Results 
LBI-HTA | 2014 43 
The goal of the Choosing Wisely® campaign is to enhance conversation be-
tween patients and physicians about what treatment is appropriate and neces-
sary, and to provide a tool to support adequate decision making. The initiative 
aims at reducing overuse, misuse and overtreatment and supporting optimal 
resource allocation [73]. 
Recommendations are formulated by using various methods, including evi-
dence review, consensus building (e.g. using the Delphi Method) and online 
surveys. Criteria applied include effectiveness, cost/efficiency and benefit. In 
a next step, the identified tests and treatments are prioritised by the societies’ 
members according to quite heterogeneous criteria (e.g., available evidence, 
frequency of use, costs, appropriateness), using non-standardised methods [75]. 
The final Top-5 lists can be downloaded on the Choosing Wisely® website. 
In cooperation with Consumer Reports, patient-friendly resources covering 
a majority of the recommendations have been created to facilitate patients’ 
engagement in the dialogue on appropriate healthcare.  
 
Choosing Wisely Canada 
Choosing Wisely Canada is based on the US-American Choosing Wisely® 
campaign and is managed in partnership with the Canadian Medical Associ-
ation (CMA). The initiative is funded by the CMA, the University of Toron-
to, the Government of Ontario and The Commonwealth Fund [76]. 
Like the original initiative, Choosing Wisely Canada aims at ensuring high-
quality care by supporting physicians and patients to have conversation about 
the appropriateness of tests and treatments, leading to smart decision mak-
ing. Initially starting in Ontario in early 2014, the initiative is growing and 
currently includes Top-5 lists of 8 specialty societies. 
There is no standardised set of methods neither for identifying inappropriate 
tests and treatments nor for creating the lists. For identification, methods in-
clude literature search and adaptations of the US-American lists whereas for 
prioritisation, surveys and consensus methods are used. The Top-5 lists, in-
cluding all recommendations as well as patient-friendly material can be down-
loaded on the initiative’s website.  
 
The NICE ‘Do not do’ Recommendations and  
Referral Advice Databases 
Since 1999, the National Institute for Health and Care Excellence (NICE) 
supports the National Health Service (NHS) in identifying ‘low value’ (i.e. in-
effective, not evidence based) interventions in the UK health care system. 
In 2005, NICE has been given the mandate to develop a disinvestment pro-
gramme by the Ministry of Health [77-79]. It was decided to integrate disin-
vestment activities in the routine guideline development, focusing on effec-
tiveness, safety and costs [80]. 
Therefore, NICE deduces its ‘do not do’ recommendations and referral advice 
from existing guidance and NICE assessments [78]. There is no description 
of specific methods used for identification or prioritisation of inappropriate 
technologies and treatments available in the literature: The same HTA meth-
ods are used for investment and disinvestment guidance development [81]. 
Criteria applied include effectiveness, costs and efficiency [78]. 
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Derived ‘do not do’ recommendations are fed into the 2007 established pub-
licly available and searchable database that relates recommendations to the 
specific NICE guidance serving as a basis. Currently, more than 800 recom-
mendations are stored in the database. As the reduction of inappropriate re-
ferrals additionally increases efficiency, a second searchable database includes 
NICE’s recommendations on referrals to secondary care [78]. 
 
The ACR Appropriateness Criteria® 
The ACR (American College of Radiology) Appropriateness Criteria® (AC) 
are evidence-based guidelines in tabular form developed by radiology experts 
to support physicians in making appropriate imaging decisions for a range of 
clinical conditions. The guidelines aim at enhancing the quality of care and 
enable an effective and efficient use of imaging technologies in order to op-
timally use limited health care resources [82]. 
Development started in 1994 by the ACR Task Force on Appropriateness Cri-
teria. Methods applied include systematic literature search, evidence review, 
expert consensus and input from other medical specialties. Each procedure 
in the Appropriateness Criteria® topics is rated by an expert panel relating 
to its appropriateness on an ordinal scale from 1 to 9 using a modified Delphi 
method.  
The median appropriateness ratings are displayed in the published tables: rat-
ings 1, 2 and 3 represent ‘usually not appropriate’ (i.e., under most circum-
stances, the study or procedure is unlikely to be indicated in these specific 
clinical settings, or the risk-benefit ratio for patients is likely to be unfavoura-
ble, as shown in published peer-reviewed, scientific studies supplemented by 
expert opinion [83]) whereas ratings 4-9 represent ‘may be appropriate’ or 
‘usually appropriate’ [82, 83]. 
Currently, 201 clinical conditions with 983 variants are publicly available on 
the ACR website, making the ACR Appropriateness Criteria® a comprehen-
sive collection of evidence-based guidelines for appropriate diagnostic imag-
ing. All topics are biennially reviewed and updated if necessary [82, 83]. 
 
The ACCF Appropriate Use Criteria 
The American College of Cardiology Foundation (ACCF), in cooperation with 
other subspecialty societies, published the first set of the Appropriate Use 
Criteria (AUC) in 2005 [84]. During the ensuing years, the AUC have been 
updated and expanded, currently covering 8 exclusively cardiovascular-related 
topic areas. 
The objective of the ACCF AUC is to actively promote evidence-based, effec-
tive use of cardiovascular technologies, including imaging, devices and pro-
cedures [84]. Thus, the AUC aim at defining when and how often a given pro-
cedure should be provided in the context of scientific evidence, the health 
care environment, patient needs and physicians’ judgement [85]. 
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After literature review (including the review of relevant guidelines) and indi-
cation development by experts of multiple societies, a rating panel evaluates 
each procedure relating to its appropriateness in a standardised way, includ-
ing a modified Delphi process. The rating categories range from ‘appropri-
ate’ to ‘may be appropriate’ and ‘rarely appropriate’, representing a scale from 
1 to 9 [84]. Recommendations are published online and are publicly availa-
ble on the ACCF website. The AUC are updated following the update of un-
derlying guidelines [84].  
 
The CAR Diagnostic Imaging Referral Guidelines 
The Canadian Association of Radiologists (CAR) Diagnostic Imaging Refer-
ral Guidelines, developed in 2012, are evidence-informed recommendations 
based on expert opinion or case studies. They are published on the CAR web-
site in tabular form, aiming at assisting referring physicians and other health 
care professionals in making decisions about appropriate diagnostic imaging. 
Methods applied for compiling the recommendations include literature search 
and expert consensus in an expert advisory group [86, 87].  
Inappropriate utilisation of diagnostic imaging is labelled with the term ‘not 
indicated’: Examinations which will usually not contribute to the manage-
ment of the patient [86]. 
Terms labelling categories indicating that utilisation of diagnostic imaging 
may be inappropriate under certain circumstances [86]: 
 Not indicated initially: Includes situations where experience shows that 
the clinical problem usually resolves with time, and where deferring 
the study is suggested. 
 Indicated only in specific circumstances: Non-routine studies to be 
carried out if a physician provides cogent reasons or if the radiologist 
feels the examination represents an appropriate way of furthering the 
diagnosis and management of the patient. 
 Appropriate or equivocal applications of diagnostic imaging are la-
belled with either indicated or specialised investigation. 
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Table 4.2-1: Characteristics of identified programmes for recommendations against the use of MRI 
 
Choosing Wisely® USA 
Choosing Wisely 
Canada 
NICE ‘Do not do’ 
recommendations and 
Referral Advice databases 
The ACR 
Appropriateness 
Criteria® 
The ACCF Appropriate 
Use Criteria 
The CAR Diagnostic 
Imaging Referral 
Guidelines 
Country USA Canada United Kingdom USA USA Canada 
Initiator National Physicians 
Alliance (NPA)/American 
Board of Internal 
Medicine (ABIM) 
Foundation 
Canadian Medical 
Association (CMA) 
UK Ministry of Health American College of 
Radiology (ACR) 
b American College of 
Cardiology Foundation 
(ACCF) 
Canadian Association 
of Radiologists (CAR) 
Methods Not standardised; e.g., 
literature search, Delphi 
method, online survey 
Not standardised; 
e.g., literature 
search, expert 
consensus 
Standardised; HTA methods, 
NICE guidance as a basis 
Standardised Standardised; 
literature search and 
review, expert 
consensus, Delphi 
method, face-to-face 
meeting 
Standardised; 
literature search, 
expert consensus 
Use of 
Guidelines 
Unsystematically  
(US-American, English) 
Unsystematically 
(Canadian,  
US-American, 
English) 
NICE guidelines; indirect: 
other current guidelines 
Systematically  
(mostly US-American, 
Canadian) 
Systematically  
(mostly ACCF/AHA 
practice guidelines 
n/a 
Dissemination Top-5 lists;  
published online 
Patient-friendly material; 
published online,  
via Consumer Reports 
Top-5 lists; 
published online 
Patient-friendly 
material;  
published online 
Publicly available and 
searchable databases; online 
Monthly ‘recommendation 
reminders’; sent out actively to 
physicians and NHS managers 
Guidelines in  
tabular form;  
published online 
Guidelines in tabular 
form; published online 
Guidelines in tabular 
form; published 
online 
Update 
methods 
n/a n/a Update or replacement as 
new guidance is published 
Biennial review and 
update if necessary 
Update as underlying 
guidance is updated 
n/a 
n/a – not applicable 
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4.2.2 General Results 
A total of 293 recommendations have been identified from the 6 programmes. 
253, relating to the inappropriate use of MRI and advanced medical imaging, 
were included in the analysis. The majority of recommendations (64%) derive 
from the ACR Appropriateness Criteria®, 12% from Choosing Wisely® USA 
and 11% from the NICE databases. The CAR Referral Guidelines, the ACCF 
Appropriate Use Criteria and Choosing Wisely Canada account for the re-
maining 13%. 
 
Figure 4.2-1: Percentage of recommendations against MRI use contributed  
per programme 
Recommendations against MRI use can be classified according to 12 medical 
fields. The analysis shows that most nominations of inappropriate use fall in 
the field of Oncology (27%). In the oncological field, several recommendations 
relate to tumour staging (e.g., bladder cancer, uveal melanoma, bronchogenic 
carcinoma) or screening (e.g., for distant metastases in patients with testicu-
lar cancer). The inappropriateness of MRI utilisation may relate to a very low 
incidence of metastasis in certain tumours, not resulting in changes to patient 
management but potentially yielding false positive results and leading to un-
necessary further diagnosis and treatment, or to technical inferiority of MRI 
compared to other imaging methods (e.g., in staging NSCLC). Orthopaedics 
and Neurology are also strongly represented. 
64% 
12% 
11% 
7% 
3% 3% 
ACR Appropriateness
Criteria
Choosing Wisely USA
NICE Do Not Do
CAR Referral guidelines
ACCF Appropriate Use
Criteria
Choosing Wisely Canada
insgesamt wurden  
253 Empfehlungen 
analysiert 
 
der Großteil stammt 
von den ACR 
Appropriateness Criteria 
Empfehlungen  
beziehen sich auf  
12 Fachrichtungen 
 
die meisten 
Empfehlungen beziehen 
sich auf die Onkologie, 
Orthopädie und 
Neurologie 
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Figure 4.2-2: Identified recommendations against MRI use per medical field  
(absolute numbers) 
Regarding body areas, MRI of the head is mentioned most often (21%) 
throughout the medical specialties in the recommendations, followed by heart, 
abdomen, pelvis, chest and spine. Most recommendations (69%) against the 
use of MRI refer to MRI as initial diagnostic method, whereas follow-up di-
agnosis, screening, staging or surveillance are mentioned less frequently. How-
ever, since the programmes do not systematically cover all indications, inap-
propriate procedures related to follow-up, staging or screening might be missed 
by the programmes. 
 
Figure 4.2-3: Identified recommendations against MRI use – distribution per selected 
body areas (absolute numbers) 
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Figure 4.2-4: Identified recommendations against MRI use – distribution per purpose 
(absolute numbers and percentage) 
On a more detailed level, e.g. in Oncology, MRI is also described as being in-
appropriate most often for initial diagnosis. However, when stratified by body 
parts, other purposes take the lead in certain cases. 
 
Figure 4.2-5: Recommendations against MRI use in Oncology – distribution per body parts and purpose  
(absolute numbers) 
Overall, only 13 overlapping recommendations against MRI use were identi-
fied throughout the programmes (Table 4.2-2). Unsurprisingly, the highest 
rate of overlap exists between the Choosing Wisely® campaigns of USA and 
Canada: Choosing Wisely Canada is based on the US-American recommen-
dations in large part. The highest degree of agreement was reached for the 
diagnosis of low back pain with no red flags present (mentioned by 4 pro-
grammes). 
47 (19%) 
173 (69%) 
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Table 4.2-2: Overlapping recommendations against MRI use across medical fields 
Indication Intervention Programmes 
Initial diagnosis/primary investigation   
Headache: uncomplicated, no red flags or specific risk 
factors for structural disease 
Imaging CW CAN, CW USA 
Low back pain: acute, non-specific, within first 6 weeks Imaging lower spine CW USA 
Low back pain: no Red Flags6 MRI lumbar spine ACR AC, CW CAN, 
CW USA, CAR 
Lower urinary tract symptoms: suspicion of benign 
prostatic hyperplasia 
MRI pelvis resp. upper-tract 
imaging 
ACR AC, CW USA 
Pre-operative assessment in patients scheduled to 
undergo low-risk (or intermediate risk) non-cardiac 
surgery 
(Stress) cardiac imaging or 
advanced non-invasive 
imaging 
CW CAN, CW USA, 
ACCF AUC 
Rhinosinusitis: uncomplicated, acute MRI paranasal sinuses  
(and other imaging) 
CW USA 
Routine evaluation: no cardiac symptoms,  
no high-risk markers present 
Stress cardiac imaging or 
advanced non-invasive 
imaging 
CW CAN, CW USA 
Seizures in children: simple febrile seizures and  
post-traumatic seizures resp. simple febrile seizures 
MRI head resp. neuroimaging 
(MRI, CT) 
ACR AC, CW USA, 
CAR 
Sinusitis in children: uncomplicated, acute MRI paranasal sinuses 
without (and with) contrast 
resp. imaging 
ACR AC, CAR 
Syncope: simple, in patients with a normal 
neurological examination 
Neuro-imaging studies  
(MRI, CT) 
CW CAN, CW USA 
Follow-up   
Ductal carcinoma in situ, prior to definitive surgery MRI breast ACR AC, NICE DB 
Routine follow-up in asymptomatic patients  
(e.g., every one to two years or at a heart procedure 
anniversary) 
Annual stress cardiac imaging 
or advanced non-invasive 
imaging 
CW CAN, CW USA 
Staging   
Bronchogenic carcinoma: non- small cell and  
small cell lung carcinoma 
MRI chest ACR AC, CAR 
 
The ACR AC, the CAR Guidelines and the ACCF AUC are not only focused 
on recommendations against the use of imaging in defined medical areas (so 
called ‘do not do’ recommendations) but also include appropriate or equivo-
cal utilisation of technologies. Therefore, they provide a more comprehensive 
description of the appropriateness of e.g. MRI throughout different medical 
fields. However, the more focused approaches by Choosing Wisely Canada, 
CW USA and the NICE databases may better highlight those areas in which 
there is potential for improvement. 
In the ACR AC, procedures are differentiated between imaging with and with-
out contrast. For some clinical conditions, MRI without contrast may be inap-
propriate but at the same time, it may be appropriate given that contrast is 
applied – and vice versa. In addition, a procedure being rated inappropriate 
under certain circumstances may be appropriate for other disease variants.  
 
                                                             
6 Red flags include: age <20 or >55 years, neurologic deficits, history of tumours, 
HIV infection, general illness, increasing pain etc. (cf. Orientierungshilfe Radiologie, 
accessed 7 November 2014, http://orientierungshilfe.vbdo.at/empfehlungen/C/#7). 
3 Programme  
beinhalten auch 
Empfehlungen für MRT 
nicht alle Empfehlungen 
differenzieren zwischen 
Untersuchungen mit 
und ohne 
Kontrastmittel 
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Thus, it is crucial for physicians to always evaluate the actual circumstances 
and clearly define the clinical condition, consulting imaging recommendations 
as a decision support only. 
In the chapters below, recommendations against MRI use are presented in a 
categorised and simplified way, lacking background information and reason-
ing. This information is available from the original references (e.g., the ACR 
AC Narrative documents and NICE guidance documents related to the rec-
ommendations).  
To increase the applicability for Austria, recommendations are categorised ac-
cording to the 9 organ-related sections A to I of the Orientation Guide Radi-
ology (OGR) edited by Verband für Bildgebende Diagnostik Österreich (As-
sociation imaging diagnostics Austria), Bundesfachgruppe Radiologie der Ös-
terreichischen Ärztekammer (Radiology expert group of the Austrian medical 
association), Österreichische Röntgengesellschaft (Austrian Radiology Asso-
ciation) and Verband für medizinischen Strahlenschutz Österreich (Associa-
tion of medical radiation protection in Austria) that is commonly used in 
clinical practice in Austria. 
Comparisons of the identified recommendations against MRI use with the 
OGR are complex because first, the Orientation Guide includes a rougher, 
higher-level classification according to organ-related sections and describes 
clinical conditions less differentiated than most of the analysed programmes 
do. Therefore, several recommendations had to be classified into umbrella 
terms (e.g., the clinical condition of ‘spina bifida occulta’ is classified into 
‘malformations of the spine’). In addition, not all clinical conditions includ-
ed in the recommendations are represented in the OGR. Third, the OGR does 
not differentiate between MRI examinations with and without contrast ap-
plication. The OGR also does not specify an MRI technique as angiographic, 
functional or spectroscopic imaging. Thus, comparing it one-to-one with the 
ACR AC or other programmes drawing a clear distinction between different 
applications is not always feasible. Of note, the OGR also does not specify the 
kind of neoplasm or setting in which imaging is justified to search for distant 
metastases. Overall, a direct comparison, due to recommendations being on 
the same level and relating to the same intervention and patient group, was 
possible for 60 clinical conditions. 
 
  
Hintergrundinformation 
zu den Empfehlungen 
ist verfügbar 
Empfehlungen  
sind anhand der  
9 Kapitel A bis I der 
Orientierungshilfe 
Radiologie kategorisiert 
der Vergleich mit  
der Orientierungshilfe 
Radiologie ist komplex 
und nur eingeschränkt 
möglich 
 
 
ein direkter  
Vergleich war für  
50 Empfehlungen 
möglich 
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4.2.3 Specific results by body part 
Brain/Cranium 
Overall, 48 recommendations related to inappropriate MR imaging of the brain 
and cranium were identified (Table 8-2). More than 75% relate to MRI as 
the initial diagnosis procedure, the rest concern follow-up, staging and screen-
ing. Headache and head trauma are the clinical conditions mentioned most 
often. Only 3 indications were included in more than one programme: un-
complicated headache, simple febrile seizures in children and simple synco-
pe, with the strongest agreement existing for simple febrile seizures in chil-
dren. For head trauma (excluding special cases), conductive hearing loss and 
simple febrile seizures in children, CT was described as being preferred to 
MRI due to its advantage in imaging bony structures. 
For 23 clinical conditions, a related recommendation in the OGR was identi-
fied. However, a direct comparison, due to recommendations being on the same 
level and relating to the same intervention and patient group, was possible 
for the following conditions only. 
 
Matching recommendations against the use of MRI (Table 4.2-3): 
 The CAR advise against MRI utilisation for diagnosing chronic/re-
current headache in the absence of focal features. CW USA rates neu-
roimaging studies as being inappropriate in patients with stable head-
ache (meeting criteria of migraine) in the absence of neurologic find-
ings. In the OGR, as well, MRI (or CT) is recommended only after ob-
servation in case focal features or changes of headache type occur.  
 Children with moderate to severe head injury or a suspected non-ac-
cidental trauma or a subacute injury with neurologic signs following 
a head trauma should, as per ACR AC, not be diagnosed by head MRI 
with contrast. MRI head without contrast is, however indicated for all 
three conditions. In the OGR, MRI is rated appropriate as follow-up 
diagnosis for head injury.  
 Both the OGR and ACR AC advise against MRI for the initial exam-
ination of hearing loss.  
 For uncomplicated headache in the absence of red flags, both CW USA 
and CW CAN advise against imaging. In the OGR, CT is recommend-
ed as initial diagnostic procedure for acute, severe headache. There is 
no analogy for ‘uncomplicated’ (i.e. no red flags present) described in 
the OGR. However, severity of headache is described as a red flag by 
CW CAN and acute and severe headache may be caused by subarach-
noid hemorrhage, a potentially severe condition. MRI is recommend-
ed as follow-up in case of inflammatory reasons as it is more sensitive 
than CT. MRA is indicated for initial diagnosis of venous sinus throm-
bosis, demonstrating the more conservative approach of the OGR.  
 
48 Empfehlungen 
 
75 % beziehen sich auf 
MRT als Erstdiagnose 
 
Kopfschmerz und 
Schädeltrauma werden 
am häufigsten genannt 
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Radiologie  
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Table 4.2-3: MRI – Brain/Cranium: Recommendations matching with OGR 
Indication MEL Code Recommendation/Programme 
Orientation  
Guide Radiology 
Headache, 
chronic/ 
recurrent:  
no focal features 
ZA030 CAR: 
Headache chronic/recurrent: MRI indicated only in 
specific circumstances. In the absence of focal features 
imaging is not often helpful. 
MRI indicated after 
observation in case 
of focal features and 
changes. A.6* 
Headache: 
stable, meeting 
criteria for 
migraine 
ZA030 CW USA: 
Don’t perform neuroimaging studies in patients with 
stable headaches that meet criteria for migraine.  
Numerous evidence-based guidelines agree that the 
risk of intracranial disease is not elevated in migraine. 
However, not all severe headaches are migraine. To 
avoid missing patients with more serious headaches,  
a migraine diagnosis should be made after a careful 
clinical history and an examination that documents 
the absence of any neurologic findings such as 
papilledema. Diagnostic criteria for migraine are 
contained in the International Classification of 
Headache Disorders. 
MRI indicated after 
observation in case 
of focal features and 
changes. A.6* 
Head trauma  
in children 
ZA030 ACR AC: 
Head trauma-child: MRI head with contrast for moderate 
– severe injury or suspected non-accidental trauma or 
subacute injury with neurologic signs; rated 2 
Comment: MRI head without contrast indicated for 
moderate to severe head injury or minor head trauma, 
suspected non-accidental trauma and sub-acute head 
injury. 
MRI indicated as 
follow-up for head 
injury. M.13* 
Hearing loss: 
conductive 
ZA030 ACR AC: 
Hearing loss/vertigo: MRI head and internal auditory 
canal without and with contrast for conductive hearing 
loss; rated 2 
Comment: CT of the temporal bone without contrast 
is the most appropriate initial imaging study in patients 
with conductive hearing loss. 
MRI indicated as 
follow-up. A.11* 
Headache: 
uncomplicated, 
no Red Flags  
ZA030 CW CAN: 
Don’t do imaging for uncomplicated headache unless 
red flags are present.  
Red flags include recent onset, rapidly increasing 
frequency and severity of headache; headache causing 
the patient to wake from sleep; associated dizziness, 
lack of coordination, tingling or numbness, new 
neurologic deficit; and new onset of a headache in a 
patient with a history of cancer or immunodeficiency. 
CW USA: 
Don’t do imaging for uncomplicated headache.  
Imaging headache patients absent specific risk factors 
for structural disease is not likely to change management 
or improve outcome. Those patients with a significant 
likelihood of structural disease requiring immediate 
attention are detected by clinical screens that have 
been validated in many settings. Many studies and 
clinical practice guidelines concur. Also, incidental 
findings lead to additional medical procedures and 
expense that do not improve patient well-being. 
MRI indicated as 
follow-up, MRA 
indicated as initial 
diagnosis for acute, 
severe headache. 
A.5* 
* refers to the respective chapter number in the OGR 
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Differing recommendations against the use of MRI (Table 4.2-4): 
 The ACR AC advise against head MRI in children with primary head-
ache without neurologic signs or signs of increased intracranial pres-
sure whereas according to the OGR, MRI is indicated as initial diag-
nostic method for headache in children.  
 NICE advises against MRI utilisation as a routine part of the initial 
investigations for the management of first-episode psychosis The OGR 
recommends MRI as initial diagnostic method to rule out organic rea-
sons in patients with psychosis whereas.  
 CW USA rate brain imaging an inappropriate method to screen for 
brain metastases in patients with suspected or biopsy proven Stage I 
NSCLC in the absence of neurologic symptoms, whereas the OGR 
generally describes MRI as the preferred method to diagnose brain me-
tastases or follow up on them in patients with lung cancer. 
 The ACR AC advise against MRI of the head without and with contrast 
for post-treatment follow-up of brain metastases in asymptomatic pa-
tients with renal cell carcinoma. The OGR generally describes MRI 
as the preferred method to diagnose brain metastases. 
 For pre-treatment staging in patients with invasive bladder cancer who 
have no neurologic symptoms, the ACR AC rate MRI of the head with-
out and with contrast inappropriate to search for brain metastases. The 
reason is that neurologic complications are rare. The OGR generally 
describes MRI as the preferred method to diagnose brain metastases. 
 For renal cell carcinoma staging, the ACR AC advises against MRI of 
the head without and with contrast for the evaluation of brain metas-
tasis if the patients do not have neurologic symptoms or other metas-
tases. The OGR generally describes MRI as the preferred method to 
diagnose brain metastases. 
 The CAR advise against MRI of the brain in staging uveal melanoma 
stage I or IIA/B and stage IIC or III if no neurological symptoms are 
present as the incidence of brain metastases is very low. The OGR gen-
erally describes MRI as the preferred method to diagnose brain metas-
tases. 
Table 4.2-4: MRI – Brain/Cranium: Recommendations differing from OGR 
Indication MEL Code Recommendation/Programme 
Orientation  
Guide Radiology 
Headache  
in children: 
primary 
headache 
ZA030 ACR AC: 
Headache-child: MRI head without and with contrast 
for primary headache (chronic or recurrent, including 
migraine without permanent neurologic signs or signs 
of increased intracranial pressure); rated 3 
MRI indicated as 
initial diagnosis. 
K.10* 
Psychosis,  
first-episode 
ZN270 NICE DB: 
Structural neuroimaging techniques (either magnetic 
resonance imaging [MRI] or computed axial tomography 
[CT] scanning) are not recommended as a routine part 
of the initial investigations for the management of 
first-episode psychosis. 
MRI indicated as 
initial diagnosis. 
A.13* 
 
Kopfschmerz  
bei Kindern 
Psychose 
Hirnmetastasen/ 
Lungenkrebs 
Hirnmetastasen/ 
Nierenzellkarzinom 
Hirnmetastasen/ 
invasiver Blasenkrebs 
Hirnmetastasen/ 
Nierenzellkarzinom 
Hirnmetastasen/ 
Aderhautmelanom 
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Indication MEL Code Recommendation/Programme 
Orientation  
Guide Radiology 
Brain 
metastases: 
patients with 
suspected or 
biopsy proven 
Stage I NSCLC 
ZA030 CW USA: 
Patients with suspected or biopsy proven Stage I NSCLC 
do not require brain imaging prior to definitive care in 
the absence of neurologic symptoms.  
 The incidence of occult brain metastasis in Stage I 
lung cancer is low (<3%) and so routine brain 
imaging results in increased costs, delays in therapy 
and rarely changes patient management.  
 False-positive studies occur in up to 11% of patients 
resulting in further invasive testing or incorrect 
over staging, with potentially tragic effects on 
treatment decisions and outcomes. 
MRI indicated as 
initial diagnosis for 
assessing brain 
metastases.** L.27, 
L.7* 
Renal cell 
carcinoma/Brain 
metastases in 
asymptomatic 
patients 
ZA030 ACR AC***: 
Post-treatment follow-up of renal cell carcinoma:  
MRI head without and with contrast for asymptomatic 
patients; rated 1 
MRI indicated as 
initial diagnosis for 
assessing brain 
metastases.** L.27* 
Invasive bladder 
cancer/Brain 
metastases: lack 
of neurologic 
symptoms 
ZA030 ACR AC***: 
Pre-treatment staging of invasive bladder cancer:  
MRI head without and with contrast; rated 2 
MRI indicated as 
initial diagnosis for 
assessing brain 
metastases.** L.27* 
Renal cell 
carcinoma/Brain 
metastases: no 
neurologic signs 
or other 
metastases 
ZA030 ACR AC***: 
Renal cell carcinoma staging: MRI head without and 
with contrast; rated 1/3 
MRI indicated as 
initial diagnosis for 
assessing brain 
metastases.** L.27* 
Uveal 
melanoma/Brain 
metastases: 
Stage I or IIA/B 
ZA030 CAR: 
Uveal melanoma staging Stage I or IIA/B: MRI brain 
not indicated. Incidence of metastases very low. 
MRI indicated as 
initial diagnosis for 
assessing brain 
metastases.** L.27* 
Uveal 
melanoma/Brain 
metastases: 
Stage IIC or III 
ZA030 CAR:  
Uveal melanoma staging: Stage IIC or III with 
macrometastasis sentinel LN or LN dissection:  
MRI brain not indicated if no neurological symptoms. 
MRI indicated as 
initial diagnosis for 
assessing brain 
metastases.** L.27* 
* refers to the respective chapter number in the OGR 
** The OGR does not specify any kind of neoplasm or setting when and if imaging is justified 
for the search of distant metastases; it states that MRI generally is the best method to assess 
brain metastases. 
*** According to the ACR AC, MRI is, however, the recommended imaging technique for 
follow-up and retreatment of brain metastases and for their evaluation, particularly in pa-
tients being considered for surgery or radiosurgery. Therefore, the ACR AC do not rate MRI 
as being inappropriate to assess brain metastases in general, but identifies certain circum-
stances where MRI of the brain is not necessary.  
 
Head/Neck 
Overall, only 5 recommendations related to inappropriate MR imaging of the 
head and neck were identified, all relating to MRI as the initial diagnostic 
procedure (Table 8-3). Only 2 conditions were included in more than one pro-
gramme: uncomplicated rhinosinusitis and uncomplicated sinusitis in chil-
dren. For sinonasal disease and sinusitis in children, CT was described as 
being preferred to MRI. 
5 Empfehlungen 
 
alle beziehen sich  
auf MRT als 
Erstdiagnosemethode  
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Two related recommendations against the use of MRI were identified in the 
OGR. A direct comparison, due to recommendations being on the same level 
and relating to the same intervention and patient group, was possible for the 
following conditions. 
 
Matching recommendations (Table 4.2-5): 
 Uncomplicated acute sinusitis in children. MRI is not indicated to 
diagnose uncomplicated acute sinusitis according to both the OGR, 
the ACR AC and CAR respectively.  
 For complicated sinusitis in children, MRI of the paranasal sinuses 
and MRI head with contrast are suggested by ACR AC. The OGR 
rates imaging in general as not being a routine indication; however, 
MRI is suggested for atypical course or complications. 
Table 4.2-5: MRI – Head and Neck: Recommendations matching with OGR 
Indication MEL Code Recommendation/Programme 
Orientation  
Guide Radiology 
Sinusitis in 
children: 
uncomplicated, 
acute 
ZA030 CAR: 
Uncomplicated acute sinusitis in children: imaging not 
indicated. Mucosal thickening is frequently seen in 
asymptomatic children, limiting the value of imaging  
for ruling in/out sinusitis. 
ACR AC: 
Sinusitis-child: MRI paranasal sinuses without (and with) 
contrast; rated 1 
Comment: CT of the paranasal sinuses is the imaging 
modality of choice in patients with persistent, recurrent, 
or chronic sinusitis (ACR AC). 
MRI no routine 
indication. K.11* 
Sinusitis in 
children, with 
complications 
ZA030 ACR AC: 
Sinusitis-child: MRI head without contrast for sinusitis 
with complications; rated 3 
Comment: MRI head with contrast and MRI paranasal 
sinuses indicated. 
MRI no routine 
indication. 
Comment: MRI 
may be indicated 
for atypical course 
and complications. 
K.11* 
* refers to the respective chapter number in the OGR 
 
Spine/Spinal cord 
Overall, 14 recommendations related to inappropriate MR imaging of the 
spine were identified, 12 relating to MRI as the initial diagnostic procedure 
and only one to each follow-up and screening (Table 8-4). Low back pain is 
the clinical condition mentioned most often, causing considerable overlaps 
between the programmes. Regarding myelopathy, CT was described as being 
the preferred first test in suspected spinal trauma as it is superior in evaluat-
ing the spine for fractures in the acute setting. 
For 12 clinical conditions, a related recommendation against the use of MRI 
was identified in the OGR. A direct comparison, due to recommendations be-
ing on the same level and relating to the same intervention and patient group, 
was possible for the following conditions.  
 
2 Empfehlungen haben 
eine Entsprechung in 
der Orientierungshilfe 
Radiologie 
Sinusitis bei Kindern 
(unkompliziert) 
Sinusitis bei Kindern 
(kompliziert) 
14 Empfehlungen 
 
Rückenschmerz wird  
am häufigsten genannt 
12 Empfehlungen haben 
Entsprechungen in der 
Orientierungshilfe 
Radiologie 
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Matching recommendations (Table 4.2-6): 
 The OGR advises against MRI utilisation within the first 4-6 weeks of 
uncomplicated, acute low back pain without the presence of ‘red flags’. 
The ACR AC, CW CAN, CW USA and CAR reach the same conclusion. 
 Although the ACR AC rate MRI lumbar spine with contrast inappro-
priate for low back pain for patients over 70 years with specific symp-
toms, MRI without contrast is considered indicated. As old age is in-
cluded in the list of ‘red flags’ in the OGR, MRI is indicated as initial 
diagnosis and/or follow-up. 
 For chronic neck pain, the OGR suggests MRI as follow-up diagnosis 
in the presence of neurologic signs. The ACR AC, too, advises against 
MRI utilisation as first study. Following up on radiographs however, 
MRI is rated appropriate in the presence of neurologic signs, for sus-
pected infection or malignancy or if the pain persists after the failure 
of conservative management.  
 In low-risk patients with suspected spine trauma, the ACR AC advises 
against MRI of the cervical spine. There is a variety of clinical condi-
tions described in the ACR AC, including various conditions for which 
MRI (primarily without contrast) is indicated. In the OGR, MRI is de-
scribed appropriate as initial diagnosis or follow-up in case of neuro-
logic deficits, considering that these may not be referred to as low-risk 
patients. 
 The OGR suggests MRI for initially diagnosing congenital mutations, 
malformations, infections and metabolic diseases in children, indicat-
ing the necessity of sedation in neonates and infants (therefore, ultra-
sound may be the method of choice). In the CAR, MRI is rated inap-
propriate for following up on spina bifida occulta in the absence of 
neurological findings and cutaneous stigmata (after X-ray). In addi-
tion, screening for spinal dysraphism in low-risk infants is not recom-
mended by the CAR due to the need for sedation. As the OGR and 
the CAR describe slightly different application areas, the recommen-
dations are interpreted consistent. 
Table 4.2-6: MRI – Spine/spinal cord: Recommendations matching with OGR 
Indication MEL Code Recommendation/Programme 
Orientation  
Guide Radiology 
Low back 
pain:  
no Red Flags 
ZN260 ACR AC: 
Low back pain: MRI lumbar spine without and with contrast 
if no red flags; rated 2 
CW CAN: 
Don’t do imaging for lower-back pain unless red flags are 
present.  
Red flags include, but are not limited to, severe or progressive 
neurological deficits or when serious underlying conditions 
such as osteomyelitis are suspected. Imaging of the lower 
spine before six weeks does not improve outcomes. 
Don’t do imaging for lower-back pain unless red flags are 
present.  
Red flags include suspected epidural abscess or hematoma 
presenting with acute pain, but no neurological symptoms 
(urgent imaging is required); suspected cancer; suspected 
infection; cauda equina syndrome; severe or progressive 
neurologic deficit; and suspected compression fracture. In 
patients with suspected uncomplicated herniated disc or 
MRI indicated 
after observation. 
Within the first  
4-6 weeks, 
imaging is usually 
not indicated. 
C.6* 
unkomplizierter 
Rückenschmerz 
Rückenschmerz 
chronischer 
Nackenschmerz 
Wirbelsäulentrauma 
kongenitale 
Veränderungen, 
Malformationen 
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spinal stenosis, imaging is only indicated after at least a  
six-week trial of conservative management and if symptoms 
are severe enough that surgery is being considered. 
CW USA: 
Don’t do imaging for low back pain within the first six weeks, 
unless red flags are present.  
Red flags include, but are not limited to, severe or progressive 
neurological deficits or when serious underlying conditions 
such as osteomyelitis are suspected. Imaging of the lower 
spine before six weeks does not improve outcomes, but does 
increase costs. Low back pain is the fifth most common 
reason for all physician visits. 
CAR: 
Lower back pain: MRI Indicated in special circumstances. 
Imaging is only indicated if there are „red flag” indications. 
Low back 
pain: acute, 
non-specific, 
within first  
6 weeks 
ZN260 CW USA: 
Avoid imaging studies (MRI, CT or X-rays) for acute low back 
pain without specific indications.  
Imaging for low back pain in the first six weeks after pain 
begins should be avoided in the absence of specific clinical 
indications (e.g., history of cancer with potential metastases, 
known aortic aneurysm, progressive neurologic deficit, etc.). 
Most low back pain does not need imaging and doing so may 
reveal incidental findings that divert attention and increase 
the risk of having unhelpful surgery. 
Don’t recommend advanced imaging (e.g., MRI) of the spine 
within the first six weeks in patients with non-specific acute 
low back pain in the absence of red flags.  
In the absence of red flags, advanced imaging within the first 
six weeks has not been found to improve outcomes, but does 
increase costs. Red flags include, but are not limited to: 
trauma history, unintentional weight loss, immunosuppression, 
history of cancer, intravenous drug use, steroid use, 
osteoporosis, age >50, focal neurologic deficit and 
progression of symptoms. 
Don’t obtain imaging studies in patients with non-specific 
low back pain. 
In patients with back pain that cannot be attributed to a 
specific disease or spinal abnormality following a history and 
physical examination (e.g., non-specific low back pain), 
imaging with plain radiography, computed tomography (CT) 
scan, or magnetic resonance imaging (MRI) does not improve 
patient outcomes. 
MRI indicated 
after observation. 
Within the first 4-
6 weeks, imaging 
is usually not 
indicated. C.6* 
Low back 
pain: patients 
over 70 years 
with specific 
symptoms 
ZN260 ACR AC: 
Low back pain: MRI lumbar spine with contrast for patient 
over 70 years with specific symptoms; rated 3 
Comment: MRI lumbar spine without contrast indicated. 
MRI indicated as 
initial diagnosis 
and after 
observation. C.7* 
Neck pain, 
chronic 
ZN260 ACR AC: 
Chronic neck pain: MRI cervical spine with contrast except 
suspected infection or malignancy; rated 1 
MRI indicated as 
follow-up. C.4* 
Neck pain, 
chronic 
ZN260 ACR AC: 
Chronic neck pain: MRI cervical spine without and with 
contrast as first study; rated 1 
MRI indicated as 
follow-up. C.4* 
Spine trauma, 
suspected 
ZN260 ACR AC: 
Suspected acute spine trauma: MRI cervical spine without 
and with contrast for low-risk patients; rated 1 
Comment: In case of e.g. myelopathy and for the evaluation 
of ligamentous injury, MRI cervical spine without contrast is 
indicated. 
MRI indicated as 
initial diagnosis  
for cervical spine 
trauma, indicated 
as follow-up for 
lumbar spine trauma 
in case of neurologic 
deficit. M.15/16* 
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Spina bifida 
occulta 
ZN260 CAR: 
Spina bifida occulta reported on XR, neurological findings 
and cutaneous stigmata of dysraphism absent in children: 
imaging not indicated. 
MRI indicated as 
initial diagnosis. 
K.1* 
MRI indicated as 
initial diagnosis or 
follow-up in older 
children when US 
is fruitless. K.14* 
Spinal 
dysraphism, 
suspected in 
low risk 
infants 
ZN260 CAR: 
Suspected spinal dysraphism, screening in low risk infants: 
MRI not indicated. MRI has the best diagnostic performance, 
but it requires sedation. It should therefore not be used as a 
screening modality. 
MRI indicated as 
initial diagnosis. 
K.1* 
MRI indicated as 
initial diagnosis or 
follow-up when 
conspicuous/ 
unclear US, 
neurologic deficit, 
pre-OP. K.15* 
* refers to the respective chapter number in the OGR 
 
Musculoskeletal 
Overall, 48 recommendations related to inappropriate MR imaging of the 
musculoskeletal system were identified and summarised in Table 8-5. They 
are further categorised according to body parts investigated: hand/wrist, foot, 
hip, knee, metastatic bone disease, joints, shoulder, soft tissue masses and 
stress fractures. Diagnosis of fractures and the evaluation of trauma and pain 
make up the bigger part of identified recommendations. More than 58% re-
late to MRI as the initial diagnosis procedure, the rest concern follow-up and 
screening. 
For soft tissue masses with non-specific clinic, suspected distal radioulnar 
joint subluxation, chronic wrist pain and primary bone tumours (definitely 
benign lesions, not osteoid osteoma), CT was described as being preferred to 
MRI due to its advantage in avoiding motion artefacts, providing better po-
sitioning and shorter acquisition times and detection of mineralisation. 
For 33 clinical conditions, a related recommendation in the OGR was identi-
fied. A direct comparison, due to recommendations being on the same level 
and relating to the same intervention and patient group, was possible for the 
following conditions.  
 
Matching recommendations (Table 4.2-7): 
 The ACR AC advise against MRI as initial diagnostic procedure for 
acute hand and wrist trauma. In the OGR, too, MRI is suggested as 
follow-up diagnosis. 
 For acute trauma to the ankle, both the ACR AC and the OGR advise 
against the utilisation of MRI as first study – in the OGR, MRI is re-
commended as follow-up diagnostic procedure. The same applies for 
patients with acute trauma to the foot. 
 In patients with avascular hip necrosis or chronic hip pain, MRI of the 
hips is not recommended as initial study by the ACR AC. The OGR 
recommends MRI as follow-up in patients with hip pain if radiographs 
are normal and femur head necrosis is suspected. 
 
48 Empfehlungen 
 
weiter kategorisiert 
nach Körperteilen 
 
58 % beziehen sich  
auf Erstdiagnose 
CT ist für einige 
Krankheitsbilder 
bevorzugt 
33 Empfehlungen haben 
Entsprechungen in der 
Orientierungshilfe 
Radiologie 
Hand- und 
Handgelenkstrauma 
Knöcheltrauma 
Hüftnekrose, 
Hüftschmerz 
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 For the initial examination of non-traumatic knee pain in adults, MRI 
is not indicated according to the ACR AC and CW USA. In the OGR, 
too, MRI is only suggested as follow-up diagnosis. CW USA indicates 
that if the pain persists, if there is recurrent swelling or if mechanical 
symptoms are present and radiographs are non-diagnostic, an MRI may 
be useful, though. 
 In patients with stage 1 or 2 carcinoma of the breast, the ACR AC ad-
vise against MRI as initial study. In case of hot spot(s) in the spine in 
asymptomatic patients, MRI spine with contrast is not recommended. 
However, MRI without contrast is indicated if radiographs are nega-
tive. According to the OGR, too, MRI is indicated as follow-up diag-
nosis to generally identify skeleton metastases. 
 Both the ACR AC and the OGR recommend the utilisation of MRI in 
patients with acute shoulder pain as follow-up diagnostic procedure 
only. 
 For diagnosing stress fractures, MRI is not suggested prior to radio-
graphs according to the ACR AC. The OGR, too, suggests MRI as fol-
low-up diagnostic procedure in case of negative radiographs. 
 In patients who underwent total knee arthroplasty, MRI is not recom-
mended as routine follow-up in asymptomatic patients or for diagnos-
ing a suspected infection. MRI is, however, indicated as follow-up fol-
lowing radiographs. The OGR suggests MRI as follow-up diagnosis for 
suspected infections in patients with a painful implant if prior radio-
graphs are negative. 
 In patients with musculoskeletal tumours, MRI with contrast is not re-
commended for the evaluation of osseous metastatic disease according 
to ACR AC. MRI without contrast is, however, indicated. In the OGR 
MRI is rated appropriate in following up on skeleton metastases in 
general and for diagnosing, staging and controlling musculoskeletal 
tumours. 
 For soft tissue masses in patients with a non-specific clinical assess-
ment, the ACR AC do not recommend MRI for initial examination. 
For other variants of this condition (e.g., if a lipoma or a cyst is sus-
pected) and in the follow-up, however, MRI is rated the appropriate di-
agnostic method. In the OGR, MRI is suggested as initial diagnostic 
procedure for delineation and staging of masses >5cm and for follow-
ing up on non-specific ultrasound. 
Table 4.2-7: MRI – Musculoskeletal: Recommendations matching with OGR 
Indication MEL Code Recommendation/Programme 
Orientation  
Guide Radiology 
Hand and wrist 
trauma: acute 
ZD030 ACR AC: 
Acute hand and wrist trauma: MRI wrist without and 
with contrast for wrist trauma, first examination; 
rated 1 
MRI indicated for 
hand/wrist trauma 
as follow-up. 
M.28/29* 
Ankle trauma, 
acute 
ZE030 ACR AC: 
Acute trauma to the ankle: MRI ankle (without and) 
with contrast; rated 1 
MRI indicated as 
follow-up. M.32* 
Knieschmerz 
Brustkarzinom 
Schulterschmerz 
Stressfrakturen 
Infektion nach  
Knie-Arthroplastie 
Muskel-/Skeletttumore 
und Metastasen 
Weichteilmasse 
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Hip necrosis ZC030 ACR AC: 
Avascular necrosis of the hip: MRI hips with or 
without contrast as initial study; rated 1 
Comment: MRI hips without contrast most sensitive 
method for detecting AVN, but not indicated before 
radiographs. 
MRI indicated as 
follow-up if 
radiographs normal 
and suspected femur 
head necrosis. D.14* 
Hip pain, chronic ZC030 ACR AC: 
Chronic hip pain: MRI hip without and with contrast 
as first test; rated 1 
MRI indicated as 
follow-up if 
radiographs normal 
and suspected femur 
head necrosis. D.14* 
Knee pain: non-
traumatic 
ZE030 ACR AC: 
Non-traumatic knee pain: MRI knee without and 
with contrast as initial examination; rated 1 
MRI indicated as 
follow-up. D.15* 
Knee pain ZE030 CW USA: 
Avoid ordering a knee MRI for a patient with anterior 
knee pain without mechanical symptoms or effusion 
unless the patient has not improved following 
completion of an appropriate functional rehabilitation 
programme.  
The most common cause of anterior knee pain is 
patellofemoral pain syndrome. Magnetic resonance 
imaging (MRI) is rarely helpful in managing this 
syndrome. Treatment should focus on a guided exercise 
programme to correct lumbopelvic and lower limb 
strength and flexibility imbalances. If pain persists, if 
there is recurrent swelling or if mechanical symptoms 
such as locking and painful clicking are present, and 
radiographs are non-diagnostic, an MRI may be useful. 
MRI indicated as 
follow-up for knee 
pain. D.15* 
Metastatic bone 
disease: stage 2 
carcinoma of the 
breast with back 
and hip pain 
ZN260 ACR AC: 
Metastatic bone disease: MRI hip and spine without 
and with contrast for stage 2 carcinoma of the breast 
with back and hip pain, initial presentation; rated 1 
MRI indicated as 
follow-up for 
identifying skeleton 
metastases. L.29* 
Metastatic bone 
disease: stage 1 
breast carcinoma, 
hot spot/s in 
spine 
ZN260 ACR AC: 
Metastatic bone disease: MRI spine with contrast for: 
stage 1 breast carcinoma, asymptomatic; single/three 
hot spot/s in spine, rated 1 
Comment: MRI without contrast indicated if 
radiographs are negative. 
MRI indicated as 
follow-up for 
identifying skeleton 
metastases. L.29* 
Metastatic bone 
disease: stage 1 
carcinoma breast 
ZN660 ACR AC: 
Metastatic bone disease: MRI area of interest 
without and with contrast for stage 1 carcinoma 
breast, initial presentation, asymptomatic; rated 1 
MRI indicated as 
follow-up for 
identifying skeleton 
metastases. L.29* 
Shoulder pain: 
acute 
ZD030 ACR AC: 
Acute shoulder pain: MRI shoulder without contrast, 
best initial study; rated 1 
MRI indicated as 
follow-up for 
traumatic shoulder 
pain. M.27* 
Stress fracture, 
prior to X-ray 
ZN660 ACR AC: 
Stress fracture: MRI area of interest without and with 
contrast as first study; rated 1 
MRI indicated as 
follow-up. D.26* 
Imaging after 
total knee 
arthroplasty 
ZE030 ACR AC: 
Imaging after total knee arthroplasty: MRI knee 
without contrast as routine follow up in 
asymptomatic patients or initial evaluation of 
suspected infection; rated 1 
Comment: MRI indicated following radiographs. 
MRI indicated as 
follow-up for 
suspected infection 
in patients with 
painful implant if 
radiographs 
negative. D.16* 
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Musculo-skeletal 
tumors 
ZN660 ACR AC: 
Follow up of malignant or aggressive musculoskeletal 
tumours for evaluation of osseous metastatic disease 
from musculoskeletal primary: MRI whole body 
without and with contrast; rated 1 
Comment: MRI without contrast is indicated. 
MRI indicated as 
follow-up for 
identifying skeleton 
metastases; 
Indicated as initial 
diagnosis, control 
and staging of 
musculoskeletal 
tumours. L.29, L.25* 
Soft tissue 
masses: 
nonspecific clinic 
ZN660 ACR AC: 
Soft tissue masses: MRI area of interest without and 
with contrast for initial examination, nonspecific 
clinic; rated 1 
Comment: Large lesions located on the abdominal or 
chest wall, where motion artefact can create suboptimal 
MR imaging, may be best evaluated with CT. 
MRI is, however, indicated for other variants of soft 
tissue masses. 
MRI indicated as 
initial diagnosis. 
D.4* 
* refers to the respective chapter number in the OGR 
 
Differing recommendations (Table 4.2-8): 
 The ACR AC advise against the use of MRI with and without contrast 
for initially diagnosing acute trauma to the knee for patients exclud-
ing infants who have no symptoms. In contrast, according to the OGR, 
MRI is generally indicated for initial diagnosis. 
Table 4.2-8: MRI – Musculoskeletal: Recommendations differing from OGR 
Indication MEL Code Recommendation/Programme 
Orientation  
Guide Radiology 
Knee trauma, 
acute 
ZE030 ACR AC: 
Acute trauma to the knee: MRI knee with and without 
contrast for patients (excluding infants) with no symptoms; 
rated 1 
MRI indicated as 
initial diagnosis 
for knee trauma. 
M.31* 
* refers to the respective chapter number in the OGR 
 
Cardiovascular 
Overall, 25 recommendations related to inappropriate MR imaging of the car-
diovascular system were identified (Table 8-6). The evaluation of chest pain 
and coronary artery disease make up the bigger part of identified recommen-
dations. 22 recommendations relate to MRI as the initial diagnosis procedure, 
the rest concern follow-up diagnosis. 
For 3 conditions, overlaps between the programmes were identified: Pre-ope-
rative assessment in patients scheduled to undergo low-risk (or intermediate 
risk) non-cardiac surgery, the routine evaluation of low-risk patients and rou-
tine follow-up in asymptomatic patients.  
A related recommendation in the OGR was identified for 11 clinical condi-
tions. However, a direct comparison, due to recommendations being on the 
same level and relating to the same intervention and patient group, was pos-
sible for the following conditions only.  
 
Knietrauma 
25 Empfehlungen 
 
Brustschmerz als 
meistgenanntes 
Krankheitsbild 
11 Empfehlungen haben 
Entsprechungen in der 
Orientierungshilfe 
Radiologie 
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Matching recommendations (Table 4.2-9): 
 For suspected pulmonary embolism in patients with acute chest pain, 
MRA of pulmonary arteries is inappropriate according to the ACR AC. 
CW USA advises against imaging for suspected pulmonary embolism 
in patients without moderate or high pre-test probability for pulmo-
nary embolism. The OGR, too, rates MRA no routine indication for di-
agnosing pulmonary embolism. 
Table 4.2-9: MRI – Cardiovascular: Recommendations matching with OGR 
Indication MEL Code Recommendation/Programme 
Orientation  
Guide Radiology 
Chest pain, 
acute 
- ACR AC: 
Acute Chest Pain — Suspected Pulmonary Embolism:  
MRA pulmonary arteries without contrast; adults, 
pregnant patients; rated 3 
MRI no routine 
indication. E.19* 
Pulmonary 
embolism (PE), 
suspected 
ZB040 CW USA: 
Don’t image for suspected pulmonary embolism (PE) 
without moderate or high pre-test probability of PE.  
While deep vein thrombosis (DVT) and PE are relatively 
common clinically, they are rare in the absence of elevated 
blood d-Dimer levels and certain specific risk factors. 
Imaging, particularly computed tomography (CT) pulmonary 
angiography, is a rapid, accurate and widely available test, 
but has limited value in patients who are very unlikely, based 
on serum and clinical criteria, to have significant value. 
Imaging is helpful to confirm or exclude PE only for such 
patients, not for patients with low pre-test probability of PE. 
Comment: MRI is only used rarely for this indication;  
CTA with contrast is the standard technique. 
MRA no routine 
indication. E.19* 
* refers to the respective chapter number in the OGR 
 
Thorax 
Overall, 16 recommendations related to inappropriate MR imaging of the 
thorax were identified (Table 8-7). Follow-up and screening for pulmonary 
metastases and nodules make up a big part of identified recommendations.  
Overlaps between the programmes were identified only for the staging of bron-
chogenic carcinoma. Interestingly, the preference of CT (partly in combina-
tion with CTA) was described for 10 clinical conditions, particularly in follow-
up, staging and screening: blunt chest trauma, chronic dyspnoea, pulmonary 
nodules, different variants of pulmonary metastases, bronchogenic carcinoma 
and NSCLC. Mentioned limitations of MRI include motion-related artefacts, 
a lower spatial resolution than CT, and an inability to detect calcification 
within lesions. 
For 5 clinical conditions, a related recommendation in the OGR was identi-
fied. A direct comparison, due to recommendations being on the same level 
and relating to the same intervention and patient group, was possible for the 
following conditions.  
 
 
Pulmonalembolie 
16 Empfehlungen 
für 10 Krankheitsbilder 
gilt CT als bevorzugt 
5 Empfehlungen haben 
Entsprechungen in der 
Orientierungshilfe 
Radiologie 
Opportunities and strategies to drive appropriate use of MRI in Austria 
64 LBI-HTA | 2014 
Matching recommendations (Table 4.2-10): 
 In the evaluation of blunt chest trauma, both the ACR AC and the OGR 
advise against the utilisation of MRI as initial diagnostic method. Ac-
cording to the OGR, MRI is indicated as follow-up diagnostic for spe-
cial issues. 
 For the initial diagnosis of acute stridor in children, imaging is not in-
dicated according to CAR. According to the OGR, MRI is indicated as 
follow-up diagnostic procedure for acute and chronic stridor (particu-
larly for diagnosing tumours and inflammatory masses).  
Table 4.2-10: MRI – Thorax: Recommendations matching with OGR 
Indication MEL Code Recommendation/Programme 
Orientation  
Guide Radiology 
Chest trauma, 
blunt 
ZB040 ACR AC: 
First-line evaluation of blunt chest trauma; high-energy 
mechanism: MRI chest without (rated 1) and with (rated 2) 
contrast 
Comment: CT chest with contrast, ideally performed with CTA, 
is indicated. 
MRI indicated 
as follow-up for 
chest trauma. 
F.2* 
Stridor, acute ZB040 CAR: 
Acute stridor, unstable child: imaging not indicated. 
Emergency airway management takes precedence over imaging. 
MRI indicated 
as follow-up. 
K.28* 
* refers to the respective chapter number in the OGR 
 
Differing recommendations (Table 4.2-11): 
 According to the ACR AC, MRI chest is not indicated as follow-up di-
agnostic procedure for blunt chest trauma in patients with normal an-
teroposterior chest radiograph, normal examination and normal men-
tal status. According to the OGR, however, MRI is indicated as follow-
up diagnostic for special issues (e.g., muscle avulsion). 
 For staging bronchogenic carcinoma, MRI chest is not indicated ac-
cording to the ACR AC and the CAR. NICE advises against routine 
MRI utilisation to assess the stage of the primary tumour (T-stage) in 
non-small cell Lung Cancer. In the OGR, however, MRI is indicated 
as follow-up diagnosis (following CT examination) for staging lung car-
cinoma in case of suspicion of infiltration of the pericardium, chest 
wall, central vessels spinal structures, Pancoast–Tumour. 
Table 4.2-11: MRI – Thorax: Recommendations differing from OGR 
Indication MEL Code Recommendation/Programme 
Orientation  
Guide Radiology 
Chest trauma, 
blunt 
ZB040 ACR AC: 
Blunt chest trauma: MRI chest without (1) and with (2) 
contrast for patients with normal anteroposterior chest 
radiograph, normal examination and normal mental status, 
no high energy mechanism 
Comment: Chest X-ray and CT/CTA are complementary  
first-line imaging modalities.  
MRI indicated  
as follow-up for 
chest trauma for 
special cases. 
F.2* 
 
Thoraxtrauma 
Stridor 
Thoraxtrauma 
Lungenkarzinom 
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Bronchogenic 
carcinoma: 
non- small 
cell and small 
cell lung 
carcinoma 
ZB040 ACR AC: 
Non-invasive clinical staging of bronchogenic carcinoma: 
MRI chest without and with contrast for non- small cell and 
small cell lung carcinoma; rated 3 
CAR: 
Staging Small Cell Lung Cancer: chest MRI not indicated 
Comment: CT of the chest (and abdomen) with contrast is 
rated most appropriate for staging. 
CAR: only Small Cell lung cancer 
MRI indicated  
as follow-up 
procedure for 
staging of lung 
tumour. L.7* 
Non-small 
cell lung 
cancer 
ZB040 NICE DB: 
Magnetic resonance imaging (MRI) should not routinely be 
performed to assess the stage of the primary tumour (T-
stage) in non-small cell Lung Cancer (NSCLC). 
Comment: Patients with known or suspected lung cancer 
should be offered a contrast-enhanced chest CT scan to 
further the diagnosis and stage the disease. 
MRI indicated  
as follow-up for 
staging of lung 
tumour. L.7* 
* refers to the respective chapter number in the OGR 
 
Gastrointestinal tract 
Overall, 8 recommendations related to inappropriate MR imaging of the gas-
trointestinal tract, including the screening for colorectal cancer, were identi-
fied (Table 8-8). 
No overlaps between the programmes were identified. CT is described as be-
ing preferred to MRI for diagnosing appendicitis in pregnant women with 
fever and leucocytosis (for the Austrian context, radiation protection issues 
need to be considered – the OGR advises CT in the 2nd and 3rd trimester if 
MRI is unavailable) whereas CTC is described as the appropriate procedure 
for colorectal cancer screening following an incomplete optical colonoscopy.  
Related recommendations in the OGR were identified for three clinical con-
ditions. A direct comparison, due to recommendations being on the same level 
and relating to the same intervention and patient group, was possible for the 
following two conditions. 
 
Matching recommendations (Table 4.2-12): 
 For acute abdominal pain, the ACR AC advises against MRI with con-
trast in pregnant women. The method is, however, suggested when no 
contrast agent is administered. According to the OGR, MRI is an ap-
propriate follow-up method for ‘acute abdomen’ in pregnant women. 
Again, no differentiation is made according to contrast agent admin-
istration. 
 For suspected appendicitis in pregnant women, MRI abdomen and 
pelvis with contrast in pregnant women with fever and leucocytosis is 
not indicated according to the ACR AC. MRI examinations without 
contrast are, however, rated appropriate following ultrasound. In the 
OGR, too, MRI is described as suitable follow-up method. 
8 Empfehlungen 
CT wird für  
2 Krankheitsbilder als 
bevorzugt beschrieben 
3 Empfehlungen haben 
Entsprechungen in der 
Orientierungshilfe 
Radiologie 
akutes Abdomen 
Appendizitis 
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Table 4.2-12: MRI – Gastrointestinal tract: Recommendations matching with OGR 
Indication MEL Code Recommendation/Programme 
Orientation  
Guide Radiology 
Abdominal pain, 
acute 
ZC030 ACR AC: 
Acute non-localized abdominal pain and fever or suspected 
abdominal abscess: MRI abdomen and pelvis with contrast 
in pregnant women; rated 2 
Comment: Because it is unclear how gadolinium-based 
contrast agents will affect the foetus, they should be 
administered only with extreme caution; only 
recommended during pregnancy when there are no 
alternatives and benefit outweighs risk. 
MRI without contrast is indicated. 
MRI indicated as 
follow-up for 
‘acute abdomen’. 
J.5* 
Right lower 
quadrant 
abdomen pain 
ZC030 ACR AC: 
Right lower quadrant abdomen pain- suspected 
appendicitis: MRI abdomen and pelvis with contrast in 
pregnant women with fever and leucocytosis; rated 2 
Comment: In general, CT is the most accurate imaging 
study for evaluating suspected appendicitis and alternative 
etiologies of RLQ abdominal pain. 
MRI without contrast indicated following ultrasound. 
MRI indicated 
as follow-up for 
appendicitis. 
J.2* 
* refers to the respective chapter number in the OGR 
 
Genito-urinary system 
Overall, 50 recommendations related to inappropriate MR imaging of the gen-
ito-urinary system were identified (Table 8-9). More than 30% of recommen-
dations relate to oncologic conditions.  
Overlaps between the programmes were identified only for the diagnosis of 
lower urinary tract symptoms with suspicion of benign prostatic hyper-plasia. 
For initial diagnosis of lower urinary tract trauma and hematuria in children, 
the preference of CT was described. For the surveillance of prostate cancer, 
MRI is becoming useful in special circumstances to evaluate for intra-pro-
static, local and distant recurrence. 
For 28 clinical conditions, a related recommendation in the OGR was identi-
fied. A direct comparison, due to recommendations being on the same level 
and relating to the same intervention and patient group, was possible for the 
following conditions.  
 
Matching recommendations (Table 4.2-13): 
 In patients with indeterminate renal mass and normal renal function, 
MRI without contrast is, according to the ACR AC, not indicated where-
as MRI with contrast is. In patients with renal insufficiency, however, 
MRI with contrast is inappropriate because this condition is a contra-
indication to intravenous contrast. According to the OGR, MRI is in-
dicated for initially diagnosing renal masses and following up on renal 
insufficiency (without administering contrast agents). 
 NICE advises against routinely using MRI for assessing women with 
suspected ovarian cancer. In the OGR, too, MRI is only recommended 
for problem solving when sonography is unclear. 
 According to NICE, MRI is not appropriate to routinely assess wom-
en with urinary incontinence. The OGR also suggests to use MRI for 
follow-up only. 
50 Empfehlungen 
 
mehr als 30 % zu 
onkologischen 
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28 Empfehlungen haben 
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 Both the ACR AC and the OGR advise against the use of MRI for ini-
tially diagnosing abnormal postmenopausal vaginal bleeding.  
 For diagnosing urinary tract infection in children, routine imaging is 
not recommended according to NICE. In the OGR, too, MRI is rated 
no routine indication and only suggested when complications occur. 
 For pre-treatment staging of invasive bladder cancer, the ACR AC sug-
gest to avoid MRI of the abdomen without contrast. However, MRI with 
contrast and MRI of the pelvis are rated appropriate. According to the 
OGR, MRI is indicated as follow-up method for pre-treatment staging. 
Table 4.2-13: MRI – Genito-urinary system: Recommendations matching with OGR 
Indication MEL Code Recommendation/Programme 
Orientation  
Guide Radiology 
Indeterminate 
renal mass, 
normal renal 
function 
ZC030 ACR AC: 
Indeterminate renal mass: MRI abdomen without 
contrast for patients with normal renal function; rated 3 
Comment: MRI with contrast indicated. 
MRI indicated as 
initial diagnosis for 
renal mass. L.16* 
Indeterminate 
renal mass, renal 
insufficiency 
ZC030 ACR AC: 
Indeterminate renal mass: MRI abdomen with contrast 
for patients for patients with renal insufficiency; rated 3 
Comment: MRI without contrast indicated as clinical 
condition is a contraindication to intravenous contrast. 
MRI indicated as 
initial diagnosis for 
renal mass, as 
follow-up for renal 
insufficiency (no 
contrast). L.16, H.7* 
Ovarian cancer, 
suspected 
ZC030 NICE DB: 
Do not use Magnetic Resonance Imaging (MRI) 
routinely for assessing women with suspected ovarian 
cancer. 
MRI indicated as 
initial diagnosis 
when US is unclear 
and CT not possible/ 
contraindicated. 
L.20, H.31* 
Urinary 
incontinence  
in women 
ZC030 NICE DB: 
Do not use imaging (MRI, CT, X-ray) for the routine 
assessment of women with urinary incontinence. 
MRI indicated as 
follow-up. H.34* 
Vaginal  
bleeding in 
postmenopausal 
women 
ZC030 ACR AC: 
Abnormal vaginal bleeding: MRI pelvis without (rated 
1) and with (rated 2) contrast as first study of 
postmenopausal bleeding or endometrium < 5mm by 
ultrasound. 
MRI indicated as 
follow-up for  
post-menopausal 
bleeding. H.29* 
Urinary tract 
infection in 
children 
ZC030 NICE DB: 
The routine use of imaging in the localisation of a 
urinary tract infection (UTI) is not recommended. 
MRI no routine 
indication. K.48* 
Bladder cancer, 
invasive 
ZC030 ACR AC: 
Pre-treatment staging of invasive bladder cancer: MRI 
abdomen without contrast; rated 3 
Comment: MRI with contrast is indicated. MRI pelvis 
without and with contrast indicated. 
MRI not indicated 
for diagnosis but 
indicated as follow-
up for staging 
bladder cancer. L.17* 
* refers to the respective chapter number in the OGR 
 
Differing recommendations (Table 4.2-14): 
 In the ACR AC, MRI abdomen with contrast is rated inappropriate for 
initially diagnosing or following up on incidentally discovered adren-
al masses (1-4cm diameter) in patients with no history of malignancy. 
However, MRI without contrast is indicated. For masses >4cm, the re-
commendation is the opposite. According to the OGR, MRI is indicat-
ed as initial diagnostic method for the characterisation of incidentally 
discovered adrenal masses. 
post- menopausale 
Blutungen 
Harnwegsinfektion  
bei Kindern 
Blasenkarzinom 
Raumforderungen  
der Nebennieren 
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 According to the ACR AC, incidentally discovered adrenal masses in 
patients with history of malignancy should not initially be diagnosed 
with MRI with contrast if the mass is <4cm. MRI without contrast is, 
however, indicated. If the mass is >4cm, MRI is neither indicated with 
nor without contrast. According to the OGR, MRI is indicated as ini-
tial diagnostic method for the characterisation of incidentally discov-
ered adrenal masses. 
 For diagnosing medication-responsive hypertension without an evi-
dence of renal disease, imaging is not indicated according to the CAR. 
In the OGR, however, MRA is rated as method of choice for this con-
dition. The lack of a definition of what ‘renal disease’ means in this 
context may be a potential reason for differing recommendations. 
Table 4.2-14: MRI – Genito-urinary system: Recommendations differing from OGR 
Indication MEL Code Recommendation/Programme 
Orientation  
Guide Radiology 
Adrenal mass, 
incidentally 
discovered 
ZC030 ACR AC: 
Incidentally discovered adrenal mass: MRI abdomen with 
contrast for patients with no history of malignancy, initial 
evaluation or follow-up, 1-4cm diameter; rated 2/1 
Comment: Also applies for follow-up. MRI without contrast 
is indicated. 
MRI indicated as 
initial diagnosis. 
H.1* 
Adrenal mass, 
incidentally 
discovered 
ZC030 ACR AC: 
Incidentally discovered adrenal mass: MRI abdomen without 
contrast for patients with no history of malignancy, mass 
>4cm diameter; rated 1 
Comment: MRI with contrast is indicated as part of  
pre-operative staging. 
MRI indicated as 
initial diagnosis. 
H.1* 
Adrenal mass, 
incidentally 
discovered 
ZC030 ACR AC: 
Incidentally discovered adrenal mass: MRI abdomen with 
contrast for patients with history of malignancy, initial 
evaluation, <4cm diameter; rated 1 
Comment: MRI without contrast indicated. 
MRI indicated as 
initial diagnosis. 
H.1* 
Adrenal mass, 
incidentally 
discovered 
ZC030 ACR AC: 
Incidentally discovered adrenal mass: MRI abdomen without 
and with contrast for patients with history of malignancy, 
mass >4cm diameter; rated 1 
MRI indicated as 
initial diagnosis. 
H.1* 
Hypertension ZC030 CAR: 
Hypertension without evidence of renal disease, responsive 
to medication: all imaging not indicated. Imaging is not 
indicated if there is no evidence of renal disease. 
MRA indicated as 
initial diagnosis 
for hypertension 
without renal 
disease. H.3* 
* refers to the respective chapter number in the OGR 
 
Mamma 
Overall, 11 recommendations related to inappropriate MR imaging of the 
breast were identified (Table 8-10). All relate to oncologic conditions.  
Overlaps between the programmes were identified only for the follow-up of 
ductal carcinoma in situ.  
Related OGR recommendations were identified for 10 clinical conditions. A 
direct comparison, due to recommendations being on the same level and re-
lating to the same intervention and patient group, was possible for the follow-
ing conditions.  
Raumforderungen  
der Nebennieren 
Bluthochdruck 
11 Empfehlungen 
10 Empfehlungen haben 
Entsprechungen in der 
Orientierungshilfe 
Radiologie 
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Matching recommendations (Table 4.2-15): 
 The ACR AC advise against the use of MRI in the initial diagnosis of 
both non-palpable and palpable mammographic findings. In the OGR, 
too, MRI is indicated as follow-up and for staging after mammogra-
phy and ultrasound have been performed. 
 To rule out local recurrence and distant metastases in asymptomatic 
women with stage I breast cancer, the ACR AC rates MRI an inappro-
priate method except for ruling out local recurrence in selected patients 
(with contrast). According to the OGR, MRI is indicated as follow-up 
in asymptomatic women >40 after mammography and ultrasound 
have been performed. 
 For breast cancer screening in average risk women without dense 
breasts, the ACR AC advise against the use of MRI. According to the 
OGR, too, MRI is only indicated as follow-up method after mammog-
raphy and ultrasound. 
 In women aged 50 years and over without a TP53 mutation, NICE ad-
vises against MRI breast cancer surveillance unless mammography has 
shown a dense breast pattern. According to the OGR, MRI is indicat-
ed as follow-up diagnostic method if mammography and ultrasound 
do not yield conclusive findings. For dense breasts, the OGR suggests 
an ultrasound examination, however. 
Table 4.2-15: MRI – Mamma: Recommendations matching with OGR 
Indication MEL Code Recommendation/Programme 
Orientation  
Guide Radiology 
Non-palpable 
mammographic 
findings 
ZB040 ACR AC: 
Non-palpable Mammographic Findings (Excluding 
Calcifications): MRI breast without and with 
contrast; rated 1 
MRI indicated as follow-
up and for staging after 
mammography. 
L.23/I.7, I.11* 
Palpable breast 
masses 
ZB040 ACR AC: 
Palpable Breast Masses: MRI breast without (rated 1) 
and with contrast (rated 2) 
MRI indicated as follow-
up and for staging after 
mammography and US. 
I.7, I.11* 
Stage I Breast 
Cancer in 
asymptomatic 
women 
ZB040 ACR AC: 
Stage I Breast Cancer: Initial workup and surveillance 
for local recurrence and distant metastases in 
asymptomatic women: MRI breast without contrast 
bilateral to rule out local recurrence; rated 1  
Stage I Breast Cancer: Initial workup and surveillance 
for local recurrence and distant metastases in 
asymptomatic women: MRI abdomen without and 
with contrast to rule out metastases; rated 2 
Comment: Also applies for surveillance for local 
recurrence and distant metastases. With contrast: 
MRI breast rated 5 
MRI indicated for 
follow-up after 
mammography and US 
in women >40. I.3-5* 
Breast cancer 
in average-risk 
women 
ZB040 ACR AC: 
Breast cancer screening: MRI breast without and 
with contrast for average-risk women, breasts not 
dense; rated 3 
MRI indicated as follow-
up after mammography, 
US. I.3-5* 
Breast cancer: 
women aged 
50 years and 
over 
ZB040 NICE DB: 
Do not offer MRI surveillance to any women aged  
50 years and over without a TP53 mutation unless 
mammography has shown a dense breast pattern. 
MRI indicated as follow-
up when mammography 
and US are non-conclu-
sive. US recommended 
for dense breast. I.4/5* 
* refers to the respective chapter number in the OGR 
Mammakarzinom 
Fernmetastasen 
Screening 
Frauen  
über 50 Jahren 
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4.2.4 Summary of findings 
 The analysis of programmes and databases aiming at promoting an 
appropriate use of health technologies and interventions, focusing on 
MRI, yielded a considerable number of recommendations (253) against 
the use of MRI throughout various clinical conditions. The ACR Ap-
propriateness Criteria® include the most comprehensive collection of 
clinical conditions and related recommendations compared to the oth-
er analysed programs. 
 Most identified recommendations against the use of MRI (53/253; 21%) 
concern MRI examinations of the head (including brain/cranium). 
 The analysis shows that most (69%) of the recommendations against 
the use of MRI advise against using MRI as first (initial) examination 
(e.g., prior to ultrasound or radiographs). 
 Oncology is the medical field the majority of recommendations against 
the use of MRI refer to (67/253; 27%). 
 Due to differences in the quantity of recommendations and the level 
of description of clinical conditions, the amount of overlapping recom-
mendations is low (13 overlaps). The highest degree of agreement was 
reached for the diagnosis of low back pain with no red flags present. 
The Orientation Guideline Radiology, too, advises against imaging 
within the first 4-6 weeks. 
 Where a direct comparison was possible, the recommendations of the 
Orientation Guideline Radiology and the recommendations of analysed 
programmes and databases matched in large part. Reasons for differ-
ing recommendations may include the aim and methods of recommen-
dation development, controversial evidence, varying assessment crite-
ria and the level of detail in the description of clinical conditions and 
interventions. 
Several limitations have to be mentioned: As the review of recommendations 
is based on an unsystematic hand search, there may be some further pro-
grammes that have not been identified and have therefore not been included 
in this review.  
Only publicly available recommendations against the use of MRI have been 
included. There are, however, programmes (e.g., the Royal College of Radi-
ologists Referral Guidelines) that are not open to the public but restricted to 
members or paying customers and that were, therefore, excluded. 
The ACR AC is the only program that guarantees biennial review and up-date 
of its recommendation tables, NICE recommendations and the ACCF AUC 
are updated following the update of guidelines they are based on. However, 
for the CAR Referral Guidelines, Choosing Wisely® and Choosing Wisely 
Canada, no such information is available. Due to fast technical changes, rec-
ommendations may therefore be based on already outdated evidence. 
Not all programs use standardised, transparent methods for evidence review 
and compilation of recommendations. As Choosing Wisely® and Choosing 
Wisely Canada are carried out by various medical societies, applied meth-ods 
and criteria are quite heterogeneous.  
Especially for Choosing Wisely® USA and Choosing Wisely Canada, the 
published recommendations only represent a selection (the ‘top 5’) of proce-
dures that were identified to be inappropriate in the respective medical spe-
insgesamt  
253 Empfehlungen 
gegen MRT-Einsatz 
21 % beziehen sich auf 
Kopfuntersuchungen 
69 % beziehen sich  
auf Erstdiagnose 
27 % beschreiben 
onkologische 
Krankheitsbilder  
nur wenige 
Überschneidungen 
die analysierten 
Empfehlungen stimmen 
zum Großteil mit der 
Orientierungshilfe 
Radiologie überein 
einige Limitationen 
bestehen 
nur öffentlich 
zugängliche 
Empfehlungen 
nicht alle Empfehlungen 
werden regelmäßig 
aktualisiert 
nicht-standardisierte 
Methoden 
die Empfehlungen stellen 
nur eine Auswahl dar 
und sind nicht vollständig 
Results 
LBI-HTA | 2014 71 
cialty. Thus, inappropriate procedures that have not been prioritised by the 
specialty societies are not translated into a recommendation and are therefore 
not published at all. Presumably, more than 5 recommendations regarding the 
inappropriate use of MRI could be suggested by the societies.  
The overrepresentation of American programmes can be determined a limi-
tation; however, it may be due to the fact that the extent of reaction to prob-
lematic overuse and overdiagnosis in health care is higher in the American 
systems than it is in Europe (yet). In addition, it seems that American pro-
grams emphasise the broad dissemination of recommendations, making them 
publicly available and easily searchable. 
 
 
4.3 Interventions for reducing inappropriate use of imaging 
4.3.1 Results from literature review 
Evidence-based clinical guidelines define whether or not imaging is appro-
priate for a specific clinical condition. Several factors may contribute to an 
incomplete implementation of these practice guidelines, leading to overuse or 
underuse of imaging [88-90] 
Factors on physician side identified were:  
 a culture of thoroughness rather than prudence,  
 misaligned incentives under fee-for-service payment,  
 physician-directed marketing, and  
 defensive medicine.  
Patient-driven factors were:  
 a preference for high technology,  
 direct-to-consumer marketing, and  
 unawareness from the true costs of care due to third-party payment.  
According to a survey amongst radiologists, the perceived causes for increased 
use of advanced medical imaging were increased possibilities due to new ra-
diology technology, people’s increased demands for a certain knowledge about 
own health, referring physician’s low tolerance for uncertainty; expanded clin-
ical indications for radiology, increased availability of radiological equipment 
and personnel. Perceived caused of unnecessary investigations are over-inves-
tigation and insufficient clinical information and unclear questions in the 
referral [90]. 
Many different interventions can be used to improve appropriate use of im-
aging: following the taxonomy of the Cochrane Effective Practice and Organi-
sation of Care (EPOC) group they can be differentiated in educational, finan-
cial, organisational and regulatory interventions, which are further distin-
guished according to whether patients or providers are the targets of the in-
tervention [91]. In the following we present the results of a literature review 
to identify proposed interventions to reduce inappropriate imaging by MRI 
and studies on their impact on appropriateness of imaging utilisation.  
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Educational interventions 
Table 4.3-1: EPOC taxonomy adapted to educational interventions to reduce inappropriate imaging 
Distribution of educational 
materials  
Distribution of published or printed recommendations for clinical care, including 
clinical practice guidelines, audio-visual materials and electronic publications. 
The materials may have been delivered personally or through mass mailings. 
For referrers: Referral guidelines, diagnostic algorithms and evidence-based 
decision rules, clinical pathways, diagnostic pathways, clinical prediction rules. 
For patients: Support for informed decision-making (resource cards), information 
on „incidental findings”, benefit risk information, information on imaging 
guidelines and actual utilisation data of respective hospital 
Educational meetings  Health care providers who have participated in conferences, lectures, 
workshops or traineeships. 
Local consensus processes  Inclusion of participating providers in discussion to ensure that they agreed that 
the chosen clinical problem was important and the approach to managing the 
problem was appropriate.  
E.g. interactions with colleagues to draft standard diagnostic algorithms for 
common clinical presentations 
Educational outreach visits  Use of a trained person who met with providers in their practice settings to give 
information with the intent of changing the provider’s practice. The information 
given may have included feedback on the performance of the providers. 
E.g. radiologist-led educational sessions for referrers 
Local opinion leaders  Use of providers nominated by their colleagues as ‘educationally influential’. 
The investigators must have explicitly stated that their colleagues identified the 
opinion leaders. 
Reminders  Patient or encounter specific information, provided verbally, on paper or on a 
computer screen, which is designed or intended to prompt a health professional 
to recall information. This would usually be encountered through their general 
education; in the medical records or through interactions with peers, and so 
remind them to perform or avoid some action to aid individual patient care.  
E.g. Computer aided decision support tools 
Marketing Use of personal interviewing, group discussion (‘focus groups’), or a survey of 
targeted providers to identify barriers to change and subsequent design of an 
intervention that addresses identified barriers. 
Mass media Varied use of communication that reached great numbers of people including 
television, radio, newspapers, posters, leaflets, and booklets, alone or in 
conjunction with other interventions; ii targeted at the population level. 
 
Referral guidelines implementation 
Technological advances and expanded medical possibilities are considered the 
most important factor in the rise of imaging utilisation: imaging studies re-
place other examinations, sometimes more invasive and expensive [62, 90]. 
The rapid technical developments and the expansion of indications for MRI 
make it increasingly difficult for healthcare professionals to stay up to date 
with current scientific knowledge: a development that has been described as 
„knowledge crisis” [92]. Lack of knowledge and/or training has been identi-
fied as a major factor leading to inappropriate use of imaging [93]. The avail-
ability of referral guidelines, however, is not in itself sufficient to drive appro-
priate use of medical imaging [94], but need to be complemented by measures 
to reinforce the use of guidelines [95]. Barriers to the adoption of guidelines 
are an incomplete dissemination in the medical community, which can be 
targeted by educational interventions, as listed in Table 4.3-1. Abramson et al. 
list these interventions in the category of „prospective utilisation manage-
ment”: it includes the drafting of standard diagnostic algorithms for common 
clinical presentations as well as radiology-led educational sessions with refer-
ring providers [61].  
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The results of RCTs studying the effects of educational interventions on guide-
line implementation show mixed effects. In a systematic review, French et al. 
reviewed interventions designed to improve appropriate use of imaging for 
musculoskeletal interventions [96]. Outcome measures included provider per-
formance, such as number of people referred to imaging or clinical outcomes 
as primary outcomes, depending on the research question the objective could 
be an increase or a decrease in imaging referral. Three of the included stud-
ies analysed MRI: Robling 2002 (knee or lumbar problems, knee and lumbar 
MRI) [97], Rossignol 2000 (low back pain, MRI) [98] and Schectman 2003 
(acute low back pain, lumbar MRI) [99]. Rossignol et al. report that prac-
tices using a concerted educational programme on clinical practice guidelines 
(http://www.core-che.com) lead to improved health outcomes and reduced 
unnecessary imaging [97]. Robling 2002, in contrast, report that seminars and 
feedback are not more effective in increasing appropriate imaging than dis-
tribution of guidelines alone [98]. Schectmann et al. finally report that guide-
line-consistent behaviour was increased following an education/audit/feed-
back model with local peer opinion leaders [99]. 
On European level, a number of initiatives on radiology training exist, such 
as the European Medical ALARA Network (EMAN) and Medical Radiation 
Protection in Education and Training (MEDRAPET, www.medrapet.eu). 
These initiatives have a strong focus on radiation protection, but might pro-
vide starting points to promote appropriate use. An EC Tender project under 
the lead of the European Society of Radiology (ESR) has surveyed the avail-
ability and use of referral guidelines in EU Member States and issued rec-
ommendations for national and community actions for guideline implemen-
tation. These recommendations included lifelong learning (continuing profes-
sional development) for referrers, clearer and stronger European measures to 
encourage both availability and use of referral guidelines and the development 
and integration of clinical decision support systems (CDS). These should in-
terface with existing electronic requesting systems (computerised physician 
order entry system, CPOE) and radiology information systems [100]. 
In Austria, the „Arbeitsgruppe, Orientierungshilfe Radiologie’ der Bundesfachgruppe 
Radiologie der Österreichischen Ärztekammer und der Österreichischen Röntgenge-
sellschaft“ has developed referral guidelines for MRI (and CT), which are avail-
able online (http://orientierungshilfe.vbdo.at/) and are also distributed in 
printed version. The „Orientierungshilfe” ranks the evidence based on the Lev-
els of Evidence for Primary research question, adopted by the North Ameri-
can Spine Society, where the highest evidence level for diagnostic studies is 
provided by diagnostic studies with consecutive patient cohort and univer-
sally applied reference „gold” standard (or systematic review of such studies) 
[101]. Another project „EBM Guidelines für Allgemeinmedizin“ (http://www. 
ebm-guidelines.at/) develops guidelines for general practitioners, based on 
the best available evidence. For imaging, this best available evidence is often 
expert consensus. We did not identify any projects in Austria aiming at in-
creasing the awareness of recommendations against the use of advanced im-
aging. 
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Decision support tools 
Imaging is most often part of a clinical pathway for clinical conditions and 
diseases. There is increasing need for advanced systems to help clinicians to 
navigate through complex and evolving pathways.  
Clinical pathways differ from practice guidelines, protocols and algorithms 
as they are utilised by a multidisciplinary team and have a focus on the qual-
ity and co-ordination of care [102]. Several national quality improvement in-
itiatives have developed such clinical pathways for a vast range of different 
conditions; others – individual care institutions and hospitals – only for a few 
high volume interventions [103]. General clinical pathways including the di-
agnostic work-up for multiple conditions and diseases in high volume and 
high cost diagnosis-related groups (DRG) (e.g. orthopaedics, surgery) are to 
be found at (examples, not comprehensive): 
NICE/GB: http://pathways.nice.org.uk/ 
Queensland Health/AU: 
http://www.health.qld.gov.au/caru/pathways/pathways.asp 
 
Diagnostic pathways (as subset of clinical pathways) have become an impor-
tant management concept in recent years [104] with the introduction of al-
gorithms for stepped utilisation of highly specialised and costly (laboratory 
and radiologic) diagnostic tests [105-110]. Diagnostic pathways can be found 
for example at: 
DoH/Western Australia/AU: 
http://www.imagingpathways.health.wa.gov.au/index.php/imaging-pathways, 
12 fields of medical specialities with 10-20 sub-indications each (about 150 to 
200 imaging pathways) – Table 4.3-1 as example for pathway for adult head 
Injury patients. 
UpToDate® (fee-based):  
http://www.uptodate.com/, Evidence based diagnostic algorithms for multiple 
indications – Figure 4.3-2 as example for diagnostic algorithm for low back pain 
patients 
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Figure 4.3-1: Pathway for adult head injury patients  
(Source: http://www.imagingpathways.health.wa.gov.au/index.php/imaging-pathways) 
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Figure 4.3-2: Diagnostic algorithm for low back pain patients (Source: www.uptodate.com) 
Several academic and commercial providers offer online decision support sys-
tems that can be integrated with computerised provider order entry, in order 
to promote the dissemination of established appropriateness criteria and clin-
ical decision rules [111]. This might be purely educative methods of utilisa-
tion management on an individual case basis, but could also enable monitor-
ing or even regulation of ordering behaviour. In Australia, a suite of Diag-
nostic imaging pathways [112] was developed both as a decision support tool 
and educational tool and disseminated with a multi-faceted approach, with 
reportedly positive impact on ordering behaviour and general knowledge of 
diagnostic imaging [111, 113, 114]. 
elektronische/online 
Entscheidungsunter-
stützung 
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Table 4.3-2: Benefits and potential problems/barriers in the introduction of pathways [104, 110] 
Benefits Potential problems and barriers 
 Support the introduction of evidence-based medicine 
and use of clinical guidelines 
 Provide and disseminate explicit and well-defined 
standards for care  
 Support continuity and co-ordination of care across 
different clinical disciplines and sectors 
 Help reduce variations in patient care  
(by promoting standardisation) 
 Support clinical effectiveness, risk management and 
clinical audit 
 Improve multidisciplinary communication, teamwork 
and care planning and between different care sectors 
 Optimise the management of resources:  
Expected to help reduce costs 
 Support training and ensure quality of care with 
providing a means of continuous quality improvement  
 Support the implementation of continuous clinical 
audit in clinical practice  
 Not prescriptive: don’t override clinical judgement 
 May appear to discourage personalised care 
 Risk increasing litigation 
 Don’t respond well to unexpected changes in  
a patient’s condition 
 Suit standard conditions better than unusual 
or unpredictable ones 
 Require commitment from staff and 
establishment of an adequate organisational 
structure 
 Problems of introduction of new technology 
 May take time to be accepted in the workplace 
 Need to ensure variance and outcomes are 
properly recorded, audited and acted upon 
 
In the Manitoba demonstration project, the guidelines in the decision sup-
port suggested that more than 10% of imaging orders were inappropriate, 
but the impact on ordering behaviour was very small [115]. Prerequisites for 
a successful introduction of such tools are that they should not disrupt patient 
care workflow and the acceptance of the underlying guidelines [62]. Wheth-
er the impact on time to order was positive or negative was depending on the 
setting [115]. Another study showed good acceptance and support in a fami-
ly practice clinic, but only 25% of the participants followed advice following 
prompts of inappropriateness [116]. One retrospective cohort evaluation of the 
effect of the implementation of an imaging management programme on lum-
bar MRI, head MRI and sinus CT – three high volume, high cost, high vari-
ability procedures – found that the utilisation decreased by 23,4% for low-
back pain lumbar MRI, 23, 2% for headache head MRI and 26,8% for sinusi-
tis after the introduction of the decision support based on evidence based 
decision rules for appropriate imaging. In this setting, providers not docu-
menting compliance with guidelines were denied MRI [117].  
Other studies reported the reduction of high-cost imaging, but without data 
on appropriateness in outpatient setting [118] or hospital setting [119], good 
acceptance and reduction in low utility examinations [120], reduction in CT, 
but only small reductions in MRI [121, 122], decreases in low yield imaging 
procedures [123, 124].  
Decision making tools may also designate clinical prediction rules, such as 
the Ottawa Ankle Rule: this clinical prediction rule identifies patients at such 
low probability of fracture that imaging is not necessary. A useful clinical 
prediction rule is clinically important, it must make sense to users, be repro-
ducible and easy to use, clinically relevant and validated [125]. They fulfil 
different purposes such as exclusion criteria in emergency settings, or a cost-
effectiveness analysis to determine the most appropriate imaging modality. 
A framework for the development of decision support applications for acute 
low back pain was presented by [126]. A group in Ottawa has developed 4 de-
cision rules for the use of imaging in trauma cases: the Ottawa Ankle Rule, 
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the Ottawa Knee Rule, the Canadian C-Spine Rule, and the Canadian CT 
Head Rule. Application of these decision rules has resulted in a 20%-30% re-
duction in imaging [127]. 
The Altarum institute (USA) is leading a community based intervention to 
reduce unnecessary imaging studies by establishing a data-exchange and de-
cision support system complemented with training of a network of area care 
providers. 
 
Patient demand 
According to a survey amongst radiologists in Norway, the perceived major 
cause of unnecessary radiological investigations are increased supply and de-
mand of services [90]. In a cross-sectional survey amongst elderly patients in 
the US, a correlation between the perceived need for radiological studies and 
imaging utilisation was found [128]. A survey amongst patients with early 
stage breast cancer showed that patients want imaging done, even if the chance 
of detecting metastases was <10% and that they would feel uncomfortable if 
imaging was not ordered, even if this was in line with guidelines [129]. Pa-
tients are increasingly aware and concerned about their health status and 
less willing to accept e.g. ageing issues as a normal status. Patients are re-
ported to be better aware of their rights as patients and to appear increasing-
ly demanding [130]. Increased patient demand is also assumed to be related 
to the „health culture”, the public opinion on the practice of medicine, with an 
increased call for prevention and strong industry influence, potentially lead-
ing to misguided patient preferences. 
As a consequence health care providers have increasing concerns for medi-
cal-legal risk (fear of litigation), promoting defensive medicine and imaging 
with no clinical rationale, other than to rule out pathology [90]. Patient satis-
faction, however, does not equate to health outcomes and increased utilisation 
and increased expectations go hand in hand [131]. Moreover, defensive med-
icine may produce VOMIT („Victims of modern imaging technology”) [132] 
through incidental findings, due to the statistics of multiple testing and the 
bias introduced by medical history (incidental findings will be used to explain 
symptoms) [133]. 
Nationwide efforts may be effective to discourage inappropriate medical im-
aging: for example the distribution of hospital-level utilisation data together 
with the latest imaging guidelines on prostate cancer imaging was associated 
with a reduction in inappropriate imaging (from 45% to 3% in the low-risk 
category) in a 10 year period [134]. Australia developed a resource card for 
practitioners and their patients providing information to both patients and 
GPs when discussing diagnostic imaging tests [135]. The resource card in-
cludes information for the healthcare professional on his responsibilities as a 
referrer and on the elements a patient needs to be educated about to make an 
informed decision: the nature of the imaging procedure, the benefits and risks, 
alternative forms of investigation that provide the same results, benefits and 
risks of the alternative investigations, benefits and risks of not undergoing 
investigation [136]. The patient information on MRI provided by the Aus-
trian Radiology Society could be complemented with these elements [137]. 
A pilot project at the Patient-Centered Outcomes Research Institute (PCORI, 
USA) aims to develop an educational intervention for primary care physicians 
based upon simulated office visits with standardised patients and to evaluate 
the effectiveness and durability of this intervention (Joshua Fenton, person-
al communication). 
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Structural and organisational interventions 
Table 4.3-3: EPOC taxonomy adapted to structural and organisational interventions to reduce inappropriate imaging 
Organisational interventions 
Revision of professional roles Also known as ‘professional substitution’, ‘boundary encroachment’ and 
includes the shifting of roles among health professionals. Also includes 
expansion of role to include new tasks. 
E.g. revision of the roles of general practitioners and radiologists in the  
Clinical multidisciplinary 
teams 
Creation of a new team of health professionals of different disciplines or 
additions of new members to the team who work together to care for patients. 
E.g. multidisciplinary imaging teams 
Communication and case 
discussion between distant 
health professionals 
Mandatory consultation, voluntary communication 
Structural interventions 
Changes in medical records 
systems  
E.g. standardisation of digital referral 
Presence and organisation of 
quality monitoring 
mechanisms 
E.g. Hospital performance benchmarking, Internal and external audit, 
monitoring of utilisation 
 
Revision of professional roles 
Blackmore et al. describe two models for the role of radiologists in defining 
quality in radiology: the first is the „radiologist production model”, the sec-
ond the „radiologist professional model” [138]. In the radiologist production 
model radiologists are paid based on the number of imaging procedures car-
ried out: in Austria, current reimbursement is based on this model. The „ra-
diologist professional model” in contrast describes a more extensive role of 
the radiologist as „experts in the use of imaging for diagnosis, specialists in 
image acquisitions and interpretation and consultants in the application of 
imaging information to patient care”, with corresponding quality metrics de-
tailed in [138] and Table 4.3-4. 
Table 4.3-4: Quality metrics – Radiologist professional model [138] 
Component of 
Professional Model  Elements Sample Metrics 
Who should be 
imaged? 
Use of evidence-based 
imaging practice 
Adherence to clinical prediction rules, compliance with local 
and national practice guidelines 
What imaging 
approach? 
Selection of optimal 
imaging strategy 
Diagnostic yield, adherence to clinical prediction rules, 
compliance with local and national practice guidelines, rate 
of additional (induced) imaging studies 
How are studies 
interpreted? 
Balance of sensitivity  
and specificity 
Rate of false-positive and false-negative diagnoses, 
diagnostic yield 
 Tailoring of 
interpretation to 
clinical scenario 
Ratios of adverse false-positive outcomes (i.e., negative 
laparotomy result, negative biopsy result) vs rate of adverse 
false-negative outcomes (i.e., delayed diagnosis) 
Patient outcome Effect of imaging on 
patient care 
Rates of specific therapeutic interventions after imaging  
(i.e., use of thrombolytics for non-haemorrhagic stroke, 
biopsy or appropriate follow-up for lung nodule, repositioning 
of endotracheal tube after misplacement identified on chest 
radiograph) 
 Effect of imaging on 
outcome 
Rates of specific medical errors after imaging (i.e., negative 
laparotomy for appendicitis, nontherapeutic knee laparoscopy, 
intracranial haemorrhage after thrombolytics for stroke) 
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One factor supposedly spurring inappropriate imaging is the „knowlegde cri-
sis” – the „overload” of physicians with reported technological advances, e.g. 
at conferences and the difficulty to stay up to date with and analyse the un-
derlying evidence. Deciding on the appropriateness of an imaging request re-
quires the expertise of multiple disciplines, depending on the clinical case. 
Fraser et al. propose the creation of joint multi-disciplinary diagnostic ser-
vices for cardiovascular imaging to coordinate the clinical use of diagnostic 
imaging technologies in a cardiac hospital unit [139]. The joint service should 
include cardiologists, radiologists and nuclear medicine specialists. We did 
not identify any studies analysing the impact of clinical multidisciplinary 
teams on medical imaging use. 
In Canada, the Medical imaging team (www.imagingteam.ca) including phy-
sicians (radiologist, nuclear medicine specialists), physicists, sonographer and 
technologists receives every request for medical imaging and assesses the po-
tential benefits and risks of the examination before the examination is booked. 
This process is carried in 3 steps: review stage, protocol stage, prioritisation 
stage. In the review stage, the alignment of the request with the patient’s histo-
ry is reviewed and the most appropriate imaging modality is identified, based 
on patient’s availability, accessibility, radiation minimisation and (cost-)ef-
fectiveness. In the protocol stage, the request becomes a prescription of a cer-
tain imaging protocol. In the last stage, the requests are prioritised according 
to their time-sensitivity [140].  
 
Communication and case discussion between distant health professionals 
Early studies did not demonstrate an effect of mandatory inpatient radiology 
consultation service on resource utilisation and suggested this as a more pro-
mising option for the outpatient setting [141].  
In the outpatient setting, point-of-care techniques aim to incorporate radiol-
ogist consultation in the clinical workflow [61]. The routine reviewing of re-
quests for diagnostic imaging by radiologists could help both the assessment 
of appropriateness and the interpretation of test results [142]. According to 
the professional model described by Blackmore 2007 [138], communication 
between radiologist and ordering physician should go beyond simple call-
backs on protocol selection or contra-indications. However, a routine review-
ing of imaging requests is time consuming and may take longer than simply 
to carry out the study – thus implementation will require financial (or regu-
latory) incentives. 
There are several ways to incorporate radiologist consultation in the clinical 
workflow. It could be a radiologist-staffed hotline for consultation of test or-
dering [138]. Duszak et al. describe radiology benefits management (RBM) as 
another option: in the US, these are business models, where health insurers 
may outsource the management of their imaging portfolios, profitability of 
the RBM depends on its success in controlling imaging expenditure [143]. 
RBM may act as pure educational initiatives or have more a more regulatory 
role with pre-authorisation by a RBM required for the provision of imaging. 
Another options to improve the case communication between referrer and ra-
diologist is to restrict imaging provision to a list of accepted referrers and to 
define a mandatory amount of information that needs to be provided with the 
imaging request [138]. Our literature search did not yield any studies ana-
lysing the impact of case discussion on medical imaging use. 
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Changes in medical records systems 
Insufficient referral information was identified as a major factor leading to 
inappropriate imaging. Information loss between providers was identified as 
a factor leading to inappropriate imaging [90]. This can be adjusted through 
communication between radiologists and ordering physicians, but requires the 
effort of radiologists to collect the missing information. Another solution is to 
standardise and digitalise referrals in order to ensure completeness of the pro-
vided information, including the patient’s imaging and clinical history. This 
requires an appropriate IT infrastructure and the use of electronic health rec-
ords.  
Electronic decision support tools may not necessarily be integrated with elec-
tronic health records, but may also be used as stand-alone tools [126, 144]. 
However the automatic provision of decision support as part of clinician work-
flow was identified as a critical feature of clinical decision support tools to 
improve clinical practice [145]. 
A systematic review of 14 observational studies of the impact of computerized 
provider order entry (CPOE) on medical-imaging services (with/without de-
cision support), found that „significant imaging-department efficiency and 
effectiveness gains associated with CPOE may be achieved. Most of these ben-
efits were associated with DSS promoting adherence to test ordering guide-
lines” [146]. The majority of the studies, however, analysed the impact on 
general radiology procedures.  
After receiving the order by the clinician, radiologists review the order and 
assign a specific protocol for the examination. This decision step may also be 
computer-assisted and -recorded to ensure documentation and standardisation. 
One such tool is the Radiology Protocol Tool Recorder – RAPTOR [147]. 
 
Presence and organisation of quality monitoring mechanisms 
Abramson et al. suggest as „retrospective” measures the profiling and targeted 
educational interventions aimed at colleagues with outlier ordering patterns 
[61]. 
In their report „Referral guidelines for medical imaging – availability and use 
in the European Union”, the ESR included recommendations for monitoring 
through clinical audit, preferably through external audit, but also through 
local internal audit. External audit has been addressed in EC guidelines on 
clinical audit (EC guidelines on clinical audit for medical radiologic practice), 
but further measures are needed to promote local internal audit. (ESR refer-
ral guidelines for medical imaging – availability and use in the European Un-
ion). Standardised documentation and terminology is a prerequisite for any 
monitoring measure [40].  
Quality improvement programmes by monitoring of imaging utilisation were 
e.g. initiated by the Centers for Medicare and Medicaid Services (CMS, US): 
the Hospital Outpatient Quality Reporting Program (HOQR) is publicly re-
porting US hospitals’ use on imaging studies with potentially problematic 
overuse, amongst which MRI studies performed for patients with low back 
pain without antecedent conservative therapy. Data emerging from this mon-
itoring were analysed with regards to the variability of imaging use, with a 
highly skewed distribution being interpreted as indicative of overuse, as it 
would be unlikely to be explained by case mix or random chance. The effect 
of publicly reporting hospital performance was deemed limited by the study 
authors, as imaging overuse was rarely consistent across indications and pa-
Treiber: ungenügende 
Informationen in 
Zuweisung 
 
... Standardisierung  
und Digitalisierung der 
Zuweisungen 
Integration in 
elektronische 
Gesundheitsakte 
 
 
effektiv in Steuerung 
angemessener 
Verwendung 
interne oder externe 
Qualitätskontrolle 
 
 
 
 
benötigt standardisierte 
Dokumentation 
Opportunities and strategies to drive appropriate use of MRI in Austria 
82 LBI-HTA | 2014 
tients often had limited choice of available hospitals in rural areas and hos-
pitals thus would experience little pressure to improve their imaging utilisa-
tion [148]. 
Cammisa et al. report a quality improvement project, in which actionable are-
as of overuse were identified from claims data (notably, management of acute 
and chronic back pain by MRI of the spine during the first 4 to 6 weeks of 
symptoms in the absence of a prescribed set of „red flags.”) by an expert panel. 
In outreach visits, primary care physicians were engaged in a „respectful dis-
cussion” on the panel’s recommendation, peer comparison data and best prac-
tices. Pre-post intervention analysis showed a decrease in the identified over-
use areas in the post-intervention time period. However, due to the study de-
sign, causality cannot be demonstrated [149]. 
 
Regulatory and financial interventions 
Table 4.3-5: EPOC Taxonomy adapted to financial and regulatory interventions to reduce inappropriate imaging 
Financial – Provider interventions 
Fee-for-service  Provider has been paid for number and type of service delivered 
Capitation  Provider was paid a fixed amount per patient for providing specific care.  
E.g. bundled payment per episode of care, population-based bundling 
Pay for performance  
Formulary  Added or removed from reimbursable available products 
Financial – Patient interventions 
Co-payment  Patient payment at the time of health care delivery in addition to health insurance  
Regulatory interventions 
Pre-authorisation Requirement for formal approval of a planned imaging procedure from the 
insurance company or its designee 
Pre-notification Requirement for review of a planned imaging procedure by the insurance 
company or its designee 
Ownership, accreditation, 
and affiliation status of 
hospitals and other facilities 
E.g. accreditation of imaging facilities, medical equipment planning by  
health authority 
 
Economic incentives of the reimbursement system should reward evidence-
based care and preferred outcomes [67]. The collection of activities to reduce 
the high levels of utilisation and spending that come with unfettered fee-for-
service is also summarised under the term „managed care” – it encompasses 
e.g. financial incentives to influence utilisation patterns, direct oversight of 
utilisation decisions, selective contracting with preferred physicians and hos-
pitals or restricted choices through closed panels and gatekeepers [150].  
In the US, new models for health care delivery using economic incentives to 
meet quality performance goals have evolved from early managed care organi-
sations (radiology benefits management – RBM) and aim to combine cost con-
tainment with quality of care performance goals [61]. These accountable care 
organisations (ACO) use fee-for-service but also capitated payment structures, 
such as bundled payments for episodes of care or global (population-based) 
bundling [61]. The rise of ACO is considered a potential threat to the revenues 
of radiologists groups, which in turn could incentivise radiologists to take on 
„a more central role within integrated care entities by developing and deploy-
ing systems service lines (...) that may include utilisation management, deci-
sion support, quality and safety assurance, and operational enhancements” [61]. 
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A retrospective analysis of medical records on imaging procedures carried out 
in Turkish hospitals reported that the temporary introduction of a capitated 
payment scheme, where a fixed amount per outpatient is paid to the hospital 
according to the discipline, regardless of the number of procedures carried 
out, led to a reduced imaging demand during this episode [151]. 
The US health care system and its fee-for-service payment process was de-
scribed a contributor to overutilization of imaging services in a report of a 
US Radiologists summit [67]. However, this finding is not easily transferra-
ble to other settings. A review of funding for diagnostic imaging services in 
Australia comes to the conclusion that „the current (...) fee for service model 
has worked well to provide reasonable patient access to high quality imaging 
services (...). Any proposal to shift to alternative funding mechanisms will 
need careful policy design.” [152]. 
Any transformation from a fee-for-service model to a pay-for-performance 
model will require both robust metrics and tools to measure performance and 
the implementation of instruments for utilisation management [143, 153]. 
Performance measures proposed are e.g. a profiling of physician ordering pat-
tern using decision support systems or radiology benefit managers [143, 153].  
 
Financial incentives targeting patients 
Shah et al. describe the consequences on health services utilisation following 
the introduction of cost-sharing by coinsurance for (amongst others) imaging 
services. The results of the cohort study showed that relatively low levels of 
cost sharing led to a long-term decrease in utilisation, however there was no 
analysis of the appropriateness of imaging utilisation [154].  
 
Regulatory interventions 
Containment of self-referral 
Physicians with ownership interests in medical imaging equipment are more 
likely to use imaging as physicians who referred their patients to radiology, 
[155-157]. Radiologists have a consultant role in this situation and may actu-
ally limit overuse. However, they may also contribute to overuse in situations 
in which they act as primary care providers and e.g. publicly advertise their 
services [158]. One measure to contain inappropriate imaging by self-referral 
is the introduction of an accreditation process for facilities furnishing ad-
vanced diagnostic procedures [159]. Such an accreditation of imaging facili-
ties and the compliance with quality standards including training of staff, is 
already a condition for reimbursement in Austria. 
Delisting of medical services 
A top-down approach to reduce inappropriate is the delisting of medical im-
aging services: e.g. the Ministry of health in the province of Ontario, Canada 
has delisted certain lumbar spine studies in the absence of suspected or known 
pathology [160]. An obligation set out in the April 1, 2012 OHIP Fee Sched-
ule of ordering physicians to repay for CT/MRI studies of the lumbar spine 
if such service is subsequently determined not to be medically necessary was 
later revoked [161]. 
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Prior authorisation 
Prior authorisation designates the requirement for formal approval of a plan-
ned imaging procedure from the insurance company or its designee (or e.g. a 
RBM company). In the absence of prior approval, reimbursement of the pro-
cedure may be refused [162].  
The success of prior authorisation in controlling imaging utilisation has been 
analysed in several studies. For example, Blachar et al. report a reduction of 
9% of MRI examinations following the introduction of pre authorisation [162]; 
similar pre-post introduction case studies showed a decline of utilisation rates 
by 8% to 15% [163]. The effects flattened out in the second year after intro-
duction [163].  
Potential problems associated with prior authorisation are a lack of transpar-
ency, the disruption of the clinical work flow and the administrative burden. 
The impact on quality improvement is not demonstrated [164].  
A recent study showed that the removal of the denial provision (i.e. refusal of 
reimbursement) in pre-authorisation did not lead to increased imaging utili-
sation [165]. Several authors state that the effect of prior authorisation on ap-
propriate utilisation may in large part be attributed to an educational effect 
on the referrers [62, 164].  
Prior notification 
Prior notification describes the process of a prior authorisation without de-
nial provision. Prior notification programmes emphasise the educational and 
collaborative aspect with referring physicians [21]. 
 
4.3.2 Results from stakeholder interviews 
In this step, we were interested to contrast the results of the literature review 
with the perspectives of stakeholders in Austria, to identify factors potentially 
contributing to inappropriate imaging in Austria and the criteria and mech-
anisms currently in place to minimise it. Furthermore the potential applica-
bility of additional interventions to the Austrian context was investigated. 
 
Educational interventions-Referrers 
In our interviews, the referrers were identified as being responsible to ensure 
the appropriateness of their imaging requests. Radiologists both in the inpa-
tient as in the outpatient setting stated, they would refuse imaging if contra-
indications are suspected and seek clarification with the referrers, but beyond 
that no assessment of appropriateness would take place: „Radiologists are not 
in the position to question every referral”. 
Lack of training and/or experience was mentioned as a factor leading to over-
utilisation of MRI: young and poorly trained physicians would be more prone 
to order imaging for the sake of reassurance and defensive medicine and are 
less familiar with other diagnostic examination methods. Consequently re-
ferrers are primarily targets for educational interventions on appropriate im-
aging and should be trained to differentiate situations in which imaging is 
appropriate or not. 
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Electronic decision support tools were poorly perceived by some: concerns 
expressed were the „alert fatigue”, the misuse by filling in the information 
needed for the desired result, the replacement of knowledge and counselling 
by a programme. Others found it a possible useful solution, if coupled with 
digitalised ordering systems. 
The „Orientierungshilfe Radiologie” was known amongst all our interviewees 
and was identified as guidance specifically targeting the referrers. In addi-
tion, guidelines on contrast agents and lists for acute indications are used. In-
tramurally, standard operating procedures (SOP) e.g. for night shifts are de-
veloped, sometimes by an interdisciplinary board. ‘Do not do’ Recommenda-
tions were often not known, or not in detail. There were concerns on the ap-
plicability to the Austrian context. Due to the lack of direct risks from MRI 
(as opposed to techniques using ionising radiation), several interviewees ex-
pressed the concern, that in clinical practice it is difficult to identify situations 
in which MRI imaging would clearly not be justified, and refusal would af-
fect the diagnosis by exclusion.  
Table 4.3-6: Interview responses: Educational interventions – referrers 
Current decision making process in practice 
We make an anamnesis prior to each examination. We refuse exams due to implants or other contraindications. 
A standardised documentation of refusal justifications is currently a matter of debate. 
The radiologist on duty will contact the referrer if he thinks an investigation is not indicated. 
No examination without referral. 
The radiologist on duty is in charge to refuse MRIs that are not indicated, but this occurs very rarely. 
Outpatient radiology institutes are not in the position to question referrals. 
The basis of each MRT exam are the clinical examination and the referral.  
MRT is often used for diagnosis of exclusion, to rule out severe conditions. 
We have no time for unnecessary examinations, we contact the referrer if something needs to be clarified. 
If an MRI is requested by a referrer and authorised by the health insurance it is very difficult, as a private 
institute, to refuse it. 
The radiologist is not in the position to control or question a referral, if it is an usual indication. 
Referrers as targets for educational interventions 
There are deficits in the communication and in the education. It should be communicated that certain 
methods benefit only a selected patient pool. There is not enough knowledge about diagnostics. 
We offer a service hotline for referrers. It is a service, not mandatory. 
Physicians with poor training are a problem, as they tend to compensate lack of knowledge by investigations. 
The referrer must know whether a MRI is appropriate or not and use criteria for decision making. He is 
responsible for the ensuing treatment of the patient. 
The referrer is in charge [of evaluating appropriateness]. 
A negative result may be useful, if it allows for example to discharge a patient, sparing the costs for a day at 
the hospital. But there should be limitations to the use for exclusion of diagnosis. 
The referrers need to be trained to follow the guidelines; the radiologist is not in the position to question 
every referral. 
There is also an increased demand from the physician’s side: young practitioners are dependent of high-tech 
methods, less familiar with other diagnostic methods. 
Diagnostic investigations are performed for reassurance. 
The referrers are the targets, able to steer appropriate use of MRI. 
Deviation from guidelines must be possible e.g. depending on local circumstances: available equipment, 
doctor/patient readiness for watchful waiting, concerns of complications, time pressure. 
A desire for reassurance, notably of young physicians, certainly promotes the use of MRI, also because there 
are increasingly lawsuits. 
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The referrers are more aware of MRI.  
Frequently the examination has no consequences and provides no additional information. The referrers 
should be aware that MRI is not always the superior method. 
The referrers should be in charge [of evaluating appropriateness]. 
Inadequate education is the problem, insufficient knowledge leads to uncertainty, which is compensated by 
investigations. It is very difficult to identify the situations in which an examination is necessary. 
Decision support tools 
Decision support tools are useful, as the referrers have less expertise. The referrals should be digitalised so 
they can be examined before arrival of the patient. 
Decision support tools could be a solution, but there is a lot of suspicion against it: It is a tool, they cannot 
replace the examination and counselling by a human. A standardisation of the communication would benefit 
all. It would also help to justify a decision.  
There is the problem of „alert fatigue“ with electronic decision support tools, the problem of a feeling of false 
security, and the danger of distracting from the consultation. 
DST are poorly received in practice. 
DST are replacing knowledge by a programme. 
From the experience with DST for mammography, we see that the tools are filled with the information to  
get the desired result. 
The „Orientierungshilfe Radiologie” is an educational tool and decision support for referrers. 
The „Orientierungshilfe Radiologie“ is a good start, but there might be room for improvement of its  
user-friendliness as a decision support tool. 
We are using the „Orientierungshilfe Radiologie”. There are regular updates and trainings. 
We use the „Orientierungshilfe Radiologie“. There are clear acute indications. It is difficult to enforce 
guidelines without affecting the diagnosis of exclusion. It is not possible to refuse an examination if the 
[referring] clinical is not confident e.g. that it is safe to discharge a patient. 
Guidelines development and implementation 
We use international guidelines. Regular continuing training is mandatory. 
There is a lack of robust evidence on imaging from trials. Guidance is developed based on the best available 
evidence, often qualitative decisions.  
Disinvestment recommendations are known, but not in detail. There are concerns that they are not applicable 
to the situation in Austria. 
Disinvestment recommendations are not known. Obvious situations in which MRI is not recommended: 
presence of implants, patients soon after an operation. 
The inclusion of new indications in the benefits catalogue is possible only after demonstration of clinical benefit. 
Guidelines provide a professional background, they must be adapted to individual situation. 
We have a monthly meeting of the interdisciplinary board, where we discuss and agree on guidelines and SOP. 
There are no guidelines for pre-authorisation. It is difficult to argue against imaging, no major risks of MRI 
(except contrast agents). 
We follow international guidelines (e.g. ESUR guideline for contrast agents); in addition we have internal 
SOPs and specific lists e.g. for acute indications during night shift. 
 
Educational interventions-patients 
An increase in patient demand was also indicated as a factor leading to in-
creased imaging utilisation in our interviews. Patients expect to receive the 
best available treatment, including high tech methods, driven by a political 
„promise” of „elite medicine” and by mass media driving fear from complica-
tions and suspicion against economisation of health services. 
On the radiologist’s side this increases fear of litigation for wrongly refusing 
or delaying an examination.  
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Evidence based information is available, but due to literacy barriers are not 
considered suitable information tools for patients. Rather interviewees iden-
tified public campaigns, educational measures targeting the patients and 
journalists, e.g. through key opinion leaders as important measures. These 
measures should explain negative aspects associated with inappropriate use 
of diagnostics, such as incidental findings and therapeutic consequences.  
The GP with a strong patient relationship could act as a multiplicator of such 
messages. In contrast, radiologists do not consider themselves in the position 
to directly influence patient preferences, notably as extramural service pro-
viders.  
Table 4.3-7: Interview responses: Educational interventions: patients and public 
Patient demand 
As a service provider it is our interest to satisfy our patients. We inform them if examinations are 
unnecessary, but we do not refuse anything, that could cause conflicts. 
The patient has the expectation, that imaging is the best method. If he is not satisfied with the 
recommendation, he is free to choose another doctor. 
Patients inform themselves in the internet and explicitly request MRIs. 
Patients claim rightfully to receive the best available treatment, including comprehensive examination. 
In Austria there is for many years a political pressure for elite medicine. The population expects that services 
are available all the time. 
Patient demand plays a role – a young athlete might be more impatient, needs a diagnosis to resume his training. 
Maybe patients are more responsible, more inquisitive and demanding. 
All patients consider themselves as acute cases. 
In an unfettered system, patients are able to resort to private medicine if they insist on imaging that their GP 
would not order. Pressure on patients is exerted via mass media, that increase fear from complications and 
suspicion towards refusal of procedures. This promotes overuse and pressure on referrers. 
Patients believe in a „right to health“ and requests immediate diagnosis. Imaging is ordered to satisfy patients. 
From the radiologist’s perspective this is difficult to control, he can verify the indication, but not the full 
anamnesis of the patient. 
Defensive medicine 
Referring physicians are unwilling to discharge patients without an MRI or to delay a MRI to the next day. 
The desire for reassurance out of fear of litigation is certainly a reason, because there is an increase in lawsuits. 
Out of fear of litigation, guidelines are bended/interpreted until a MRI is indicated. 
Notably in acute situations there is a practice of defensive medicine: MRI is used for quick diagnosis to decide 
for or against admission. 
At our hospital there is the „juridical“ indication: the fear to discharge a patient with unspecific symptoms 
who is diagnosed hours later with a severe condition, issuing a lawsuit for incomplete clarification. This 
tendency is increasing: there is also a patient advocate.  
Educational interventions targeting patient and public 
The communication targeting patients is essential. The patients need more transparency. We would need 
opinion leaders with a message similar to Choosing Wisely, that is targeted to patients, to educate them 
about diagnostics. 
There is no need for steering instruments on the medical side, but rather on the organisational level. The one-sided 
perception that radiology only increases spending should be avoided, rather this needs an objective appraisal. 
There is evidence-based patient information available (e.g. TGAM, DEGAM, IQWIG), but many patients are not 
reached (literacy). We need education about negative aspects, incidental findings and therapeutic consequences. 
Qualification trainings for journalists would make sense- these are the ones steering public opinion and are in 
the position to create pressure. 
A sensible public campaign could help: „We are all mortal, we spend to much money for examinations of 
conditions that will resolve by themselves, one must not always see a doctor.“ to educate patients, promote 
health literacy, self-responsibility and a awareness of the problem. 
I interrogate my patients on their readiness to undergo operation [when requesting an exam] 
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Patients already receive information of the costs [of their medical services]. In the journals, it is more 
frequently promoted to get examinations. 
It is extremely difficult to explain the patients that [by using unnecessary imaging] they are using up 
resources from others. 
Politicians need to communicate that not every examination makes always sense and also is not always 
available. The image of a high tech medicine leads to strong patient expectations and in consequence to 
litigations. Patients need to accept practice according to guidelines. 
The readiness of the patients to wait for self-recovery needs to be increased. 
Patients are not always responsive to information on appropriateness. 
 
Structural and organisational interventions 
Revision of professional roles 
In our interviews, representatives of general practitioners called for a gate-
keeper function of the GP: according to their statements, the GP is in a good 
position to contain diagnostic imaging, due to his/her long-lasting and con-
tinuous relationship with the patients. Moreover a central aspect in the prac-
tical training of GP is the critical use of diagnostics and use of alternative 
methods (to imaging). In the outpatient setting, both general practitioners and 
specialists such as neurologists, orthopaedists are allowed to refer patients to 
radiologists for MRI scans. For GPs, radiology training is not a mandatory 
element of medical training. In contrast to Australia, for example, where over 
65% of requests for diagnostic imaging are made by general practitioners [60], 
referrals by general practitioners are rare in comparison to referrals by other 
specialties in Austria. Our literature search did however not identify any re-
ports on the effect of strengthening the role of general practitioners gatekeeper 
function on appropriateness of imaging requests. 
Radiologists in our interviews expressed that current patient and work flow 
does not allow them to ultimately make the decision on whether a certain im-
aging request is appropriate or not. Notably in the outpatient setting, radiol-
ogists perceive themselves as service providers with an interest in customer 
satisfaction – the „customers” being both the patients and the referrers. There 
are feedback loops on protocol selection, if there are concerns on the feasibil-
ity of an imaging requests, e.g. if a patient is referred early after an operation 
or suspected to carry implants. Beyond these obvious contraindications, radi-
ologists state, an assessment of appropriateness is not feasible due to time con-
straints, respect towards the referrer and lack of oversight of the patient’s full 
clinical history. 
 
Communication and case discussion 
Our interview partners explained that communication between referrers and 
radiologists is common, both in hospital and outpatient setting. This commu-
nication is, however usually carried out only in case of ambiguity – from either 
side – and does not constitute a routine reviewing of imaging requests. 
 
Standardisation of information exchange 
The interviewees generally supported electronic referrals, and stated that elec-
tronic referrals improve their completeness and allow a timely review of im-
aging requests. Standardised referrals are implemented in some departments 
of some hospitals. In Austria, such a system – ELGA (ELektronische Gesund-
heitsAkte) – has been deployed in 2014 and will be gradually expanded first 
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to the Austrian hospitals and as of 2016 in the outpatient sector. An example 
for an MRI request using ELGA can be found at the ELGA website [166]. 
ELGA could provide a mean to implement it in the outpatient sector.  
Furthermore, some interviewees identified a need for improving data linkage 
between hospital and outpatient sector. Storage of images in the standardised 
DICOM (Digital Imaging and Communications in Medicine) format and pro-
vision of patients with a CD-ROM with the images are tools currently used 
for data exchange. Images may be stored in a picture archiving and commu-
nication system (PACS) allowing the electronic storage, retrieval, distribution 
and presentation of images. 
A standardised documentation of justifications for refusal of referrals was 
mentioned as currently under debate. 
Standardisation of the MRI examination itself is difficult, as the diagnosis is 
a dynamic process dependent of the radiologist and the software used. A dou-
ble reading – as for mammographies – could be a way to reduce variability. 
Finally since 2014 there is an official catalogue for ambulatory services and 
concrete routine data on outpatient services will be available in 2015. Together 
with a standardised diagnosis documentation, this could provide the basis for 
future analyses and planning, including analyses of appropriateness. 
 
Monitoring 
Some of our interview partners reported internal quality control measures 
while one indicated that internal control is often not feasible due to a lack of 
resources. Internal control data are not for external use. Concerns towards ex-
ternal control were that clinicians would feel restricted in their clinical deci-
sion making and that quality metrics are difficult to define and would need 
to be adapted to local features such as case mix.  
Table 4.3-8: Interview responses: structural and organisational interventions 
Role of the general practitioner  
The critical use of diagnostics is a central element in the practical training of GPs. 
GP would like to be the first contact point, in the position to provide directions and prevent unnecessary 
admissions.  
There is a need for education/training on appropriate use of MRI for GPs, but they also need more 
competencies. 
A containment of diagnostic exams requires the trustful, continuous and long-lasting relationship with the  
GP and his position in the system. 
Communication between professionals 
We check back with the referrers, if there is ambiguity. 
We communicate a lot to clarify referrals, to check the indication and requested method or if the medical 
history is insufficient. 
We communicate with the referrers in writing or per telephone if necessary. Each patient is discussed weekly. 
[GP] inquiry with radiologists on expected image quality. 
We check referrals, but it is not really our duty. 
If there is ambiguity (e.g. possible contra-indications, choice of imaging method) we clarify it with the referrers. 
There is a service hotline at out institute for referrers. It is a service, not mandatory. 
Standardised, digitalised information exchange 
ELGA does not allow GP to make entries, here many data are lost. 
Hopefully for certain areas there are data sampling standards, but the diagnosis is dependent of the radiologist 
and the software used. It is a dynamic process and difficult to standardise. A double reading – as for 
mammographies – could be a way to reduce variability.  
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We have electronic referrals this improves the completeness of referrals. If there is still ambiguity, we check 
back with the referrers. This is a standardised process. 
Standardised referrals are only available in a few departments of our hospital. Insufficient justification of referrals 
is less a problem with external referrers. Maybe with ELGA this will be possible also in the outpatient sector. 
There is no data linkage with the WGKK (health insurance) to identify repeat investigations. There are 
technical barriers for data exchange at the interface between outpatient sector and hospital. 
The e-card would allow the identification of the patients, this is essential for data exchange and hence, the 
prevention of repeat investigations. 
The current technology of ELGA does not allow the distribution of large imaging files. 
DICOM is standardised file format, that is universally readable. 
Repeat investigations are extremely rare: each patient has his images on CR-ROM, there is a dedicated 
department responsible for archiving them.  
Referrals should be digitalised so that they can be consulted before the patient arrives. 
The interpretation of the image is dependent of the radiologist, the technical quality of the device.  
The MRI scan is stored in the standard DICOM format. 
A standardised documentation of refusal justifications is currently a matter of debate. 
Standardisation of MRI examination is difficult, there are no pre-defined windows and absolute measurements. 
In previous years, there was a „black box“ of routine data on outpatient services, since 2014 there is an  
official catalogue and concrete routine data on outpatient services will be available 2015. Together with a 
standardised diagnosis documentation this could provide the basis for future analyses and planning, including 
analyses of appropriateness. 
A standardisation of referrals would be very useful. There were plans to implement this and referrers would 
receive in return the image interpretation.  
Monitoring 
We are running an evaluation project in the acute ward, where referrals are compared with the examinations 
carried out. The results are for internal use only. 
We have continuous quality control, but these internal controls are not standardised enough to be reported 
externally. External quality control is legitimate but difficult. It needs to be adjusted to the specific patient 
pool of each hospital. 
Costs should be evaluated by department, there is a lack of awareness on costs amongst hospital personnel. 
We have weekly discussion with radiologists and referrers, each case and referral is discussed, documented 
and quality controlled. 
At our hospital, quality control is punctual due to lack of resources. There would be massive resistance from 
clinicians towards external quality control, as they would feel limited in their decision making. 
The standardised documentation [of MRI exams] will lead to more objective data and therefore facilitate the 
discussion. 
 
Regulatory and financial interventions 
Capitation 
In the outpatient clinics MRI examinations are reimbursed based on a fee-
for-service model within a pre-defined limit of overall payments. It was point-
ed out that this limit on overall payment was not intended as a measure to 
specifically decrease inappropriate use. The perceptions on its impact on in-
appropriate use were mixed. Some stated that limited supply constitutes an 
incentive for referrers to reconsider the necessity of medical imaging more 
thoroughly. Also, longer waiting times may be a disincentive for MRI exam-
inations in patients whose conditions would ameliorate in the meantime. 
Concerns were expressed with regards to acute cases: possible negative effects 
reported were an overload of the ambulatory departments of hospitals or the 
avoidance of waiting times by private payments.  
The quantification of the actual need is considered challenging: some inter-
viewees stated that hospital MRI scanners are often underused. Regional 
variability in availability of MRI scanners does not translate in differences 
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in mortality. It is expected that the recently introduced standardised docu-
mentation of services provided in outpatient sector will help future planning 
and analyses.  
 
Pay for performance 
The current Austrian fee-for-service model does not allow to sanction either 
referrer or radiologists based on performance. An external quality control 
would therefore be entirely voluntary and is therefore unlikely to be accept-
ed by the providers.  
 
Prior authorisation 
The formal approval of imaging referrals by a representative of the health in-
surance was not perceived as an effective instrument to reduce inappropriate 
imaging. As a reason it was mentioned, that there are no guidelines with ap-
propriateness criteria for authorisation – in fact, denials are more likely to be 
caused by procedural errors, than clinical necessity. It was further criticised 
that current processes were inadequate to take into account the specific situ-
ation of the patient.  
One interviewee accordingly suggested the option of a mandatory second opin-
ion from a (multidisciplinary) point-of-service as an alternative to the current 
prior authorisation process. 
Table 4.3-9: Interview responses: regulatory and financial interventions 
Capitation 
Waiting times may have real disadvantages for patients. 
Currently MRI usage is steered by financial restrictions [the benefit cap]. The waiting lists benefit the private 
sector. 
The benefits cap in the outpatient sector led to reduced frequencies and longer waiting lists, which is more 
economically than to work in the communication with referrers and the quality of referrals: this would be an 
additional effort to make me earn less. 
There is no increase in the expense plan for new equipment, this would not make sense because more powerful 
MRI scanners reduce sampling time and therefore allow to increase frequencies. For many indications scanners 
with lower field strengths (<1 Tesla) are as good as the higher ones, but these devices are not included in the 
federal equipment planning. MRI frequencies were very high until introduction of the benefits cap, which was 
a reaction to an austerity package not to inappropriate use. With currently available data inappropriate use 
cannot be analysed. 
The benefits cap is co-responsible for bulging hospital costs and also poor patient care. 
MRI frequencies in outpatient sector are limited by the benefit cap, but overall there is a high standard of 
health service. 
In our hospital, the two MRI scanners are sufficient, there are no long waiting lists. 
The benefits cap and the associated waiting lists leads in some cases to use of inappropriate but more accessible 
imaging methods (e.g. CT). 
Reducing the [public] service supply will increase the private suppliers: who can afford it, will pay privately. 
This is against the principle of solidarity of the health system.  
Waiting lists are not that bad, some cases resolve on their own, acute cases can be dealt with in acute wards. 
Some patients will get their exam quicker than others, depending on their health insurance.  
The payment contracts with health insurers force the GP to consider the necessity of referrals. 
According to unverified reports, the waiting times in the outpatient sector are regularly avoided by private 
payments. In the hospitals, the MRI scans are often under-utilised: there is no economic pressure, but other 
limitations such as availability of the personnel. 
Initiatives in Germany to reduce utilisation by fixed budgets by hospital department had negative 
consequences for the patients, as e.g. laparoscopies were preferred over MRI due to lower costs. MRI may also 
help save costs, if imaging leads to avoidance of unnecessary therapies. 
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Quantification of need for MRI 
The quantification of MRI need is a challenge. In the outpatient sector, radiologists consider themselves as 
service providers, in the hospitals are more critical regarding appropriate utilisation. 
There is a high regional variability concerning the availability of MRIs. In Vienna there is a high availability, 
but long waiting times, in other regions availability is lower but this had no effect on mortality.  
Many MRI scanners are located in small hospitals for formal reasons, but are underused. The overall number 
of devices is not representative. The patient flow needs to be improved. 
A standardised documentation could provide an essential resource for future planning and analyses. 
Pay for performance 
An external monitoring can only be enforced within a contractual agreement. The Austrian Medical Chamber 
would not agree on that, not without massive concessions on another side. 
A decision on the appropriateness of a procedure is not possible without knowledge of the results of clinical 
examination. This may even become a legal problem, if without solid evidence, a procedure is refused. 
The current fee-per-service system does not allow to sanction the radiologist, nor the referrer (who has no 
financial interest in imaging). In a managed care model (e.g. HMO) it is possible to set financial incentives 
such as a fixed budget per patient and focus on quality control based on outcomes.  
Pre-authorisation 
The pre-authorisation was useless: referrers knew how to word their referrals to get them authorised. 
The pre-authorisation interferes between patient and referrer, without knowing the patient and the situation. 
It is ok if referrals are refused because there is no indication, but it should not be used to limit costs. 
One option could be to introduce a mandatory second opinion from a point-of-service with representatives of 
all fields. Precondition: available capacity and the readiness to take on the responsibility for the second 
opinion. Limitations: patients could be tempted to avoid centres with more rigorous control. 
As pre-authorising physician it is very difficult to decide on the appropriateness of a referral, because of lack 
of information and the lack of guidelines. 
The pre-authorisation can be easily avoided (via medical specialist or walk-in clinic). 
The pre-authorisation has failed: there were also refusals for necessary exams, but the majority of referrals 
got authorised. There are no restrictions on private supply. 
The pre-authorisation is not offensive enough. The referrers should be targeted.  
95% of our referrals got authorised. 
Pre-authorisation has not turned out as desired, the responsibility should be with the referrer. 
The pre-authorisation was a mere formality. With the benefits cap, the institutes are under pressure to steer 
the referrals.  
 
4.3.3 Summary of findings 
The literature review identified a variety of instruments that were proposed 
to contribute to a decrease in inappropriate use of medical imaging. Addition-
al information on some (pilot) projects (Altarum institute, PCORI) could be 
found per hand search. 
Educational interventions: 
 Development and dissemination of referral guidelines, based on  
evidence and consensus processes 
 Development of decision support tools, such as diagnostic pathways, 
clinical decision rules, possibly as electronic decision support tools. 
 Distribution of hospital utilisation data together with imaging  
guidelines to raise public awareness of over-utilisation. 
 Resource cards and training with simulated patients to train referrers 
how to address increasing patient demand. 
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Structural and organisational interventions: 
 Revision of the professional roles: gatekeeper function of the general 
practitioners and expert/consultant role of radiologists  
 Creation of multi-disciplinary teams to join radiologist and referring 
specialist expertise to coordinate medical imaging in hospitals 
 Point-of-care involvement of radiologist consultation through hotlines 
or radiology benefits managers. 
 Standardised digital referrals to ensure completeness of referral  
information, possibly coupled with electronic decision support. 
 Quality improvement through monitoring of imaging utilisation  
coupled with either public reporting or with targeted educational 
outreach visits for referrers with outlier patterns. 
Regulatory and financial interventions: 
 Pay-for-performance models based on robust metrics and tools for 
performance 
 Capitated payment schemes with fixed payments per patient,  
independent of number of procedures. 
 Co-payments by patients  
 Accreditation of advanced imaging providers to limit self-referral 
practice. 
 Delisting of medical services with demonstrated low-value 
 Formal approval of planned imaging procedures by the insurance 
company 
In some selective projects educational interventions, decision support tools 
or fixed payment schemes proved to be effective in reducing imaging over-
utilisation. In general, it was mentioned, that a bundle of interventions might 
possibly be the most successful endeavour to change a „culture” of inappro-
priate imaging. 
Key findings from the interviews with our stakeholders were: 
 Current workflow does not allow involvement of radiologist expertise 
in the decision making process 
 There is a need for education and training of referrers on appropriate 
advanced medical imaging  
 Current decision support mainly consists in the Austrian referral 
guidelines „Orientierungshilfe Radiolgie” and occasional exchange 
between radiologists and referrers. 
 Patient demand is perceived as a cause for inappropriate utilisation 
of medical imaging. 
 Standardised information exchange could contribute to improved  
utilisation management. 
 External monitoring/pay per performance is difficult to implement 
in the current reimbursement model 
 The current pre-authorisation system is inadequate to reduce  
inappropriate imaging.  
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There were several limitations of our methodological approach. Due to the 
broad scope of our literature review with no restrictions on specific indica-
tions and interventions categories, it was not possible to conduct a systemat-
ic review and a critical appraisal of the studies identified. Most of the reported 
studies are observational studies. The reported effects on reduction of inap-
propriate imaging therefore need to be considered with caution: a causal re-
lationship cannot necessarily be deduced. Another limitation is the restriction 
to studies analysing MRI: many of the interventions identified will be rele-
vant not only to MRI but also to other advanced imaging methods. 
A limitation of our stakeholder interviews was the over-representation of gen-
eral practitioners as referrers. Many referrals for MRI are issued from medi-
cal specialists, e.g. neurologist and orthopedists. The interviews were conduct-
ed in German, as a consequence main messages of the interviews were trans-
lated by the authors in English for representation in this report. We are aware 
that this might have led to distortion of the initial statements. 
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5 Discussion and Recommendations 
The goal of the present report was to explore the need for measures to improve 
appropriate use of MRI in Austria. We approached this topic from several 
sides. In a first step, we searched for definitions to clarify the terms appro-
priateness/inappropriateness, over-utilisation and over-diagnosis. Second, we 
screened databases for recommendations against the use of MRI in specified 
indications and compared to the Austrian referral guideline „Orientierungs-
hilfe Radiologie”. Third, we performed a literature review to identify which 
tools and strategies are used for utilisation management of MRI and their 
expected risks and benefits and fourth, we conducted interviews with relevant 
Austrian stakeholders, in which we explored their perspectives on existing 
and future measures to steer appropriate use of MRI in Austria. 
Between 2009 and 2012 overall numbers of MRI examinations increased from 
974,818 to 1,006,673, with around a fourth of the exams carried out for inpa-
tients and the rest in an outpatient setting, either in hospital ambulatory de-
partments or extramural outpatient imaging institutes. This makes Austria 
worldwide leading in the number of MRI examinations in relation to the pop-
ulation. The overall high numbers of imaging utilisation in Austria are indic-
ative of potential over-utilisation, however no data on the appropriateness of 
MRI utilisation in Austria were available. Data detailing the MRI examina-
tions by medical procedure (corresponding to body part) were available only 
for the inpatient sector. Here, major areas of MRI utilisation are MRI of head 
and neck and MRI of the spine, with a trend for increasing utilisation.  
Our analysis yielded the following indications where recommendations against 
the use of MRI from appropriateness programmes and databases differed from 
the OGR:  
Table 5-1: Overview recommendations differing from Austrian referral guideline 
Indication Appropriateness databases OGR 
Headache in children ACR AC: MRI head with and without contrast not 
recommended in children with chronic or recurrent 
primary headache, including migraine, without neurologic 
signs or signs of increased intracranial pressure; rated 3. 
MRI is indicated as initial 
diagnostic method for 
headache in children. 
Psychosis NICE: MRI not recommended as a routine part of the 
initial investigations for the management of first-episode 
psychosis. 
MRI indicated as initial 
diagnostic method to rule 
out organic reasons of 
psychosis. 
Screening for  
brain metastases: 
  
Lung cancer CW USA: MRI not recommended for pre-operative 
screening for occult brain metastases in asymptomatic 
patients with early lung cancer. 
MRI indicated as initial 
diagnosis for assessing 
brain metastases.** 
Renal cell carcinoma  ACR AC***: MRI head without and with contrast not 
recommended in post-treatment follow-up of renal cell 
carcinoma for asymptomatic patients; rated 1 
MRI indicated as initial 
diagnosis for assessing 
brain metastases.**  
Invasive bladder 
cancer 
ACR AC***: MRI head without and with contrast not 
recommended in pre-treatment staging of invasive bladder 
cancer in patients with no neurologic symptoms; rated 2 
MRI indicated as initial 
diagnosis for assessing 
brain metastases.**  
Renal cell carcinoma ACR AC***: MRI head without and with contrast not 
recommended in renal cell carcinoma staging for patients 
with no neurologic signs or other metastases; rated 1/3 
MRI indicated as initial 
diagnosis for assessing 
brain metastases.**  
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Indication Appropriateness databases OGR 
Uveal melanoma: 
Stage I or IIA/B 
CAR: MRI brain not indicated for uveal melanoma staging 
Stage I or IIA/B. Incidence of metastases very low. 
MRI indicated as initial 
diagnosis for assessing 
brain metastases.**  
Uveal melanoma: 
Stage IIC or III 
CAR: MRI brain not indicated for uveal melanoma staging 
Stage IIC or III with macrometastasis sentinel LN or LN 
dissection if no neurological symptoms. 
MRI indicated as initial 
diagnosis for assessing 
brain metastases.**  
Acute knee trauma ACR AC: MRI knee with and without contrast not 
recommended for patients (excluding infants) with no 
symptoms; rated 1. 
MRI indicated for initial 
diagnosis of knee trauma. 
Blunt chest trauma ACR AC: MRI chest is not indicated as follow-up in patients 
with normal anteroposterior chest radiograph, normal 
examination and normal mental status.   
MRI indicated as follow-
up for special issues (e.g., 
muscle avulsion). 
Staging of 
bronchogenic 
carcinoma 
ACR AC, NICE: MRI chest not indicated for staging  
of NSCLC.  
ACR AC, CAR: MRI not indicated for SCLC. 
MRI indicated as follow-
up (following CT 
examination) for staging 
lung carcinoma in special 
cases. 
Incidentally 
discovered adrenal 
masses 
ACR AC: MRI abdomen with and without contrast not 
indicated for adrenal masses >4cm  
MRI is indicated for 
initial characterisation of 
incidentally discovered 
adrenal masses. 
Hypertension CAR: imaging not indicated without evidence of renal 
disease. 
MRA „method of choice” 
for initial diagnosis. 
** The OGR does not specify any kind of neoplasm or setting when and if imaging is justified for the search of distant metastases; 
it states that MRI generally is the best method to assess brain metastases. 
*** According to the ACR AC, MRI is, however, the recommended imaging technique for follow-up and retreatment of brain 
metastases and for their evaluation, particularly in patients being considered for surgery or radiosurgery. Therefore, the 
ACR AC do not rate MRI as being inappropriate to assess brain metastases in general, but identifies certain circumstances 
where MRI of the brain is not necessary.  
 
Of note, we did not find any differing recommendations for MRI of the spine. 
Imaging of low back pain (in the first 4-6 weeks) is one of the most prominent 
indications in the discussion of inappropriate imaging. Since our utilisation 
dataset did not include any clinical information to the MRI procedures car-
ried out, any conclusion on the appropriateness of MRI examinations in Aus-
tria is speculative. The impact of the identified discrepancies in appropri-
ateness definitions on MRI utilisation would need to be analysed in further 
studies. 
Especially the ACR AC provide a comparably much more detailed guidance 
than the OGR, allowing to differentiate situations in which MRI is appropri-
ate based on clinical information (e.g. differentiation by type of carcinoma, 
size of adrenal masses, or the presence or absence of clinical symptoms) and 
including recommendations on the preferred imaging protocol (e.g., with or 
without contrast). The majority of the recommendations identified target MRI 
as primary diagnostic method: this indicates the importance of highly select-
ing the patients based on thorough clinical examination, prior to referring 
them to MRI. The literature review and our interviews show that determin-
ing the appropriateness of imaging is complex and requires training, exper-
tise and experience that referring physicians or early-stage hospital clinicians 
(often) are lacking.  
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Together with a practice of defensive medicine and increasing patient de-
mand, this might significantly contribute to overuse of diagnostic imaging, 
for the sake of reassurance of both patients and physicians. Our interviews 
showed that the OGR has achieved a high level of awareness and acceptance 
in Austria, while other sources on appropriateness criteria were either not 
known and possibly would not be accepted as a justification for denial of an 
imaging procedure. It would thus be advisable to take advantage of the high 
awareness level and standing of the OGR and to explicitly include differen-
tiated recommendations also on indications in which MRI is not appropriate. 
The recommendations on the preferred imaging protocol found in ACR guide-
lines will generally be less useful to referring physicians and should be left to 
the discretion of the imaging experts. 
Due to the wide range of MRI indications, rather than globally applying de-
cision support to all imaging indications, an economic approach would be to 
concentrate management efforts on selected procedures based on evidence on 
high levels of inappropriate utilisation, high volume and high cost of proce-
dures. It will be important to put recommendations for the use of magnetic 
resonance imaging in context with other imaging modalities and in context 
with clinical care pathways. Restrictions or „do not do“ recommendations for 
one imaging modality should not result in the increased use of other modali-
ties such as computed tomography or radiography if they are less sensitive to 
disease and result in increased irradiation of the patients.  
More detailed referral guidelines empowering the referrers to make differen-
tiated decisions on appropriateness of imaging are one important element to 
increase appropriate utilisation, but the results of our literature review suggest 
that guidelines should be complemented by educative measures targeting re-
ferrers and patients. These measures identified are decision support tools for 
referrers, resource cards and training for the discussion of appropriate imag-
ing with patients and public awareness of over-utilisation and imaging guide-
lines. This was well aligned with the perceptions of our interviewees who iden-
tified a need for education and training of referrers on appropriate advanced 
medical imaging and patient demand as a factor contributing to inappropri-
ate utilisation of medical imaging. Current decision support for referrers in 
Austria mainly consists in the Austrian referral guidelines „Orientierungs-
hilfe Radiologie” and occasional exchange between radiologists and referrers. 
An active involvement of referrers in guideline development could both serve 
to increase awareness and acceptance of the referral guidelines. 
The implementation of decision support in the clinical workflow could be 
complemented by structural and organisational interventions: here, a major 
point was the incorporation of radiologist expertise as consultants in point-of-
care models or in multi-disciplinary teams in hospitals. In Austria, this would 
require a revision of the professional role of radiologists. Based on the re-
sponses of our interviews, current workflow does not allow a formalised in-
volvement of radiologist expertise in the decision making process and is lim-
ited to occasional case discussions in case of unclear referrals or concerns 
about contra-indications. Both in our literature search and our interviews, 
standardised, digital referrals were considered an essential enabling factor for 
information exchange to assess appropriateness of imaging requests between 
professionals. 
Quality improvement through monitoring of imaging utilisation and pay for 
performance models were reported in the literature as measures that could 
limit inappropriate imaging. From our interviews it became clear that exter-
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nal quality monitoring would be difficult to implement, as the current reim-
bursement system in Austria does not allow to reward or penalize radiology 
providers based on their performance and hence there would be no incentive 
for providers to allow external audit. 
In contrast to the US, e.g., factors contributing to over-utilisation such as „lit-
tle control over number of imaging devices available to a specific population 
of patients” and „little action (...) to control inappropriate, financially moti-
vated self-referral practices” do not apply to MRI utilisation in the Austrian 
setting: the number of imaging devices is regulated within the structural plan 
for large medical devices („Großgeräteplan”) [52] and patients are always re-
ferred to radiologists or radiology institutes for the imaging procedures. In 
addition, most health insurances require the pre-authorisation of MRI pro-
cedures in the outpatient setting. No co-payments are required for imaging 
services by physicians contracted to health insurances.  
In its present form, however, pre-authorisation by Austrian Health insurances 
is widely unpopular and not considered an appropriate measure for utilisa-
tion management based on utility criteria in our interviews. Instead, a point-
of-service model with a selected network of preferred providers could be en-
visaged. 
Standardisation and digitalisation of referrals is an essential enabling factor 
for any such exchange between professionals: information provided might be 
aligned with decision support systems in order to facilitate referral review and 
decision making. Finally, public awareness is needed to change a culture of 
patient demand and defensive medicine towards a conscious and emancipat-
ed use of imaging techniques for those who really need them. 
 
Recommendations 
We recommend 
 to conduct prospective studies of MRI utilisation and appropriateness 
using pre-specified definitions of appropriateness for selected proce-
dures and collection of the necessary clinical parameters to determine 
appropriateness. 
 to select procedures based on evidence of high regional variability in 
MRI utilisation and on high volume (and costs) indications for which 
initiation of measures to contain inappropriate use may be warranted, 
 to pilot those interventions in „motivated“ hospitals and to monitor, 
to evaluate and to publish the results 
complemented by 
 an initiation of a consensus building process on appropriateness cri-
teria and adaption of the „Orientierungshilfe Radiologie” for selected 
procedures based on areas with missing consensus between guideline 
and recommendations,  
 decision support for referrers and patients and 
 awareness raising of overdiagnosis and overutilisation. 
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6 Outlook: implications for further activities 
6.1 Comparative Effectiveness Research 
Medical technologies are continually changing and magnetic resonance im-
aging (MRI) is no exception. Not only are newer MRI modalities faster and 
therefore possibly more efficient, but also with increasing magnet strengths 
(e.g. 3.0 Tesla), more sophisticated device capabilities are offered. Whether 
these capabilities lead not only to differences in findings on imaging or in di-
agnosis, but also to increased patient relevant clinical effectiveness in differ-
ences in clinical outcomes or in clinical management in specific indications 
(e.g. in cerebrovascular conditions such as stroke, intracerebral aneurysms, ca-
rotid or intracerebral stenosis) is an issue in comparative assessments on ad-
vanced imaging [167].  
The identification of indications for which MRI is inappropriate is complex. 
Elshaug et al. state that the search for ineffective interventions parallels com-
parative effectiveness research (CER) – the clinical evaluation of medical in-
terventions relative to alternative available interventions for this intervention 
[168]. They further state that, due to the uncertainty because of inadequate 
evidence of clinical benefit, CER will most likely result in the identification 
of „marginal medicine”, based on the categories from Hoffman and Pearson 
[169]. As stated earlier, the net benefit of imaging procedures is rarely sub-
stantiated by adequate evidence of comparative evidence (category 1). On the 
other hand the lack of precise criteria on appropriate use can lead to overuse 
and misuse beyond the boundaries of established net benefit (i.e., indication 
creep) (category 2). MRI specific items of the Institute of Medicine’s list of 
100 priority comparative effectiveness research topics are [170]: 
 Establish a prospective registry to compare the effectiveness of treat-
ment strategies for low back pain without neurological deficit or spi-
nal deformity. 
 Compare the effectiveness of imaging technologies in diagnosing, stag-
ing, and monitoring patients with cancer including positron emission 
tomography (PET), magnetic resonance imaging (MRI), and comput-
ed tomography (CT). 
 Compare the effectiveness of film-screen or digital mammography alone 
and mammography plus magnetic resonance imaging (MRI) in com-
munity practice-based screening for breast cancer in high risk women 
of different ages, risk factors, and race or ethnicity. 
 Compare the effectiveness of traditional risk stratification for coronary 
heart disease (CHD) and non-invasive imaging (using coronary artery 
calcium, carotid intima media thickness, and other approaches) on CHD 
outcomes. 
 Compare the effectiveness of traditional and newer imaging modalities 
(e.g., routine imaging, magnetic resonance imaging [MRI], computed 
tomography [CT], positron emission tomography [PET]) when ordered 
for neurological and orthopaedic indications by primary care practi-
tioners, emergency department physicians, and specialists. 
 Compare the effectiveness of diagnostic imaging performed by non-
radiologists and radiologists. 
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Besides the need for comparative effectiveness studies, new MRI applications 
are on the horizon: two fields of new areas of applications with the potential 
of expansion of indications and with increased need for critical assessment 
are discussed shortly. 
 
 
6.2 Molecular Imaging for 
„Personalised“ Medicine 
„Personalised” Medicine/PM (also named tailor-made or precision medicine) 
is hyped as the future of medicine by delivering „the right treatment to the 
right patient at the right time” (3 Rs). The visualisation of loco-regional phys-
iological, biological and biochemical processes – an essential part of PM – is 
called „Molecular Imaging/MI”: MI differs from traditional imaging in that 
biomarkers are used to help image particular targets or pathways. There are 
three main areas in which PM is expected to have a major impact on health-
management: preventive medicine, personalised diagnosis and therapeutic de-
cisions on specific alterations [171]:  
 Personalised disease prevention focuses on identification – in an early pre-
clinical stage –subgroups of patients at risk of developing symptoms and 
signs of abnormal morphology.  
 Personalised diagnostics implies the identification of the specific molec-
ular information on alterations leading to disease.  
 Personalised treatment focuses on identification of patient groups likely 
to respond to a given treatment or at risk of side effects, on therapy mon-
itoring and on individualised drug delivery allowing real-time modulation 
of treatment. 
The stratification of large patient groups in smaller sub-groups by means of 
(validated) biomarker identified in advanced applications of MRI is the most 
realistic scenario. Since most „targeted therapies” are approved in oncology, 
an expansion in oncologic indications can be foreseen [172]. 
To conclude: HTA research attention is been given to contrast the expecta-
tions of Molecular Imaging as technique to enable PM-therapeutic approach-
es with the actual patient relevant clinical outcomes. The critical validation 
of biomarkers as guides in PM is an essential first step [173].  
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6.3 Screening: 
Overdiagnosis and Incidental Findings 
Molecular Imaging makes investigations of diseases in pre-symptomatic phas-
es possible. Such screenings (e.g. for dementia) in defined populations co-
horts focus on finding biomarker that allow prediction and early diagnosis 
of diseases and eventually preventive therapies [171]. Population imaging 
(http://www.populationimaging.eu/) as a large scale research endeavour 
promises „to shift the focus from curative to preventive medicine“ by finding 
biomarkers and predicting later stages of disease. However, Molecular Imag-
ing approaches based on single probes/biomarker may be insufficient due to 
the heterogeneity of e.g. tumours [171]. 
The downside of such widespread screening of healthy individuals are over-
diagnosis and incidental findings.  
 Overdiagnosis is defined as the diagnosis of irrelevant disease, which is so 
stable or indolent that it would not have become clinically relevant during 
the individual´s life [171]. 
 Advanced diagnostic technologies such as MRI find smaller abnormalities 
(e.g. in prostate, breast and other tissues), that might never need interven-
tions. By means of advanced imaging many precancerous and slow-grow-
ing tumours or other pathologies are treated unnecessarily. 
 Advanced diagnostic technologies such as MRI lead to the expansion of 
the definition of disease to pre-symptomatic phases without benefit. A re-
cent evidence-synthesis for the German Igel_Monitor on MRI for early 
detection of Alzheimer-dementia [174] revealed that there is no evidence 
on a benefit for the individual due to the lack of prognostic certainty and 
the lack of a treatment to prevent or delay the disease.  
 Advanced diagnostic technologies lead to incidental findings nobody was 
searching for and nobody knows how to deal with: a recent Scottish study 
[175] of MRI of the skull in 700 symptom-free 70+ year old people re-
vealed pathological findings for some kind of brain abnormality in 32%, 
while the prevalence in symptom-free individuals is „only“ 3%. In many 
of the found abnormalities the risks for death is untreated lower than with 
invasive treatments. 
To conclude: International research attention is been given increasingly to 
identify fields of medical interventions where „less might be more“. Screen-
ing and early detection of diseases without proof of benefits for the individ-
uals is one field identified.  
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8 Annexes 
Table 8-1: Search strategies 
Cochrane database  
23.06.14 
133 Hits 
 
ID Search 
#1 MeSH descriptor: [Diagnostic Imaging] explode all trees and with qualifier(s): [Utilization – UT] 
#2 MeSH descriptor: [Magnetic Resonance Imaging] explode all trees and with qualifier(s): [Utilization – UT] 
#3 (MRI* or imaging or MRT* or magnetic resonance tomograph*) near (utili*ation* or application or 
use*):ti,ab,kw (Word variations have been searched) 
#4 #1 or #2 or #3  
#5 overuse* (Word variations have been searched) 
#6 MeSH descriptor: [Unnecessary Procedures] explode all trees 
#7 overutili*ation* (Word variations have been searched) 
#8 overdiagnos* (Word variations have been searched) 
#9 appropriate use*:ti,ab,kw (Word variations have been searched) 
#10 appropriateness* (Word variations have been searched) 
#11 inappropriate use*:ti,ab,kw (Word variations have been searched) 
#12 unnecessary near (use* or procedure* or technique* or program*) (Word variations have been searched) 
#13 inappropriateness* (Word variations have been searched) 
#14 MeSH descriptor: [Patient Care Management] explode all trees and with qualifier(s): [Utilization – UT] 
#15 utili*ation management:ti,ab,kw (Word variations have been searched) 
#16 appropriateness criteri*:ti,ab,kw (Word variations have been searched) 
#17 Decision support:ti,ab,kw (Word variations have been searched) 
#18 MeSH descriptor: [Guideline Adherence] explode all trees 
#19 #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18  
#20 #4 and #19  
 
CRD Database 
26.06.2014 
90 Hits 
 
1 MeSH DESCRIPTOR Magnetic Resonance Imaging 
2 MeSH DESCRIPTOR Diagnostic Imaging 
3 (MRI*) 
4 (MRT*) 
5 (imaging):TI 
6 (magnetic resonance):TI 
7 #1 OR #2 OR #3 OR #4 OR #5 OR #6 
8 (overuse*) 
9 MeSH DESCRIPTOR Unnecessary Procedures EXPLODE ALL TREES 
10 (overutili*ation*) 
11 (overdiagnos*) 
12 (appropriate use*) 
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13 (appropriateness*) 
14 (inappropriate use*) 
15 (unnecessary NEAR (use* OR procedure* OR technique* OR program*)) 
16 (inappropriateness*) 
17 (utili*ation management) 
18 (appropriateness criteri*) 
19 (decision support) 
20 MeSH DESCRIPTOR Guideline Adherence EXPLODE ALL TREES 
21 (utili*ation*):TI 
22 #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 
23 #7 AND #22 
 
Embase 
19.06.2014 
483 Hits 
 
#27. overuse* OR ‘unnecessary procedure’/mj OR  
overutili?ation* OR ‘appropriate use’ OR  
overdiagnos* OR ‘program appropriateness’/mj OR  
appropriateness* OR ‘inappropriate use’ OR  
unnecessary NEAR/1 (use* OR procedure* OR  
technique*) OR inappropriateness* OR ‘utilization  
management’ OR ‘utilisation management’ OR  
‘appropriate use’ NEAR/1 criteri* OR  
‘appropriateness criteria’ OR ‘appropriate use  
criteria’ OR ‘decision support’ OR ‘guideline  
adherence’ AND (‘diagnostic imaging’/mj OR  
(imaging OR mrt* OR mri* OR ‘magnetic resonance 
tomography’) NEAR/1 (utili?ation* OR application*  
OR use*)) 
#26. ‘diagnostic imaging’/mj OR (imaging OR mrt* OR  
mri* OR ‘magnetic resonance tomography’) NEAR/1  
(utili?ation* OR application* OR use*) 
#25. (imaging OR mrt* OR mri* OR ‘magnetic resonance  
tomography’) NEAR/1 (utili?ation* OR application*  
OR use*) 
#24. ‘diagnostic imaging’/mj  
#22. overuse* OR ‘unnecessary procedure’/mj OR  
overutili?ation* OR ‘appropriate use’ OR  
overdiagnos* OR ‘program appropriateness’/mj OR  
appropriateness* OR ‘inappropriate use’ OR  
unnecessary NEAR/1 (use* OR procedure* OR  
technique*) OR inappropriateness* OR ‘utilization  
management’ OR ‘utilisation management’ OR  
‘appropriate use’ NEAR/1 criteri* OR  
‘appropriateness criteria’ OR ‘appropriate use  
criteria’ OR ‘decision support’ OR ‘guideline  
adherence’ 
#21. ‘guideline adherence’  
#20. ‘decision support’  
#19. ‘appropriate use criteria’  
#18. ‘appropriateness criteria’  
#17. ‘appropriate use’ NEAR/1 criteri*  
#16. ‘utilisation management’  
#15. ‘utilization management’  
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#14. inappropriateness*  
#13. unnecessary NEAR/1 (use* OR procedure* OR  
technique*) 
#12. ‘inappropriate use’  
#11. appropriateness*  
#10. ‘program appropriateness’/mj  
#9. overdiagnos*  
#8. ‘appropriate use’  
#7. overutili?ation*  
#6. ‘unnecessary procedure’/mj  
#5. overuse*  
 
Ovid Medline 
23.06.2014 
598 Hits 
 
1 *Magnetic Resonance Imaging/ut [Utilization]  
2 *Diagnostic Imaging/ut [Utilization]  
3 ((MRI* or imaging or MRT* or magnetic resonance tomograph*) adj3 (utili#ation* or application or use*)).mp.  
4 1 or 2 or 3  
5 overuse*.mp.  
6 *Unnecessary Procedures/ 
7 overutili#ation*.mp.  
8 overdiagnos*.mp.  
9 appropriate use*.mp.  
10 appropriateness*.mp.  
11 inappropriate use*.mp.  
12 (unnecessary adj (use* or procedure* or technique*)).mp.  
13 inappropriateness*.mp.  
14 exp Patient Care Management/ut [Utilization]  
15 Utili#ation management.mp.  
16 (appropriate use* adj criteri*).mp.  
17 appropriateness criteri*.mp.  
18 Decision support.mp.  
19 *Guideline Adherence/ 
20 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19  
21 4 and 20  
22 remove duplicates from 21  
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Table 8-2: Recommendations against the use of MRI – Brain/Cranium 
Indication 
MEL 
code Recommendation/Programme 
Orientation  
Guide Radiology1 
Initial diagnosis/primary investigation 
Acute concussion, 
unless progressive 
neurological 
symptoms, focal 
neurological 
findings or 
concern for a 
skull fracture 
ZA030 CW USA: 
Avoid ordering a brain CT or brain MRI to evaluate an acute 
concussion unless there are progressive neurological symptoms, 
focal neurological findings on exam or there is concern for a 
skull fracture.  
Concussion is a clinical diagnosis. Concussion is not associated with 
clinically relevant abnormalities on standard neuroimaging with 
CT or MRI. These studies should be ordered if more severe brain 
injury is suspected. CT is best utilized for skull fracture and 
intracranial bleeding, whereas MRI may be ordered for prolonged 
symptoms, worsening symptoms or other suspected structural 
pathology. 
– 
Autism in adults ZA030 NICE DB: 
Do not use biological tests, genetic tests or neuroimaging for 
diagnostic purposes routinely as part of a comprehensive 
assessment. 
MRI indicated as initial 
diagnosis for develop-
mental disorders. 
A.18* 
Brain injury: 
clinically 
important, in 
patients who 
have sustained a 
head injury 
ZA030 NICE DB: 
For safety, logistic and resource reasons, do not perform 
magnetic resonance imaging (MRI) scanning as the primary 
investigation for clinically important brain injury in patients 
who have sustained a head injury, although it is recognised that 
additional information of importance to the patient’s prognosis 
can sometimes be detected using MRI. 
– 
Comment:  
MRI may be adequate 
as follow-up for head 
injury in children.  
M 13* 
Breast cancer: 
local recurrence 
and distant 
metastases in 
asymptomatic 
women with 
Stage I Breast 
Cancer 
ZA030 ACR AC: 
Stage I Breast Cancer: Initial workup and surveillance for local 
recurrence and distant metastases in asymptomatic women: 
MRI head without and with contrast to rule out metastases; 
rated 2 
 
Comment: Applies also for surveillance. 
MRI indicated as initial 
diagnosis for staging 
distant metastases 
and as follow-up care 
when US and mammo-
graphy are unclear. 
For evaluation of 
distant metastases, 
CT/MRI/PET indicated 
as single examination 
or in combination, 
according to individual 
situation, after 
clearance with local 
tumour board 
L.23*, I.11* 
Cerebrovascular 
disease 
ZN270 ACR AC: 
Cerebrovascular disease: MRI functional (fMRI) head without 
contrast; rated 1 
– 
Cerebrovascular 
disease 
ZA040 ACR AC: 
Cerebrovascular Disease: MRA head without and with contrast; 
Asymptomatic. Structural lesion on physical examination 
(cervical bruit) and/or risk factors; rated 3 
– 
Cerebrovascular 
Disease 
ZA040 ACR AC:  
Cerebrovascular Disease: MRA neck without and with contrast 
for clinically suspected acute subarachnoid haemorrhage (SAH), 
not yet confirmed; Risk of unruptured aneurysm. Positive family 
history; Clinically suspected parenchymal haemorrhage 
(hematoma), not yet confirmed; rated 2/3 
– 
Dementia and 
movement 
disorders 
ZN270 ACR AC: 
Dementia and movement disorders: MRI functional (fMRI)  
head without contrast; rated 2 
MRI indicated as 
initial diagnosis for 
differential diagnosis. 
A.12* 
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Double Vision ZA030 CW USA: 
Don’t routinely order imaging for all patients with double vision.  
Many people with double vision, or diplopia, want a CT scan or 
MRI to see if it is caused by a brain tumour or other serious 
problem. Much of the time, following a comprehensive eye 
evaluation, neither test is necessary. The most common causes 
of double vision are refractive error, dry eyes, cataract and non-
neurologic eye misalignment, all readily diagnosed by a complete 
exam. Only a minority of cases of diplopia result from problems 
within the brain. 
– 
Epilepsy: in adults 
with idiopathic 
generalized 
epilepsy 
ZA030 CAR: 
Epilepsy in adults: MRI rated as specialized investigation. Imaging 
is not required in patients with idiopathic generalized epilepsy. 
MRI indicated as 
initial diagnosis of 
epilepsy. 
A.16* 
Eye disease:  
no symptoms  
or signs of 
significant disease 
pathology 
ZA030 CW USA: 
Don’t routinely order imaging tests for patients without 
symptoms or signs of significant eye disease.  
If patients do not have symptoms or signs of significant disease 
pathology, then clinical imaging tests are not generally needed 
because a comprehensive history and physical examination will 
usually reveal if eye disease is present or is getting worse. 
Examples of routine imaging include: visual-field testing; optical 
coherence tomography (OCT) testing; retinal imaging of patients 
with diabetes; and neuro imaging or fundus photography. If 
symptoms or signs of disease are present, then imaging tests may 
be needed to evaluate further and to help in treatment planning. 
– 
Focal neurologic 
deficit: 
unexplained acute 
confusion or 
altered level of 
consciousness 
ZA030 ACR AC: 
Focal neurologic deficit: MRI head perfusion with contrast for 
unexplained acute confusion or altered level of consciousness; 
rated 3 
– 
Focal neurologic 
deficit 
ZN270 ACR AC: 
Focal neurologic deficit: MRI functional (fMRI) head without 
contrast; rated 2/3 
– 
Headache ZA040 ACR AC: 
Headache: MRA head without and with contrast for Chronic 
headache. No new features. Normal neurologic examination; 
Headache of oromaxillofacial origin; New headache. Suspected 
meningitis/encephalitis; New headache in pregnant woman; 
Positional headache; rated 2/3 
MRI indicated after 
observation for 
migraine, chronic 
headache (tension 
headache). 
A.6* 
Headache, 
chronic/recurrent: 
no focal features 
ZA030 CAR: 
Headache chronic/recurrent: MRI indicated only in specific 
circumstances. In the absence of focal features imaging is not 
often helpful. 
MRI indicated after 
observation in case of 
focal features and 
changes. 
A.6* 
Headache: 
uncomplicated, 
no Red Flags  
ZA030 CW CAN: 
Don’t do imaging for uncomplicated headache unless red flags 
are present.  
Red flags include recent onset, rapidly increasing frequency and 
severity of headache; headache causing the patient to wake 
from sleep; associated dizziness, lack of coordination, tingling or 
numbness, new neurologic deficit; and new onset of a headache 
in a patient with a history of cancer or immunodeficiency. 
CW USA: 
Don’t do imaging for uncomplicated headache.  
Imaging headache patients absent specific risk factors for structural 
disease is not likely to change management or improve outcome. 
Those patients with a significant likelihood of structural disease 
requiring immediate attention are detected by clinical screens that 
have been validated in many settings. Many studies and clinical 
MRI indicated as 
follow-up, MRA 
indicated as initial 
diagnosis for acute, 
severe headache. 
A.5* 
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practice guidelines concur. Also, incidental findings lead to 
additional medical procedures and expense that do not improve 
patient well-being. 
Headache:  
stable, meeting 
criteria for 
migraine 
ZA030 CW USA: 
Don’t perform neuroimaging studies in patients with stable 
headaches that meet criteria for migraine.  
Numerous evidence-based guidelines agree that the risk of 
intracranial disease is not elevated in migraine. However, not all 
severe headaches are migraine. To avoid missing patients with 
more serious headaches, a migraine diagnosis should be made 
after a careful clinical history and an examination that documents 
the absence of any neurologic findings such as papilledema. 
Diagnostic criteria for migraine are contained in the International 
Classification of Headache Disorders. 
MRI indicated after 
observation in case of 
focal features and 
changes. 
A.6* 
Headache: 
associated with 
cough, sexual 
activity or 
exertion 
ZN260 ACR AC: 
Headache: MRI spine include MR myelography for headache 
associated with cough, sexual activity or exertion; rated 2 
– 
Headache in 
children: primary 
headache  
ZA030 ACR AC: 
Headache-child: MRI head without and with contrast for primary 
headache (chronic or recurrent, including migraine without 
permanent neurologic signs or signs of increased intracranial 
pressure); rated 3 
MRI indicated as 
initial diagnosis. 
K.10* 
Headache in 
children: primary 
headache  
ZA040 ACR AC: 
Headache child: MRA head without and with contrast for primary 
headache (chronic or recurrent headache including migraine 
without permanent neurologic signs or signs of increased 
intracranial pressure). If no vascular pathology is suspected 
based on CT or MRI; rated 1 
– 
Head trauma: 
subacute or 
chronic close 
head injury  
ZN270 ACR AC: 
Head trauma: MRI functional (fMRI) head without contrast for 
subacute or chronic close head injury; rated 2 
– 
Comment:  
MRI indicated for 
initial diagnosis of 
subacute, old head 
trauma in children. 
Head trauma: 
minor or mild 
acute closed head 
injury  
ZA040 ACR AC: 
Head Trauma: MRA head and neck without and with contrast 
for minor or mild acute closed head injury (GCS ≥ 13), without 
risk factors or neurologic deficit; rated 3 
– 
Head trauma, 
except for special 
cases 
ZA030 ACR AC: 
Head trauma: MRI with contrast except for special cases;  
rated 2/3 
Comment: CT is the most appropriate initial study for acute 
evaluation of the head-injured patient who may harbour 
lesion(s) that require immediate neurosurgical intervention. 
– 
Head trauma: 
minor, unless Red 
Flags are present 
ZA030 CW CAN: 
Don’t do imaging for minor head trauma unless red flags are 
present.  
Red flags include Glasgow Coma Scale (GCS) less than 13; GCS less 
than 15 at 2 hours post-injury; a patient aged 65 years or older; 
obvious open skull fracture; suspected open or depressed skull 
fracture; any sign of basilar skull fracture (e.g., hemotympanum, 
raccoon eyes, Battle’s Sign, CSF otorhinorrhea); retrograde 
amnesia to the event lasting 30 minutes or longer after the event; 
„dangerous“ mechanism (e.g., pedestrian struck by motor vehicle, 
occupant ejected from motor vehicle, or fall from higher than  
3 feet or down more than 5 stairs); and coumadin-use or 
bleeding disorder. 
– 
Comment:  
CT and X-ray no 
routine indication. 
M.3* 
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Head trauma in 
children 
ZA030 ACR AC: 
Head trauma-child: MRI head without and with contrast,  
no signs, low risk; rated 1 
– 
Head trauma in 
children 
ZA030 ACR AC: 
Head trauma-child: MRI head with contrast for moderate – 
severe injury or suspected non-accidental trauma or subacute 
injury with neurologic signs; rated 2 
Comment: MRI head without contrast indicated for moderate  
to severe head injury or minor head trauma, suspected non-
accidental trauma and sub-acute head injury. 
MRI indicated as 
follow-up for head 
injury. 
M.13* 
Head trauma in 
children 
ZA040 ACR AC: 
Head trauma child: MRA head without and with contrast;  
rated 1/2 
Comment: MRI and MRA head without contrast indicated for 
moderate to severe head injury (GCS ≤13) or minor head trauma 
with high-risk factors, excluding non-accidental trauma. 
– 
Hearing loss: 
conductive  
ZA030 ACR AC: 
Hearing loss/vertigo: MRI head and internal auditory canal 
without and with contrast for conductive hearing loss; rated 2 
Comment: CT of the temporal bone without contrast is the most 
appropriate initial imaging study in patients with conductive 
hearing loss. 
MRI indicated as 
follow-up. 
A.11* 
Hearing loss 
and/or vertigo 
ZA040 ACR AC: 
Hearing Loss and/or vertigo: MRA head without and with 
contrast; except for Persistent vertigo with or without 
neurological symptoms (central vertigo); rated 1 
– 
Intracranial 
disease: 
Colorectal cancer, 
distant 
metastases 
ZA030, 
ZD030 
NICE DB: 
If intracranial disease is suspected in patients with colorectal 
cancer, offer contrast-enhanced MRI of the brain. Do not offer 
imaging of the head, neck and limbs unless involvement of 
these sites is suspected clinically. 
MRI indicated as 
initial diagnosis for 
brain metastases. 
L.27, A.4* 
Neuroendocrine 
Imaging:  
no vascular 
pathology known 
or suspected 
ZA040 ACR AC: 
Neuroendocrine Imaging: MRA head without and with contrast 
if no vascular pathology is known or suspected; rated 3 
– 
Psychosis,  
first-episode 
ZN270 NICE DB: 
Structural neuroimaging techniques (either magnetic resonance 
imaging [MRI] or computed axial tomography [CT] scanning) are 
not recommended as a routine part of the initial investigations 
for the management of first-episode psychosis. 
MRI indicated as 
initial diagnosis. 
A.13* 
Seizures and 
epilepsy 
ZN270 ACR AC: 
Seizures and epilepsy: MRI functional (fMRI) head without 
contrast for new-onset seizure unrelated to trauma or acute 
post-traumatic; rated 2/3 
– 
Seizures in 
children:  
simple febrile 
seizures and  
post-traumatic 
seizures resp. 
simple febrile 
seizures 
ZA030 ACR AC: 
Seizures-child: MRI head without and with contrast for simple 
febrile seizures and post-traumatic seizures; rated 2 
CW USA: 
Neuroimaging (CT, MRI) is not necessary in a child with simple 
febrile seizure.  
CT scanning is associated with radiation exposure that may 
escalate future cancer risk. MRI also is associated with risks 
from required sedation and high cost. The literature does not 
support the use of skull films in the evaluation of a child with a 
febrile seizure. Clinicians evaluating infants or young children 
after a simple febrile seizure should direct their attention 
toward identifying the cause of the child’s fever. 
– 
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CAR: 
Febrile seizure in children: imaging not indicated. 
Comment: Post-traumatic seizures should first be evaluated by 
CT. Late post-traumatic seizures may be better evaluated by 
MRI (ACR AC). 
Syncope: simple, 
in patients with a 
normal 
neurological 
examination 
ZA030 CW CAN: 
Don’t routinely obtain neuro-imaging studies (CT, MRI, or 
carotid dopplers) in the evaluation of simple syncope in patients 
with a normal neurological examination.  
Although an uncommon cause for syncope, providers must 
consider a neurological cause in every patient presenting with 
transient loss of consciousness. In the absence of signs or 
symptoms concerning for neurological causes of syncope (such 
as but not limited to focal neurological deficits), the utility of 
neuro-imaging studies are of limited benefit. Despite a lack of 
evidence for the diagnostic utility of neuroimaging in patients 
presenting with true syncope, providers continue to perform 
brain computed tomographic (CT) scans. Thus, inappropriate 
use of this diagnostic imaging modality carries high costs and 
subject patients to the risks of radiation exposure. 
CW USA: 
In the evaluation of simple syncope and a normal neurological 
examination, don’t obtain brain imaging studies (CT or MRI).  
In patients with witnessed syncope but with no suggestion of 
seizure and no report of other neurologic symptoms or signs, 
the likelihood of a central nervous system (CNS) cause of the 
event is extremely low and patient outcomes are not improved 
with brain imaging studies. 
– 
Syncope: simple, 
without other 
neurologic 
symptoms 
ZA040 CW USA: 
Don’t perform imaging of the carotid arteries for simple syncope 
without other neurologic symptoms.  
Occlusive carotid artery disease does not cause fainting but rather 
causes focal neurologic deficits such as unilateral weakness. 
Thus, carotid imaging will not identify the cause of the fainting 
and increases cost. Fainting is a frequent complaint, affecting 
40% of people during their lifetime. 
– 
Follow-up diagnosis 
Brain metastases 
in patients 
symptomatic on 
physical 
examination  
ZA030 ACR AC: 
Follow up of brain metastases: Subsequent MRI head when 
symptomatic on physical examination only, after treatment, for 
the first year; rated 3 
Comment: Initial MRI head ≤ 3 months is indicated. 
MRI indicated as 
initial diagnosis. 
L.27* 
Epilepsy: 
idiopathic 
generalised 
ZA030 NICE DB: 
Neuroimaging should not be routinely requested when a 
diagnosis of idiopathic generalised epilepsy has been made. 
MRI indicated as 
initial diagnosis. 
A.16* 
Headache ZA030 NICE DB: 
Do not refer people diagnosed with tension-type headache, 
migraine, cluster headache or medication overuse headache for 
neuroimaging solely for reassurance. 
MRI indicated after 
observation (change 
of headache 
characteristics or 
focal neurologic 
deficit). 
A.6* 
Parkinson’s 
disease 
ZN270 NICE DB: 
Structural magnetic resonance imaging should not be used in 
the differential diagnosis of Parkinson’s disease. 
MRI indicated as 
initial diagnosis. 
A.12* 
Parkinson’s 
disease:  
parkinsonian 
syndromes 
ZN270 NICE DB: 
Magnetic resonance spectroscopy should not be used in the 
differential diagnosis of parkinsonian syndromes. 
– 
Comment: MRI 
indicated as initial 
diagnosis. 
A.12* 
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Renal cell 
carcinoma/Brain 
metastases in 
asymptomatic 
patients, after 
treatment 
ZA030 ACR AC: 
Post-treatment follow-up of renal cell carcinoma: MRI head 
without and with contrast for asymptomatic patients; rated 1 
MRI best method for 
diagnosis of brain 
metastasis. L.27*  
MRI indicated as 
initial diagnosis of 
renal cell carcinoma.  
L.15* 
Staging 
Invasive bladder 
cancer/Brain 
metastases: lack 
of neurologic 
symptoms 
ZA030 ACR AC: 
Pre-treatment staging of invasive bladder cancer:  
MRI head without and with contrast; rated 2 
 
MRI best method for 
diagnosis of brain 
metastasis. L.27* 
MRI not indicated for 
diagnosis but MRI 
abdomen and pelvis 
indicated for staging 
of bladder cancer. 
L.17* 
Renal cell 
carcinoma/Brain 
metastases: no 
neurologic 
symptoms or 
other metastases  
ZA030 ACR AC: 
Renal cell carcinoma staging: MRI head without and with  
contrast for asymptomatic patients; rated 1/3 
MRI best method for 
diagnosis of brain 
metastasis. L.27*  
MRI abdomen 
indicated for staging 
renal cell carcinoma. 
L.15* 
Uveal 
melanoma/Brain 
metastases:  
Stage I or IIA/B* 
ZA030 CAR: 
Uveal melanoma staging Stage I or IIA/B*: MRI brain not 
indicated. Incidence of metastasis very low. 
MRI best method for 
diagnosis of brain 
metastasis.  
L.27*  
Uveal melanoma/ 
Brain metastases:  
Stage IIC or III 
ZA030 CAR: 
Uveal melanoma staging: Stage IIC or III with macrometastasis 
sentinel LN or LN dissection: MRI brain not indicated if no 
neurological symptoms. 
MRI best method for 
diagnosis of brain 
metastasis.  
L.27*  
Screening 
Brain metastases:  
patients with 
suspected or 
biopsy proven 
Stage I NSCLC 
(lung cancer) 
ZA030 CW USA: 
Patients with suspected or biopsy proven Stage I NSCLC do not 
require brain imaging prior to definitive care in the absence of 
neurologic symptoms.  
• The incidence of occult brain metastasis in Stage I lung cancer 
is low (<3%) and so routine brain imaging results in increased 
costs, delays in therapy and rarely changes patient 
management.  
• False-positive studies occur in up to 11% of patients resulting in 
further invasive testing or incorrect over staging, with potentially 
tragic effects on treatment decisions and outcomes. 
Some clinicians perform routine screening by brain magnetic 
resonance imaging (MRI) or computed tomography (CT) scans to 
rule out occult brain metastasis in asymptomatic patients prior to 
surgical resection of early stage lung cancer. This practice of routine 
screening for occult brain metastases has not been evaluated by a 
randomized clinical trial and may not be cost-effective or medically 
necessary. Pooled data from retrospective studies that included 
a comprehensive clinical evaluation demonstrated that only 3% 
of patients who have a negative neurologic evaluation present 
with intracranial metastasis. One study, limited to Stage I patients, 
reported a prevalence of 1.3%. The joint statement of the American 
Thoracic Society and the European Respiratory Society did not 
advocate preoperative imaging of the brain in patients with 
NSCLC who present without neurologic symptoms, and the 
current National Comprehensive Cancer Network (NCCN) non-
small cell lung cancer guidelines do not recommend preoperative 
brain imaging for asymptomatic patients with Stage IA non-small 
cell lung carcinoma. 
MRI indicated as 
initial diagnosis or 
follow-up for 
assessing brain 
metastases. 
L.27, L.7* 
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Ratings 1, 2 and 3 represent ‘usually not appropriate’; grey marking refers to overlapping recommendations 
* refers to the respective chapter number in the OGR 
1 OGR usually does not specify MRI technique as contrast application, angiographic, functional or spectroscopic imaging; 
OGR does not specify kind of neoplasm or setting when and if imaging is justified for search of distant metastases. 
 
Table 8-3: Recommendations against the use of MRI – Head/Neck 
Indication 
MEL 
code Recommendation/Programme 
Orientation  
Guide Radiology 
Initial diagnosis/primary investigation 
Hoarseness, 
primary 
complaint, prior 
to examining the 
larynx 
ZA030 CW USA: 
Don’t obtain computed tomography (CT) or magnetic resonance 
imaging (MRI) in patients with a primary complaint of hoarseness 
prior to examining the larynx.  
Examination of the larynx with mirror or fiberoptic scope is the 
primary method for evaluating patients with hoarseness. Imaging 
is unnecessary in most patients and is both costly and has 
potential for radiation exposure. After laryngoscopy, evidence 
supports the use of imaging to further evaluate 1) vocal fold 
paralysis, or 2) a mass or lesion of the larynx. 
– 
Rhinosinusitis: 
uncomplicated, 
acute 
ZA030 CW USA: 
Don’t order sinus computed tomography (CT) or indiscriminately 
prescribe antibiotics for uncomplicated acute rhinosinusitis.  
Viral infections cause the majority of acute rhinosinusitis and 
only 0.5 percent to 2 percent progress to bacterial infections. 
Most acute rhinosinusitis resolves without treatment in two 
weeks. Uncomplicated acute rhinosinusitis is generally diagnosed 
clinically and does not require a sinus CT scan or other imaging. 
Antibiotics are not recommended for patients with 
uncomplicated acute rhinosinusitis who have mild illness and 
assurance of follow-up. If a decision is made to treat, amoxicillin 
should be first-line antibiotic treatment for most acute 
rhinosinusitis. 
Don’t routinely obtain radiographic imaging for patients who 
meet diagnostic criteria for uncomplicated acute rhinosinusitis.  
Imaging of the paranasal sinuses, including plain film 
radiography, computed tomography (CT) and magnetic 
resonance imaging (MRI) is unnecessary in patients who meet 
the clinical diagnostic criteria for uncomplicated acute 
rhinosinusitis. Acute rhinosinusitis is defined as up to four weeks 
of purulent nasal drainage (anterior, posterior or both) 
accompanied by nasal obstruction, facial p ain-pressure-fullness 
or both. Imaging is costly and exposes patients to radiation. 
Imaging may be appropriate in patients with a complication of 
acute rhino-sinusitis, patients with comorbidities that predispose 
them to complications and patients in whom an alternative 
diagnosis is suspected. 
– 
Comment: MRI 
indicated as follow-
up for diseases of 
the paranasal 
sinuses (with 
intracranial 
complications and 
suspected malignant 
tumour). 
B.3* 
Sinonasal disease: 
acute/subacute, 
uncomplicated or 
recurrent acute or 
chronic 
rhinosinusitis 
ZA030 ACR AC: 
Sinonasal disease: MRI head and paranasal sinuses with (and 
without) contrast for acute or subacute uncomplicated or recurrent 
acute or chronic rhinosinusitis; rated 2  
Comment: CT of the sinuses without contrast is the imaging 
method of choice in patients with recurrent acute sinusitis or 
chronic sinusitis, or to define sinus anatomy prior to surgery. 
MRI indicated as 
follow-up in case  
of affection of 
paranasal sinuses, 
intracranial 
complications and 
suspected malignant 
tumour. 
B.3* 
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Sinusitis in 
children: 
uncomplicated, 
acute 
ZA030 CAR: 
Uncomplicated acute sinusitis in children: imaging not indicated. 
Mucosal thickening is frequently seen in asymptomatic children, 
limiting the value of imaging for ruling in/out sinusitis. 
ACR AC: 
Sinusitis-child: MRI paranasal sinuses without (and with) 
contrast; rated 1 
Comment: CT of the paranasal sinuses is the imaging modality of 
choice in patients with persistent, recurrent, or chronic sinusitis 
(ACR AC). 
MRI no routine 
indication. 
K.11* 
Sinusitis in 
children, with 
complications 
ZA030 ACR AC: 
Sinusitis-child: MRI head without contrast for sinusitis with 
complications; rated 3 
Comment: MRI head with contrast and MRI paranasal sinuses 
indicated. 
MRI no routine 
indication. 
Comment: MRI may 
be indicated for 
atypical course and 
complications. 
K.11* 
Ratings 1, 2 and 3 represent ‘usually not appropriate’; grey marking refers to overlapping recommendations 
* refers to the respective chapter number in the OGR 
 
Table 8-4: Recommendations against the use of MRI – Spine/Spinal Cord 
Indication 
MEL 
code Recommendation/Programme 
Orientation  
Guide Radiology1 
Initial diagnosis/primary investigation 
Low back pain: 
no Red Flags 
ZN260 ACR AC: 
Low back pain: MRI lumbar spine without and with contrast if no 
red flags; rated 2 
CW CAN: 
Don’t do imaging for lower-back pain unless red flags are present.  
Red flags include, but are not limited to, severe or progressive 
neurological deficits or when serious underlying conditions such as 
osteomyelitis are suspected. Imaging of the lower spine before six 
weeks does not improve outcomes. 
Don’t do imaging for lower-back pain unless red flags are present.  
Red flags include suspected epidural abscess or hematoma presenting 
with acute pain, but no neurological symptoms (urgent imaging is 
required); suspected cancer; suspected infection; cauda equina 
syndrome; severe or progressive neurologic deficit; and suspected 
compression fracture. In patients with suspected uncomplicated 
herniated disc or spinal stenosis, imaging is only indicated after at 
least a six-week trial of conservative management and if symptoms 
are severe enough that surgery is being considered. 
CW USA: 
Don’t do imaging for low back pain within the first six weeks,  
unless red flags are present.  
Red flags include, but are not limited to, severe or progressive 
neurological deficits or when serious underlying conditions such as 
osteomyelitis are suspected. Imaging of the lower spine before six 
weeks does not improve outcomes, but does increase costs. Low 
back pain is the fifth most common reason for all physician visits. 
CAR: 
Lower back pain: MRI Indicated in special circumstances. Imaging is 
only indicated if there are „red flag” indications. 
MRI indicated after 
observation. Within 
the first 4-6 weeks, 
imaging is usually  
not indicated. 
C.6* 
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Low back pain: 
acute,  
non-specific, 
within first  
6 weeks 
ZN260 CW USA: 
Avoid imaging studies (MRI, CT or X-rays) for acute low back pain 
without specific indications.  
Imaging for low back pain in the first six weeks after pain begins 
should be avoided in the absence of specific clinical indications (e.g., 
history of cancer with potential metastases, known aortic aneurysm, 
progressive neurologic deficit, etc.). Most low back pain does not 
need imaging and doing so may reveal incidental findings that divert 
attention and increase the risk of having unhelpful surgery. 
Don’t recommend advanced imaging (e.g., MRI) of the spine within 
the first six weeks in patients with non-specific acute low back pain 
in the absence of red flags.  
In the absence of red flags, advanced imaging within the first six 
weeks has not been found to improve outcomes, but does increase 
costs. Red flags include, but are not limited to: trauma history, 
unintentional weight loss, immunosuppression, history of cancer, 
intravenous drug use, steroid use, osteoporosis, age >50, focal 
neurologic deficit and progression of symptoms. 
Don’t obtain imaging studies in patients with non-specific low  
back pain. 
In patients with back pain that cannot be attributed to a specific 
disease or spinal abnormality following a history and physical 
examination (e.g., non-specific low back pain), imaging with plain 
radiography, computed tomography (CT) scan, or magnetic 
resonance imaging (MRI) does not improve patient outcomes. 
MRI indicated after 
observation. Within 
the first 4-6 weeks, 
imaging is usually 
not indicated. 
C.6* 
Low back pain: 
patients over  
70 years with 
specific 
symptoms 
ZN260 ACR AC: 
Low back pain: MRI lumbar spine with contrast for patient over  
70 years with specific symptoms; rated 3 
Comment: MRI lumbar spine without contrast indicated. 
MRI indicated as 
initial diagnosis and 
after observation. 
C.7* 
Low back pain: 
non-specific 
ZN260 NICE DB: 
Only offer a magnetic resonance imaging (MRI) scan for non-specific 
low back pain within the context of a referral for an opinion on 
spinal fusion. 
MRI indicated after 
observation. 
C.6* 
Myelopathy ZN260 ACR AC: 
Myelopathy: MRI spine without and with contrast if traumatic; 
without contrast if painful, sudden onset, stepwise or slowly, 
progressive, infectious or oncology patients; rated2 
Comment: CT usually is the preferred first test in suspected spinal 
trauma. 
MRI indicated as 
initial diagnosis in 
nontraumatic 
(C.13*) and 
traumatic (M.14*) 
situations. 
Myelopathy  ACR AC: 
Myelopathy: MRA spine without and with contrast; traumatic, 
infectious disease patient, oncology patient; rated 2/3 
– 
Neck pain, 
chronic 
ZN260 ACR AC: 
Chronic neck pain: MRI cervical spine without and with contrast  
as first study; rated 1 
MRI indicated as 
follow-up. 
C.4* 
Neck pain, 
chronic 
ZN260 ACR AC: 
Chronic neck pain: MRI cervical spine with contrast except suspected 
infection or malignancy; rated 1 
MRI indicated as 
follow-up. 
C.4* 
Spine trauma, 
suspected 
ZN260 ACR AC: 
Suspected acute spine trauma: MRI cervical spine without and with 
contrast for low-risk patients; rated 1 
Comment: In case of e.g. myelopathy and for the evaluation of 
ligamentous injury, MRI cervical spine without contrast is indicated. 
MRI indicated as 
initial diagnosis for 
cervical spine trauma, 
indicated as follow-
up for lumbar spine 
trauma in case of 
neurologic deficit. 
M.15/16* 
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Spine trauma, 
suspected, 
except for 
children 
ZN260 ACR AC: 
Suspected spine trauma: MRI with contrast except for children; 
rated 2/1 
MRI indicated as 
initial diagnosis for 
cervical spine 
trauma, indicated as 
follow-up for 
lumbar spine 
trauma in case of 
neurologic deficit. 
M.15/16* 
Spine trauma ZN260 ACR AC: 
Suspected spine trauma: MRI (without and) with contrast for 
various situations; rated 1 
Comment: for most cases, MRI without contrast is indicated. 
MRI indicated as 
initial diagnosis for 
cervical spine 
trauma, indicated as 
follow-up for 
lumbar spine 
trauma in case of 
neurologic deficit. 
M.15/16* 
Spine trauma, 
suspected 
ZA040 ACR AC: 
Suspected Spine Trauma: MRA neck without and with contrast; 
except for suspected acute cervical spine trauma, Imaging indicated 
by clinical criteria (NEXUS or CCR), Clinical or imaging findings 
suggest arterial injury; rated 1 
– 
Follow-up diagnosis 
Spina bifida 
occulta 
ZN260 CAR: 
Spina bifida occulta reported on XR, neurological findings and 
cutaneous stigmata of dysraphism absent in children: imaging not 
indicated. 
MRI indicated as 
initial diagnosis. 
K.1* 
MRI indicated as 
initial diagnosis or 
follow-up in older 
children when US is 
fruitless. 
K.14* 
Screening 
Spinal 
dysraphism, 
suspected in 
low risk infants 
ZN260 CAR: 
Suspected spinal dysraphism, screening in low risk infants: MRI not 
indicated. MRI has the best diagnostic performance, but it requires 
sedation. It should therefore not be used as a screening modality. 
MRI indicated as 
initial diagnosis. 
K.1* 
MRI indicated as 
initial diagnosis or 
follow-up when 
conspicuous/unclear 
US, neurologic 
deficit, pre-OP.  
K.15* 
Ratings 1, 2 and 3 represent ‘usually not appropriate’; grey marking refers to overlapping recommendations 
* refers to the respective chapter number in the OGR 
1 OGR usually does not specify MRI technique as contrast application, angiographic, functional or spectroscopic imaging. 
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Table 8-5: Recommendations against the use of MRI – Musculoskeletal 
Indication 
MEL 
code Recommendation/Programme 
Orientation  
Guide Radiology1 
Initial diagnosis/primary investigation 
Arm, Hand/wrist 
Elbow pain, 
chronic 
ZD030 ACR AC: 
Chronic elbow pain: MRI elbow without contrast as first test; rated 1 
– 
Hand and wrist 
trauma: acute 
ZD030 ACR AC: 
Acute hand and wrist trauma: MRI wrist without and with contrast 
for wrist trauma, first examination; rated 1 
MRI indicated for 
hand/wrist trauma 
as follow-up. 
M.28/29* 
Metacarpal 
fracture or 
dislocation, 
suspected 
ZD030 ACR AC: 
Acute hand and wrist trauma: MRI hand without and with contrast 
for suspected metacarpal fracture or dislocation; rated 1 
MRI indicated for 
hand/wrist trauma 
as follow-up. 
M.28/29* 
Phalangeal 
fracture, 
suspected 
ZD030 ACR AC: 
Acute hand and wrist trauma: MRI finger without and with contrast 
for suspected phalangeal fracture; rated 1 
MRI indicated for 
hand/wrist trauma 
as follow-up. 
M.28/29* 
Scaphoid 
fracture, 
suspected 
ZD030 ACR AC: 
Acute hand and wrist trauma: MRI wrist with and without contrast 
for suspected acute scaphoid fracture, first examination; rated 1 
MRI indicated for 
hand/wrist trauma 
as follow-up. 
M.28/29* 
Wrist pain, 
chronic 
ZD030 ACR AC: 
Chronic wrist pain, with or without prior injury: MRI wrist without 
and with contrast as first study; rated 1 
– 
Wrist pain, 
chronic: 
suspected 
carpal tunnel 
syndrome 
ZD030 ACR AC: 
Chronic wrist pain: MRI wrist without and with contrast for suspect 
carpal tunnel syndrome; rated 1 
– 
Foot 
Ankle pain, 
chronic 
ZE030 ACR AC: 
Chronic ankle pain: MRI ankle without and with contrast as best 
initial study; rated 1 
– 
Ankle trauma, 
acute 
ZE030 ACR AC: 
Acute trauma to the ankle: MRI ankle (without and) with contrast; 
rated 1 
MRI indicated as 
follow-up. 
M.32* 
Foot pain, 
chronic 
ZE030 ACR AC: 
Chronic foot pain: MRI foot without and with contrast as first test; 
rated 1 
– 
Foot trauma, 
acute 
ZE030 ACR AC: 
Acute trauma to the foot: MRI foot without contrast as initial study, 
rated 1  
MRI indicated as 
follow-up. 
M.32* 
Hip 
Hip necrosis**  ZC030 ACR AC: 
Avascular necrosis of the hip: MRI hips with or without contrast as 
initial study; rated 1 
Comment: MRI hips without contrast most sensitive method for 
detecting AVN, but not indicated before radiographs. 
MRI indicated as 
follow-up if radio-
graphs normal and 
suspected femur 
head necrosis. 
D.14* 
Hip pain,  
acute 
ZC030 ACR AC: 
Acute hip pain – suspected fracture: MRI pelvis and affected hip 
without and with contrast as first study; rated 1 
– 
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Hip pain, 
chronic 
ZC030 ACR AC: 
Chronic hip pain: MRI hip without and with contrast as first test; 
rated 1 
MRI indicated as 
follow-up if radio-
graphs normal and 
suspected femur 
head necrosis. 
D.14* 
Knee 
Knee pain, in 
children 
ZE030 ACR AC: 
Non-traumatic knee pain: MRI knee without and with contrast as 
initial examination; rated 1 
– 
Comment: MRI 
indicated as follow-
up for all patients. 
D.15* 
Knee pain: non-
traumatic 
ZE030 ACR AC: 
Non-traumatic knee pain: MRI knee without and with contrast as 
initial examination; rated 1 
MRI indicated as 
follow-up. 
D.15* 
Knee pain ZE030 CW USA: 
Avoid ordering a knee MRI for a patient with anterior knee pain 
without mechanical symptoms or effusion unless the patient has not 
improved following completion of an appropriate functional 
rehabilitation program.  
The most common cause of anterior knee pain is patellofemoral pain 
syndrome. Magnetic resonance imaging (MRI) is rarely helpful in 
managing this syndrome. Treatment should focus on a guided exercise 
program to correct lumbopelvic and lower limb strength and flexibility 
imbalances. If pain persists, if there is recurrent swelling or if mechanical 
symptoms such as locking and painful clicking are present, and 
radiographs are non-diagnostic, an MRI may be useful. 
MRI indicated as 
follow-up for knee 
pain. 
D.15* 
Knee trauma, 
acute 
ZE040 ACR AC: 
Acute Trauma to the Knee: MRA knee without and with contrast 
except for patients (excluding infants) with significant trauma to the 
knee from motor vehicle accident, suspect posterior knee dislocation. 
First study; rated 1 
– 
MRI indicated as 
initial diagnosis. 
M.31* 
Knee trauma, 
acute 
ZE030 ACR AC: 
Acute trauma to the knee: MRI knee without and with contrast for 
patients excluding infants; rated 1 
Comment: MRI knee without contrast indicated except for patients 
without symptoms. 
MRI indicated as 
initial diagnosis. 
M.31* 
Metastatic bone disease 
Metastatic bone 
disease: stage 2 
carcinoma of 
the breast with 
back and hip pain 
ZN260 ACR AC: 
Metastatic bone disease: MRI hip and spine without and with 
contrast for stage 2 carcinoma of the breast with back and hip pain, 
initial presentation; rated 1 
MRI indicated as 
follow-up for 
identifying skeleton 
metastases. 
L.29* 
Metastatic 
bone disease: 
stage 1 breast 
carcinoma, hot 
spot/s in spine 
ZN260 ACR AC: 
Metastatic bone disease: MRI spine with contrast for: stage 1 breast 
carcinoma, asymptomatic; single/three hot spot/s in spine, rated 1 
Comment: MRI without contrast indicated if radiographs are 
negative. 
MRI indicated as 
follow-up for 
identifying skeleton 
metastases. 
L.29* 
Metastatic  
bone disease: 
stage 1  
carcinoma breast  
ZN660 ACR AC: 
Metastatic bone disease: MRI area of interest without and with 
contrast for stage 1 carcinoma breast, initial presentation, 
asymptomatic; rated 1 
MRI indicated as 
follow-up for 
identifying skeleton 
metastases. 
L.29* 
Metastatic 
bone disease  
in pregnant 
women 
ZN660 ACR AC: 
Metastatic bone disease: MRI whole body with contrast for pregnant 
women; rated 1 
Comment: MRI without contrast indicated. 
- 
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Peripheral joints 
Inflammatory 
arthritis 
ZN660 CW USA: 
Don’t perform MRI of the peripheral joints to routinely monitor 
inflammatory arthritis.  
Data evaluating MRI for the diagnosis and prognosis of rheumatoid 
arthritis are currently inadequate to justify widespread use of this 
technology for these purposes in clinical practice. Although bone 
edema assessed by MRI on a single occasion may be predictive of 
progression in certain RA populations, using MRI routinely is not 
cost-effective compared with the current standard of care, which 
includes clinical disease activity assessments and plain film 
radiography. 
Comment: Also applies for surveillance. 
– 
MRI indicated as 
follow-up for 
unspecific joint 
arthropathy. 
D.10* 
Shoulder 
Shoulder pain: 
acute 
ZD030 ACR AC: 
Acute shoulder pain: MRI shoulder without contrast, best initial 
study; rated 1 
MRI indicated as 
follow-up for 
traumatic shoulder 
pain. 
M.27* 
Soft tissue masses 
Soft tissue 
masses: 
nonspecific 
clinic 
ZN660 ACR AC: 
Soft tissue masses: MRI area of interest without and with contrast 
for initial examination, nonspecific clinic; rated 1 
Comment: Large lesions located on the abdominal or chest wall, 
where motion artefact can create suboptimal MR imaging, may be 
best evaluated with CT. 
MRI is, however, indicated for other variants of soft tissue masses. 
MRI indicated as 
initial diagnosis, 
follow-up and 
staging. 
D.4* 
Stress fractures 
Stress fracture, 
prior to X-ray 
ZN660 ACR AC: 
Stress fracture: MRI area of interest without and with contrast as 
first study; rated 1 
MRI indicated as 
follow-up. 
D.26* 
Stress fracture  ZN660 ACR AC: 
Stress fracture: MRI area of interest with contrast rated 1 except for 
clinical differential fracture versus metastasis in long bone. 
Radiographs normal, bone scan hot but nonspecific; rated 1 
MRI indicated as 
follow-up for stress 
fractures. 
D.26* 
Follow-up diagnosis 
Hand/wrist 
Distal radial 
fracture, 
suspected: 
acute 
ZD030 ACR AC: 
Acute hand and wrist trauma: MRI wrist with contrast for suspected 
acute distal radial fracture, radiographs normal and comminuted 
intra-articular distal radius fracture; rated 1 
Comment: MRI without contrast indicated following radiographs. 
MRI indicated as 
follow-up for 
hand/wrist trauma. 
M.28/29* 
Distal 
radioulnar joint 
subluxation, 
suspected 
ZD030 ACR AC: 
Acute hand and wrist trauma: MRI wrist with contrast for suspected 
distal radioulnar joint subluxation; rated 1 
Comment: If optimum positioning of the wrist is not possible 
because of the injury or overlying cast, CT scanning is recommended. 
Repositioning the patient and scanning both wrists is more complex, 
time-consuming, and less comfortable with MRI compared to CT. 
MRI indicated for 
hand/wrist trauma 
as follow-up. 
M.28/29* 
Hook of the 
hamate 
fracture, 
suspected 
ZD030 ACR AC: 
Acute hand and wrist trauma: MRI wrist with contrast for suspected 
hook of the hamate fracture, radiographs normal or equivocal; rated 1 
Comment: MRI without contrast indicated following radiographs. 
MRI indicated for 
hand/wrist trauma 
as follow-up. 
M.28/29* 
Scaphoid 
fracture, 
suspected  
ZD030 ACR AC: 
Acute hand and wrist trauma: MRI wrist with contrast for suspected 
acute or occult scaphoid fracture, radiographs normal; rated 1 
Comment: MRI without contrast indicated following radiographs. 
MRI indicated for 
hand/wrist trauma 
as follow-up. 
M.28/29* 
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Thumb fracture 
or dislocation 
or gamekeeper 
injury 
ZD030 ACR AC: 
Acute hand and wrist trauma: MRI thumb with contrast for suspected 
thumb fracture or dislocation or suspected gamekeeper injury; rated 1 
Comment: MRI without contrast indicated following radiographs. 
MRI indicated as 
follow-up for hand 
(ligament) injuries 
following hand 
trauma. 
M.29* 
Wrist pain, 
chronic 
ZD030 ACR AC: 
Chronic wrist pain: MRI wrist with contrast for persistent symptoms, 
radiographs normal/non-specific or suspected/proven Kienböck’s 
disease or persistent pain, suspected fracture; rated 1/3 
Comment: Advantages of CT over MRI for the wrist include its ability 
to obtain high-resolution images of both wrists simultaneously, and 
the much shorter acquisition times for CT. 
– 
Wrist pain, 
chronic 
ZD030 ACR AC: 
Chronic wrist pain: MRI wrist without and with contrast for radiographs 
normal or show non-specific arthritis, exclude infection; rated 1 
– 
Foot 
Ankle pain, 
chronic 
ZE030 ACR AC: 
Chronic ankle pain: MRI ankle with contrast as next study; rated 1, 
except for suspected inflammatory arthritis detected by radiographs  
– 
Foot pain, 
chronic 
ZE030 ACR AC: 
Chronic foot pain: MRI foot for radiographs unremarkable or equivocal 
and clinical concern for complex regional pain syndrome type I, pain 
and tenderness over head of second metatarsal and clinical concern 
for Freiberg infraction; rated 2 
– 
Foot pain, 
chronic: various 
circumstances 
ZE030 ACR AC: 
Chronic foot pain: MRI foot with contrast for painful rigid flat foot. 
Radiographs unremarkable or equivocal and clinical concern for tarsal 
coalition, Pain and tenderness over tarsus, unresponsive to conservative 
therapy. Radiographs showed accessory ossicle, Localized pain at the 
plantar aspect of the heel. Radiographs unremarkable or equivocal. 
Clinical concern for plantar fasciitis, Athlete with pain and tenderness 
overtarsal navicular. Radiographs unremarkable or equivocal. Clinical 
concern for stress injury or occult fracture 
– 
Hip 
Hip pain: 
chronic 
ZC030 ACR AC: 
Chronic hip pain: MRI hip with contrast for positive radiographs and 
suspected infection; rated 2 
– 
Knee 
Imaging after 
total knee 
arthroplasty 
ZE030 ACR AC: 
Imaging after total knee arthroplasty: MRI knee without contrast as 
routine follow up in asymptomatic patients or initial evaluation of 
suspected infection; rated 1 
Comment: MRI indicated following radiographs. 
MRI indicated as 
follow-up for 
suspected infection 
in patients with 
painful implant if 
radiographs 
negative. 
D.16* 
Metastatic bone disease 
Suspected metastases, known primary tumor 
Bone 
metastases  
ZN260 NICE DB: 
The routine use of spinal magnetic resonance imaging (MRI) for all 
men with hormone-refractory prostate cancer and known bone 
metastases is not recommended. 
MRI indicated as 
follow-up for 
identifying skeleton 
metastases. 
L.29* 
Metastatic 
bone disease: 
after 
radiography 
ZE030 ACR AC: 
Metastatic bone disease: MRI femur without and with contrast for 
known metastatic bone disease after radiography; rated 1  
MRI indicated as 
follow-up, unspecific 
radiographs. 
L.29* 
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Metastatic 
bone disease 
ZN660 ACR AC: 
Metastatic bone disease: MRI area of interest without and with 
contrast for asymptomatic patients with prostate nodule or 
osteosarcoma follow up; rated 1 
MRI indicated as 
follow-up for 
identifying skeleton 
metastases. 
L.29* 
Metastatic 
bone disease 
ZN660 ACR AC: 
Metastatic bone disease: MRI with contrast for known malignancy 
and pain or multiple myeloma and pain; rated 1 
MRI indicated as 
follow-up for 
identifying skeleton 
metastases. 
L.29* 
Metastatic 
spinal cord 
compression  
ZN260 NICE DB: 
Metastatic spinal cord compression: In patients with a previous 
diagnosis of malignancy, routine imaging of the spine is not 
recommended if they are asymptomatic. 
MRI indicated as 
initial diagnosis and 
staging of spinal 
cord tumours; 
indicated as follow-
up for identifying 
skeleton metastases. 
L.2, L.29* 
Musculoskeleta
l tumors 
ZN660 ACR AC: 
Follow up of malignant or aggressive musculoskeletal tumours for 
evaluation of osseous metastatic disease from musculoskeletal 
primary: MRI whole body without and with contrast; rated 1 
Comment: MRI without contrast is indicated. 
MRI indicated as 
follow-up for 
identifying skeleton 
metastases; 
Indicated as initial 
diagnosis, control 
and staging of 
musculoskeletal 
tumours. 
L.29, L.25* 
Primary bone 
tumours: 
definitely 
benign lesions, 
not osteoid 
osteoma 
ZN660 ACR AC: 
Primary bone tumours: MRI area of interest with contrast for 
definitely benign lesions, not osteoid osteoma; rated 1 
Comment: CT is preferred for patients with suspected osteoid 
osteoma or subtle cortical abnormalities, and for evaluating matrix 
mineralization. 
MRI indicated as 
follow-up. 
D.2* 
Screening 
Primary bone 
tumours 
ZN660 ACR AC: 
Primary bone tumours: MRI area of interest without and with 
contrast as screening, first study; rated 1 
MRI indicated as 
follow-up; indicated 
as initial diagnosis 
for musculoskeletal 
tumours. 
D.2, L.25* 
Ratings 1, 2 and 3 represent ‘usually not appropriate’ 
* refers to the respective chapter number in the OGR 
** Recent studies provide new insight: Mueller D, et al.: Magnetic resonance perfusion and diffusion imaging characteristics of 
transient bone marrow edema, avascular necrosis and subchondral insufficiency fractures of the proximal femur. Eur J Radiol. 
2014 Oct;83(10):1862-9; Merlini L, et al.: Diffusion-weighted imaging findings in Perthes disease with dynamic gadolinium-
enhanced subtracted (DGS) MR correlation: a preliminary study. Pediatr Radiol. 2010 Mar;40(3):318-25 
1 OGR usually does not specify MRI technique as contrast application, angiographic, functional or spectroscopic imaging; 
OGR does not specify kind of neoplasm or setting when and if imaging is justified for search of distant metastases. 
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Table 8-6: Recommendations against the use of MRI – Cardiovascular 
Indication 
MEL 
code Recommendation/Programme 
Orientation  
Guide Radiology 
Initial diagnosis/primary investigation 
Chest pain, 
acute 
– ACR AC: 
Acute Chest Pain — Suspected Pulmonary Embolism: MRA pulmonary 
arteries without contrast; adults, pregnant patients; rated 3 
MRI no routine 
indication. 
E.19* 
Chest pain, 
acute 
ZB060 ACCF AUC: 
Acute Chest Pain: symptomatic, High pre-test probability of CAD, 
ECG—ST-segment elevation and/or positive cardiac enzymes: 
Vasodilator Perfusion Coronary Magnetic Resonance imaging (CMR) 
or Dobutamine Stress Function CMR; score 1 
MRI heart 
indicated as 
follow-up. 
E.1/2* 
Chest pain ZB060 ACR AC: 
Chest pain suggestive of acute coronary syndrome: MRI heart  
function and morphology without contrast; rated 3 
MRI heart 
indicated as 
follow-up. 
E.1/2* 
Chest pain, 
chronic 
ZB060 ACR AC: 
Chronic chest pain – low to intermediate probability of coronary artery 
disease: MRI heart function and morphology without contrast; rated 3 
MRI heart 
indicated as initial 
diagnosis of stable 
angina pectoris. 
E.3* 
Chest pain, 
chronic 
ZB040 ACR AC: 
Chronic chest pain – low to intermediate probability of coronary artery 
disease: MRI chest without (rated 2) and with contrast; rated 3 
MRI heart 
indicated as initial 
diagnosis of stable 
angina pectoris. 
E.3* 
Chest pain, 
chronic 
– ACR AC: 
Chronic Chest Pain — High Probability of Coronary Artery Disease: 
MRA coronary arteries without and with contrast; rated 3 
– 
Cold,  
painful leg 
ZB060 ACR AC: 
Sudden onset of cold painful leg (vascular): MRI heart function and 
morphology without and with contrast; rated 2 
MRA indicated as 
initial diagnosis. 
E.23* 
Coronary  
artery disease 
ZB060 ACR AC: 
Asymptomatic patient at risk for coronary artery disease: MRI heart 
function with stress without and with contrast; rated 1/2  
– 
Coronary  
artery disease 
ZB060 ACR AC: 
Asymptomatic patient at risk for coronary artery disease: MRI heart 
function and morphology without and with contrast; rated 1/2 
– 
Coronary  
artery disease 
– ACR AC: 
Asymptomatic Patient at Risk for Coronary Artery Disease: MRA 
coronary arteries without and with contrast; rated 1-3 
– 
Coronary  
artery disease 
ZB060 ACCF AUC: 
Coronary Artery disease: symptomatic, Low pre-test probability of 
CAD, ECG interpretable and able to exercise: Vasodilator Perfusion 
CMR or Dobutamine Stress Function CMR; score 2 
– 
Coronary  
artery disease 
– ACCF AUC: 
Coronary Artery disease: symptomatic, intermediate pre-test probability 
of CAD, ECG interpretable AND able to exercise: MRA coronary 
arteries; score 2 
Coronary Artery disease: symptomatic, intermediate pre-test probability 
of CAD, ECG uninterpretable OR unable to exercise: MRA coronary 
arteries; score 2 
– 
Coronary  
artery disease 
– ACCF AUC: 
Coronary Artery disease: symptomatic, High pre-test probability of 
CAD: MRA coronary arteries; score 1 
– 
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Coronary  
artery disease 
– ACCF AUC: 
Coronary Artery disease: Post-Revascularization (PCI or CABG) – 
Evaluation of Chest Pain Syndrome, Evaluation of bypass grafts  
(score 2), History of percutaneous revascularization with stents  
(score 1): MRA coronary arteries 
– 
Non-ischemic 
myocardial 
disease 
ZB040 ACR AC: 
Non-ischemic myocardial disease with clinical manifestations: MRI 
chest without and with contrast; rated 1/2 
MRI indicated as 
initial diagnosis 
for myocardial 
vitality. 
E.11* 
Pre-operative 
assessment in 
patients 
scheduled to 
undergo low-
risk (or 
intermediate 
risk) non-
cardiac surgery 
ZB060 CW CAN: 
Don’t perform stress cardiac imaging or advanced non-invasive 
imaging as a pre-operative assessment in patients scheduled to 
undergo low-risk non-cardiac surgery.  
Non-invasive testing is not useful for patients undergoing low-risk 
non-cardiac surgery (e.g., cataract removal). These types of tests do 
not change the patient’s clinical management or outcomes. 
CW USA: 
Don’t perform stress cardiac imaging or advanced non-invasive 
imaging as a pre-operative assessment in patients scheduled to 
undergo low-risk non-cardiac surgery.  
Non-invasive testing is not useful for patients undergoing low-risk 
non-cardiac surgery (e.g., cataract removal). These types of tests do 
not change the patient’s clinical management or outcomes and will 
result in increased costs. 
Don’t perform cardiac imaging as a pre-operative assessment in patients 
scheduled to undergo low- or intermediate-risk non-cardiac surgery.  
Non-invasive testing is not useful for patients undergoing low-risk 
non-cardiac surgery or with no cardiac symptoms or clinical risk factors 
undergoing intermediate-risk non-cardiac surgery. These types of testing 
do not change the patient’s clinical management or outcomes and will 
result in increased costs. Therefore, it is not appropriate to perform 
cardiac imaging procedures for non-cardiac surgery risk assessment in 
patients with no cardiac symptoms, clinical risk factors or who have 
moderate to good functional capacity. 
ACCF AUC: 
Risk Assessment: Preoperative Evaluation for Non-Cardiac Surgery – 
Low Risk Surgery, Intermediate perioperative risk predictor: Vasodilator 
Perfusion CMR or Dobutamine Stress Function CMR; score 2 
– 
Pulmonary 
embolism (PE), 
suspected 
ZB040 CW USA: 
Don’t image for suspected pulmonary embolism (PE) without 
moderate or high pre-test probability of PE.  
While deep vein thrombosis (DVT) and PE are relatively common 
clinically, they are rare in the absence of elevated blood d-Dimer levels 
and certain specific risk factors. Imaging, particularly computed 
tomography (CT) pulmonary angiography, is a rapid, accurate and 
widely available test, but has limited value in patients who are very 
unlikely, based on serum and clinical criteria, to have significant value. 
Imaging is helpful to confirm or exclude PE only for such patients, not 
for patients with low pre-test probability of PE. 
Comment: MRI is only used rarely for this indication; CTA with 
contrast is the standard technique. 
MRA no routine 
indication. 
E.19* 
Pulmonary 
hypertension 
– ACR AC: 
Pulmonary Hypertension: MRA pulmonary arteries without contrast; 
rated 2 
Comment: MRA with contrast is indicated. 
MRA indicated as 
initial diagnosis 
for hypertension. 
E.24* 
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Routine 
evaluation:  
no cardiac 
symptoms,  
no high-risk 
markers present 
ZB060 CW CAN: 
Don’t perform stress cardiac imaging or advanced non-invasive imaging 
in the initial evaluation of patients without cardiac symptoms unless 
high-risk markers are present.  
Asymptomatic, low-risk patients account for up to 45 percent of 
unnecessary „screening”. Testing should be performed only when the 
following findings are present: diabetes in patients older than 40-years-
old; peripheral arterial disease; or greater than 2 percent yearly risk for 
coronary heart disease events. 
CW USA: 
Don’t perform stress cardiac imaging or advanced non-invasive imaging 
in the initial evaluation of patients without cardiac symptoms unless 
high-risk markers are present.  
Asymptomatic, low-risk patients account for up to 45 percent of 
unnecessary „screening.” Testing should be performed only when the 
following findings are present: diabetes in patients older than 40-years-
old; peripheral arterial disease; or greater than 2 percent yearly risk for 
coronary heart disease events. 
– 
Routine 
evaluation:  
no cardiac 
symptoms,  
no high-risk 
markers present 
ZB060 CW USA: 
Don’t perform stress cardiac imaging or coronary angiography in patients 
without cardiac symptoms unless high-risk markers are present.  
Asymptomatic, low-risk patients account for up to 45 percent of 
inappropriate stress testing. Testing should be performed only when 
the following findings are present: diabetes in patients older than 40 
years old, peripheral arterial disease, and greater than 2 percent yearly 
coronary heart disease event rate. 
– 
Stable angina: 
patients with 
chest pain of 
resent onset 
ZB060 NICE DB: 
Do not use magnetic resonance (MR) coronary angiography for 
diagnosing stable angina. 
MRI heart 
indicated as initial 
diagnosis. 
E.3* 
Venous 
thrombo-
embolism 
(VTE) 
ZE030 CW USA: 
In patients with low pre-test probability of venous thromboembolism 
(VTE), obtain a high-sensitive D-dimer measurement as the initial 
diagnostic test; don’t obtain imaging studies as the initial diagnostic test.  
In patients with low pre-test probability of VTE as defined by the Wells 
prediction rules, a negative high-sensitivity D-dimer measurement 
effectively excludes VTE and the need for further imaging studies. 
MRA no routine 
indication for 
pulmonary 
embolism. 
E.19* 
Follow-up diagnosis 
Lower-
extremity 
arterial bypass 
surgery 
ZE040 ACR AC: 
Follow-up of Lower-Extremity Arterial Bypass Surgery: MRA lower 
extremity without and with contrast for infrainguinal vein graft, 
Asymptomatic patient. Surveillance; rated 2 
– 
Routine  
follow-up in 
asymptomatic 
patients  
ZB060 CW CAN: 
Don’t perform annual stress cardiac imaging or advanced non-invasive 
imaging as part of routine follow-up in asymptomatic patients.  
Performing stress cardiac imaging or advanced non-invasive imaging in 
patients without symptoms on a serial or scheduled pattern (e.g., every 
one to two years or at a heart procedure anniversary) rarely results in any 
meaningful change in patient management. This practice may, in fact, 
lead to unnecessary invasive procedures and excess radiation exposure 
without any proven impact on patients’ outcomes. An exception to this 
rule would be for patients more than five years after a bypass operation. 
CW USA: 
Don’t perform annual stress cardiac imaging or advanced non-invasive 
imaging as part of routine follow-up in asymptomatic patients.  
Performing stress cardiac imaging or advanced non-invasive imaging in 
patients without symptoms on a serial or scheduled pattern (e.g., every 
one to two years or at a heart procedure anniversary) rarely results in any 
meaningful change in patient management. This practice may, in fact, 
lead to unnecessary invasive procedures and excess radiation exposure 
without any proven impact on patients’ outcomes. An exception to this 
rule would be for patients more than five years after a bypass operation. 
– 
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Risk assessment 
with prior test 
results 
ZB060 ACCF AUC: 
Risk Assessment With Prior Test Results: Normal prior stress test, High 
CHD risk (Framingham), Within 1 year of prior stress test: Vasodilator 
Perfusion CMR or Dobutamine Stress Function CMR; score 2 
– 
Ratings 1, 2 and 3 represent ‘usually not appropriate’; grey marking refers to overlapping recommendations 
* refers to the respective chapter number in the OGR 
 
Table 8-7: Recommendations against the use of MRI – Thorax 
Indication 
MEL 
code Recommendation/Programme 
Orientation  
Guide Radiology 
Initial diagnosis/primary investigation 
Chest pain, 
acute 
– ACR AC: 
Acute non-specific chest pain- low probability of coronary artery 
Disease: MRA pulmonary and coronary arteries without and with 
contrast; rated 2/3 
– 
Chest pain, 
acute 
ZB060 ACR AC: 
Acute non-specific chest pain- low probability of coronary artery 
disease: MRI heart function with or without stress without and with 
contrast; rated 3 
– 
Comment:  
MRI indicated as 
follow-up. 
E.1/2* 
Chest trauma, 
blunt 
ZB040 ACR AC: 
First-line evaluation of blunt chest trauma; high-energy mechanism: 
MRI chest without (rated 1) and with (rated 2) contrast 
Comment: CT chest with contrast, ideally performed with CTA, is 
indicated. 
MRI indicated as 
follow-up for 
chest trauma. 
F.2* 
Pleural effusion ZB040 CAR: 
Pleural effusion: MRI not indicated. 
– 
Stridor, acute ZB040 CAR: 
Acute stridor, unstable child: imaging not indicated. Emergency 
airway management takes precedence over imaging. 
MRI indicated as 
follow-up. 
K.28* 
Thoracic Outlet 
Syndrome 
ZB050 ACR AC: 
Imaging in the Diagnosis of Thoracic Outlet Syndrome: MRA chest 
without contrast; rated 2 
– 
Follow-up diagnosis 
Chest trauma: 
blunt 
ZB040 ACR AC: 
Blunt chest trauma: MRI chest without (1) and with (2) contrast for 
patients with normal anteroposterior chest radiograph, normal 
examination and normal mental status, no high energy mechanism 
Comment: Chest X-ray and CT/CTA are complementary first-line 
imaging modalities.  
MRI indicated as 
follow-up for 
chest trauma for 
special cases. 
F.2* 
Dyspnoea, 
chronic 
ZB040 ACR AC: 
Chronic dyspnoea-suspected pulmonary origin: MRI chest without and 
with contrast for patients of any age, non-revealing or non-diagnostic 
clinical, standard radiography, and laboratory studies; rated 2 
Comment: MRI and PET have a role in the evaluation of chest wall 
masses and pleural disease, but their roles in diffuse lung disease are 
still investigational. Investigators acknowledge the superiority of CT  
in diffuse lung disease. 
– 
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Pulmonary 
nodules 
ZB040 ACR AC: 
Radiographically detected solitary pulmonary nodule: MRI chest 
without and with contrast for solid nodules >or = 1cm, low, moderate 
or high clinical suspicion for cancer; rated 2 
Radiographically detected solitary pulmonary nodule: MRI chest 
without (rated 1) and with (rated 2) contrast for solid nodules < 1cm, 
low, moderate or high clinical suspicion for cancer 
Comment: CT chest without and with contrast indicated. 
– 
Comment:  
MRI indicated as 
follow-up for 
staging 
pulmonary 
tumours. 
L.7* 
Screening 
Pulmonary 
metastases 
ZB040 ACR AC: 
Screening for pulmonary metastases: MRI chest without (2) and with 
(1) contrast for primary malignancy of bone and soft-tissue sarcoma 
Comment: CT is indicated as initial evaluation or surveillance. Motion-
related artefacts, a lower spatial resolution than CT, and an inability  
to detect calcification within lesions are limitations of MRI. 
– 
Pulmonary 
metastases 
ZB040 ACR AC: 
Screening for pulmonary metastases: MRI chest without contrast for 
primary malignancy of melanoma; rated 2 
Comment: CT chest without contrast indicated as initial evaluation or 
surveillance. 
– 
Pulmonary 
metastases 
ZB040 ACR AC: 
Screening for pulmonary metastases: MRI chest without contrast for 
primary malignancy of head and neck carcinoma; rated 2  
Comment: CT chest with contrast indicated. 
– 
Pulmonary 
metastases 
ZB040 ACR AC: 
Screening for pulmonary metastases: MRI chest without and with 
contrast for primary malignancy of testicular cancer; rated 2 
Comment: CT chest without contrast indicated. 
– 
Staging 
Bronchogenic 
carcinoma: 
non-small cell 
and small cell 
lung carcinoma 
ZB040 ACR AC: 
Non-invasive clinical staging of bronchogenic carcinoma: MRI chest 
without and with contrast for non- small cell and small cell lung 
carcinoma; rated 3 
CAR: 
Staging Small Cell Lung Cancer: chest MRI not indicated 
Comment: CT of the chest (and abdomen) with contrast is rated most 
appropriate for staging. 
CAR: only Small Cell lung cancer 
MRI indicated  
as follow-up 
procedure for 
staging of lung 
tumour in case  
of suspicion of 
infiltration of the 
pericardium, chest 
wall, central vessels 
spinal structures, 
Pancoast-Tumour. 
L.7* 
Non-small cell 
lung cancer 
ZB040 NICE DB: 
Magnetic resonance imaging (MRI) should not routinely be performed 
to assess the stage of the primary tumour (T-stage) in non-small cell 
Lung Cancer (NSCLC). 
Comment: Patients with known or suspected lung cancer should be 
offered a contrast-enhanced chest CT scan to further the diagnosis 
and stage the disease. 
MRI indicated  
as follow-up for 
staging of lung 
tumour in case  
of suspicion of 
infiltration of the 
pericardium, chest 
wall, central vessels 
spinal structures, 
Pancoast-Tumour. 
L.7* 
Lung nodules ZB040 ACR AC: 
Metastatic bone disease: MRI chest without and with contrast for 
lung nodule staging; rated 1 
– 
Ratings 1, 2 and 3 represent ‘usually not appropriate’; grey marking refers to overlapping recommendations 
* refers to the respective chapter number in the OGR 
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Table 8-8: Recommendations against the use of MRI – Gastrointestinal tract 
Indication 
MEL 
code Recommendation/Programme 
Orientation  
Guide Radiology1 
Initial diagnosis/primary investigation 
Abdominal 
pain, acute 
ZC030 ACR AC: 
Acute non-localized abdominal pain and fever or suspected abdominal 
abscess: MRI abdomen and pelvis with contrast in pregnant women; 
rated 2 
Comment: Because it is unclear how gadolinium-based contrast 
agents will affect the foetus, they should be administered only with 
extreme caution; only recommended during pregnancy when there 
are no alternatives and benefit outweighs risk. 
MRI without contrast is indicated. 
MRI indicated as 
follow-up for ‘acute 
abdomen’. 
J.5* 
Mesenteric 
Ischemia 
ZC040 ACR AC: 
Imaging of Mesenteric Ischemia: MRA abdomen without contrast 
for acute and chronic cases; rated 3 
– 
Right lower 
quadrant 
abdomen pain 
ZC030 ACR AC: 
Right lower quadrant abdomen pain- suspected appendicitis: MRI 
abdomen and pelvis with contrast in pregnant women with fever 
and leucocytosis; rated 2 
Comment: In general, CT is the most accurate imaging study for 
evaluating suspected appendicitis and alternative etiologies of RLQ 
abdominal pain. 
Comment: MRI without contrast indicated following ultrasound. 
MRI indicated as 
follow-up for 
appendicitis. 
J.2* 
Right upper 
quadrant pain 
ZC030 ACR AC: 
Right upper quadrant pain: MRI abdomen with contrast in pregnant 
women with fever and leucocytosis; rated 3 
Comment: MRI without contrast indicated. 
MRI indicated as 
follow-up for ‘acute 
abdomen’. 
J.5* 
Follow-up diagnosis 
Lower 
gastrointestinal 
tract bleeding 
ZC030 ACR AC: 
Management of lower gastrointestinal tract bleeding: MRI abdomen 
without and with contrast; rated 1/2 for different situations 
– 
Small bowel 
obstruction, 
suspected 
ZC030 ACR AC: 
Suspected small bowel obstruction: MR enteroclysis in patients with 
suspected high-grade small bowel obstruction, based on clinical 
evaluation or initial radiography, rated 3 
Suspected small bowel obstruction: MR enterography in patients 
with suspected high-grade small bowel obstruction, based on clinical 
evaluation or initial radiography, rated 3 
– 
Comment: MRI en-
teroclysma indicated 
as follow up in chronic 
recurring small  
bowel obstruction for 
demonstration of  
inflammatory  
changes with diffusion 
weighted imaging  
(G.10*) 
Screening 
Colorectal 
cancer 
ZC030 ACR AC: 
Colorectal cancer screening: MR colonography for high-risk 
individuals with hereditary non-polyposis colorectal cancer and/or 
ulcerative colitis or Crohn colitis; rated 2 
– 
Colorectal 
cancer 
screening after 
incomplete 
colonoscopy 
ZC030 ACR AC: 
Colorectal cancer screening after incomplete colonoscopy:  
MR colonography, rated 3 
Comment: CTC is the preferred test following an incomplete optical 
colonoscopy. 
– 
Ratings 1, 2 and 3 represent ‘usually not appropriate’ 
* refers to the respective chapter number in the OGR 
1 OGR usually does not specify MRI technique as contrast application, angiographic, functional or spectroscopic imaging. 
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Table 8-9: Recommendations against the use of MRI – Genito-urinary system 
Indication 
MEL 
code Recommendation/Programme 
Orientation  
Guide Radiology1 
Initial diagnosis/primary investigation 
Adrenal mass, 
incidentally 
discovered 
ZC030 ACR AC: 
Incidentally discovered adrenal mass: MRI abdomen without 
contrast for patients with no history of malignancy, mass >4cm 
diameter; rated 1 
Comment: MRI with contrast is indicated as part of pre-operative 
staging. 
MRI indicated as 
initial diagnosis. 
H.1* 
Adrenal mass, 
incidentally 
discovered 
ZC030 ACR AC: 
Incidentally discovered adrenal mass: MRI abdomen with contrast 
for patients with no history of malignancy, initial evaluation or 
follow-up, 1-4cm diameter; rated 2/1 
Comment: Also applies for follow-up. MRI without contrast is indicated. 
MRI indicated as 
initial diagnosis. 
H.1* 
Adrenal mass, 
incidentally 
discovered  
ZC030 ACR AC: 
Incidentally discovered adrenal mass: MRI abdomen with contrast 
for patients with history of malignancy, initial evaluation, <4cm 
diameter; rated 1 
Comment: MRI without contrast indicated. 
MRI indicated as 
initial diagnosis. 
H.1* 
Adrenal mass, 
incidentally 
discovered 
ZC030 ACR AC: 
Incidentally discovered adrenal mass: MRI abdomen without and 
with contrast for patients with history of malignancy, mass >4cm 
diameter; rated 1 
MRI indicated as 
initial diagnosis. 
H.1* 
Adnexal mass, 
clinically 
suspected 
ZC030 ACR AC: 
Clinically suspected adnexal mass: MRI pelvis without and with 
contrast for not pregnant reproductive age female with complex or 
solid mass detected OR postmenopausal female with simple ovarian 
cyst >1cm diameter; rated 3 
MRI indicated as 
follow-up in the 
diagnosis of ovarian 
carcinoma. 
H.31* 
Adnexal mass, 
clinically 
suspected 
ZC030 ACR AC: 
Clinically suspected adnexal mass: MRI pelvis without contrast for 
not pregnant reproductive age female with large and apparently 
simple cyst >5cm diameter detected; rated 3 
MRI indicated as 
follow-up in the 
diagnosis of ovarian 
carcinoma. 
H.31* 
Enuresis,  
typical 
ZC030 CAR: 
Typical enuresis in children: imaging not recommended. An anatomical 
abnormality is unlikely in the absence of unusual clinical features. 
– 
First trimester 
bleeding 
ZC030 ACR AC: 
First trimester bleeding: MRI pelvis without (rated 3) and with 
(rated 2) contrast for patients with positive pregnancy test 
– 
Hematospermia, 
transient or 
episodic 
ZC030 ACR AC: 
Hematospermia: MRI pelvis without and with contrast for men <40 
years, transient or episodic hematospermia and so other symptoms; 
rated 3 
– 
Hematuria ZC030 ACR AC: 
Hematuria: MRI abdomen and pelvis without and with contrast for 
all patients except young females with hemorrhagic cystitis; rated 3/2 
– 
Hematuria  
in children 
ZC030 ACR AC: 
Hematuria-child: MRI abdomen and pelvis without and with 
contrast; rated 3/2 
Comment: To evaluate for renal calculi, CT without contrast is the 
most useful examination. In the setting of trauma, CT with contrast 
is the most useful examination, especially with macroscopic 
hematuria. 
– 
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Hypertension ZC030 CAR: 
Hypertension without evidence of renal disease, responsive to 
medication: all imaging not indicated. Imaging is not indicated if 
there is no evidence of renal disease. 
MRA indicated as 
initial diagnosis for 
hypertension without 
renal disease. 
H.3* 
Indeterminate 
renal mass, 
normal renal 
function 
ZC030 ACR AC: 
Indeterminate renal mass: MRI abdomen without contrast for 
patients with normal renal function; rated 3 
Comment: MRI with contrast indicated. 
MRI indicated as 
initial diagnosis for 
renal mass. 
L.16* 
Indeterminate 
renal mass, 
renal 
insufficiency 
ZC030 ACR AC: 
Indeterminate renal mass: MRI abdomen with contrast for patients 
for patients with renal insufficiency; rated 3 
Comment: MRI without contrast indicated as clinical condition is a 
contraindication to intravenous contrast. 
MRI indicated as 
initial diagnosis for 
renal mass, as 
follow-up for renal 
insufficiency  
(no contrast). 
L.16, H.7* 
Lower urinary 
tract infections, 
recurrent 
ZC030 ACR AC: 
Recurrent lower urinary tract infections in women: MRI pelvis 
without and with contrast for women with no underlying risk 
factors; rated 2 
– 
Lower urinary 
tract symptoms 
(LUTS): 
uncomplicated 
ZC030 NICE DB: 
Do not routinely offer imaging of the upper urinary tract to men 
with uncomplicated lower urinary tract symptoms (LUTS) at initial 
assessment. 
– 
Lower Urinary 
tract symptoms 
(LUTS) 
ZC030 CAR: 
Lower Urinary tract symptoms [LUTS]: MRI useful only with signs 
of upper tract abnormality such as azotaemia, hematuria, infection. 
– 
Lower  
urinary tract 
symptoms: 
suspicion of 
benign prostatic 
hyperplasia 
ZC030 ACR AC: 
Lower urinary tract symptoms- suspicion of benign prostatic 
hyperplasia: MRI pelvis without and with contrast; rated 2 
CW USA: 
Don’t order creatinine or upper-tract imaging for patients with 
benign prostatic hyperplasia (BPH).  
When an initial evaluation shows only the presence of lower urinary 
tract symptoms (LUTS), if the symptoms are not significantly 
bothersome to the patient or if the patient doesn’t desire treatment, 
no further evaluation is recommended. Such patients are unlikely  
to experience significant health problems in the future due to their 
condition and can be seen again if necessary. [While the patient can 
often tell the provider if the symptom s are bothersome enough 
that he desires additional therapy, another possible option is to use 
a validated questionnaire to assess symptoms. For example, if the 
patient completes the International Prostate Symptom Scale (IPSS) 
and has a symptom score of 8 or greater, this is considered to be 
„clinically” bothersome.] 
– 
Lower urinary 
tract trauma, 
suspected 
ZC030 ACR AC: 
Suspected lower urinary tract trauma: MRI pelvis without and with 
contrast; rated 1 
Comment: CT of the pelvis with bladder contrast (CT cystography) 
is the recommended imaging study for suspected lower urinary tract 
injury due to a penetrating trauma of the lower abdomen or pelvis. 
– 
Menstrual 
bleeding,  
heavy 
ZC030 NICE DB: 
Magnetic resonance imaging (MRI) should not be used as a first-line 
diagnostic tool. 
– 
Myometrial 
invasion  
in patients with 
endometrial 
cancer 
ZC030 ACR AC: 
Pre-treatment evaluation and follow up of endometrial cancer:  
MRI pelvis without contrast for assessing the depth of myometrial 
invasion; rated 3 
Comment: Also applies for follow-up. 
MRI indicated as 
primary 
investigation for 
local staging of 
endometrial cancer. 
L.22* 
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Ovarian cancer, 
suspected 
ZC030 NICE DB: 
Do not use Magnetic Resonance Imaging (MRI) routinely for 
assessing women with suspected ovarian cancer. 
MRI indicated as 
initial diagnosis 
when US is unclear 
and CT not possible/ 
contraindicated. 
L.20, H.31* 
Pelvic floor 
dysfunction 
ZC030 ACR AC: 
Pelvic floor dysfunction: MRI pelvis endorectal coil except for clinically 
suspected recurrent prolapse following pelvic floor repair; rated 2 
– 
Pelvic pain, 
acute 
ZC030 ACR AC: 
Acute pelvic pain in the reproductive age group: MRI abdomen  
and pelvis with contrast for patients with gynaecological aetiology 
suspected, serum β-hCG positive OR non-gynaecological aetiology 
suspected, serum β-hCG positive; rated 1 
MRI indicated as 
follow-up for pelvic 
pain with suspected 
endometriosis. 
H.28* 
Prostatitis ZC030 CAR: 
Prostatitis: male chronic pelvic pain syndrome: MRI not indicated. 
Rarely useful in patients refractory to treatment. 
– 
Pyelonephritis, 
acute 
ZC030 ACR AC: 
acute pyelonephritis: MRI abdomen and pelvis without and with 
contrast for uncomplicated patients; rated 1 
– 
Renal failure: 
acute kidney 
injury 
ZC030 ACR AC: 
Renal failure: MRI abdomen without and with contrast for patients 
with acute kidney injury, unspecified; rated 2 
MRI indicated as 
follow-up for renal 
failure (without 
contrast). 
H.7* 
Renal failure: 
chronic kidney 
disease 
ZC030 ACR AC: 
Renal failure: MRI abdomen with contrast for patients with chronic 
kidney disease; rated 3 
MRI indicated as 
follow-up for renal 
failure (without 
contrast). 
H.7* 
Renal failure: 
acute kidney 
injury (AKI), 
unspecified 
ZC040 ACR AC: 
Renal Failure: MRA abdomen without and with contrast; Acute 
kidney injury (AKI), unspecified. 
MRI indicated as 
follow-up for renal 
failure, CTA superior 
for kidney injury. 
H.7, M.26* 
Reno-vascular 
hypertension 
ZC040 ACR AC: 
Reno-vascular Hypertension: MRA abdomen without and with 
contrast; Low index of suspicion of reno-vascular hypertension 
(„essential” hypertension); rated 1 
MRI indicated as 
initial diagnosis for 
hypertension. 
E.24/H.3* 
Scrotal pain, 
acute onset 
ZC030 ACR AC: 
Acute onset of scrotal pain without trauma, without antecedent 
mass: MRI pelvis (scrotum) without (rated 1) and with (rated 3) 
contrast for adults or children 
– 
Second and 
third trimester 
bleeding 
ZC030 ACR AC: 
Second and third trimester bleeding: MRI pelvis with contrast for 
patients with placenta previa and history of caesarean section; rated 3 
– 
Urinary 
incontinence  
in women 
ZC030 NICE DB: 
Do not use imaging (MRI, CT, X-ray) for the routine assessment of 
women with urinary incontinence. 
MRI indicated as 
follow-up. 
H.34* 
Vaginal 
bleeding in 
postmenopausal 
women 
ZC030 ACR AC: 
Abnormal vaginal bleeding: MRI pelvis without (rated 1) and with 
(rated 2) contrast as first study of postmenopausal bleeding or 
endometrium <5mm by ultrasound. 
MRI indicated as 
follow-up for  
post-menopausal 
bleeding. 
H.29* 
Vesicoureteric 
reflux (VUR)  
in infants and 
children 
ZC030 NICE DB: 
Routine imaging to identify vesicoureteric reflux (VUR) is not 
recommended for infants and children who have had a urinary tract 
infection (UTI), except in specific circumstances. 
– 
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Follow-up diagnosis 
Adnexal cysts: 
clinically 
inconsequential 
ZC030 CW USA: 
Don’t recommend follow-up imaging for clinically inconsequential 
adnexal cysts.  
Simple cysts and haemorrhagic cysts in women of reproductive age 
are almost always physiologic. Small simple cysts in postmenopausal 
women are common, and clinically inconsequential. Ovarian cancer, 
while typically cystic, does not arise from these benign-appearing 
cysts. After a good quality ultrasound in women of reproductive age, 
don’t recommend follow-up for a classic corpus luteum or simple 
cyst <5 cm in greatest diameter. Use 1 cm as a threshold for simple 
cysts in postmenopausal women. 
– 
Pelvic floor 
dysfunction 
ZC030 ACR AC: 
Pelvic floor dysfunction: MRI pelvis dynamic with rectal contrast for 
clinically suspected postoperative complication following pelvic floor 
repair; rated 1 
MRI indicated as 
follow-up. 
H.34, G.19* 
Prostate cancer ZC030 NICE DB: 
Do not offer routine MRI scanning prior to salvage radiotherapy in 
men with prostate cancer with evidence of biochemical relapse 
following radical treatment. 
MRI indicated as 
follow-up for 
diagnosis and initial 
investigation for 
staging prior to 
prostatectomy. 
L.18* 
Urinary tract 
infection  
in children 
ZC030 NICE DB: 
The routine use of imaging in the localisation of a urinary tract 
infection (UTI) is not recommended. 
MRI no routine 
indication. 
K.48* 
Vaginal 
bleeding in 
premenopausal 
women 
ZC030 ACR AC: 
Abnormal vaginal bleeding: MRI pelvis without and with contrast for 
premenopausal vaginal bleeding, follow-up, endometrium <16mm; 
rated 2 
– 
Vaginal 
bleeding in 
premenopausal 
women 
ZC030 ACR AC: 
Abnormal vaginal bleeding: MRI pelvis without contrast for 
premenopausal vaginal bleeding, follow-up, endometrium >16mm; 
rated 3 
– 
Vaginal 
bleeding in 
postmenopausa
l women 
ZC030 ACR AC: 
Abnormal vaginal bleeding: MRI pelvis without contrast for post-
menopausal bleeding, endometrium >5mm by ultrasound; rated 2 
Comment: MRI with contrast is indicated. 
MRI indicated as 
follow-up for post-
menopausal 
bleeding. 
H.29* 
Screening 
Prostate cancer ZC030 NICE DB: 
Magnetic resonance spectroscopy is not recommended for men with 
prostate cancer except in the context of a clinical trial. 
– 
Ovarian cancer 
in average and 
high risk women 
ZC030 ACR AC: 
Ovarian cancer screening: MRI pelvis without and with contrast for 
average and high risk women; rated 2 
MRI indicated as 
initial diagnosis, 
staging and  
follow-up care. 
L.20* 
Staging 
Bladder cancer, 
invasive 
ZC030 ACR AC: 
Pre-treatment staging of invasive bladder cancer: MRI abdomen 
without contrast; rated 3 
Comment: MRI with contrast is indicated. MRI pelvis without and 
with contrast indicated. 
MRI not indicated 
for diagnosis but 
indicated as follow-
up for staging 
bladder cancer. 
L.17* 
Prostate cancer: 
no radical 
treatment 
intended 
ZC030 NICE DB: 
Imaging is not routinely recommended for men in whom no radical 
treatment is intended. 
– 
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Surveillance 
Bladder cancer ZC030 ACR AC: 
Post-treatment surveillance of bladder cancer: MRI abdomen and 
pelvis without and with contrast for patients with superficial TCC,  
no invasion or risk factors; rated 3 
MRI not indicated 
for diagnosis but 
indicated as follow-
up for staging 
bladder cancer. 
L.17* 
Bladder cancer ZC030 ACR AC: 
Post-treatment surveillance of bladder cancer: MRI abdomen and 
pelvis without contrast for patients with superficial TCC, no invasion, 
with risk factors; rated 3 
Comment: MRI with contrast is indicated. 
MRI not indicated 
for diagnosis but 
indicated as follow-
up for staging 
bladder cancer. 
L.17* 
Gynecologic 
cancer 
ZC030 CW USA: 
Avoid routine imaging for cancer surveillance in women with 
gynaecologic cancer, specifically ovarian, endometrial, cervical, 
vulvar and vaginal cancer.  
Imaging in the absence of symptoms or rising tumour markers has 
shown low yield in detecting recurrence or impacting overall survival. 
MRI indicated as 
initial diagnosis and 
staging ovarian 
cancer, staging 
cervical cancer and 
endometrial cancer. 
L.20, L.21, L.22* 
Prostate cancer ZC030 CAR: 
Prostate cancer monitoring: MRI generally not indicated. Becoming 
useful in special circumstances to evaluate for intraprostatic, local 
and distant recurrence. 
MRI indicated for 
follow-up and 
staging. 
L.18* 
Ratings 1, 2 and 3 represent ‘usually not appropriate’; grey marking refers to overlapping recommendations 
* refers to the respective chapter number in the OGR 
1 OGR usually does not specify MRI technique as contrast application, angiographic, functional or spectroscopic imaging. 
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Table 8-10: Recommendations against the use of MRI – Mamma 
Indication 
MEL 
code Recommendation/Programme 
Orientation  
Guide Radiology1 
Initial diagnosis/primary investigation 
Breast micro 
calcifications 
ZB040 ACR AC: 
Breast Microcalcifications — Initial Diagnostic Workup: MRI breast 
without and with contrast; rated 1 
Breast Microcalcifications — Initial Diagnostic Workup: Imaging 
localization for surgical excision breast; rated 1 
– 
Non-palpable 
mammographic 
findings 
ZB040 ACR AC: 
Non-palpable Mammographic Findings (Excluding Calcifications): 
MRI breast without and with contrast; rated 1 
MRI indicated as 
follow-up and for 
staging after 
mammography. 
L.23/I.7, I.11* 
Palpable breast 
masses 
ZB040 ACR AC: 
Palpable Breast Masses: MRI breast without (rated 1) and with 
contrast (rated 2) 
MRI indicated as 
follow-up and for 
staging after 
mammography  
and US. 
I.7, I.11* 
Stage I Breast 
Cancer in 
asymptomatic 
women 
ZC030 
ZB040 
ACR AC: 
Stage I Breast Cancer: Initial workup and surveillance for local 
recurrence and distant metastases in asymptomatic women: MRI 
breast without contrast bilateral to rule out local recurrence; rated 1  
Stage I Breast Cancer: Initial workup and surveillance for local 
recurrence and distant metastases in asymptomatic women: MRI 
abdomen without and with contrast to rule out metastases; rated 2 
Comment: Also applies for surveillance for local recurrence and 
distant metastases. With contrast: MRI breast rated 5 
MRI indicated for 
follow-up after 
mammography and 
US in women >40. 
I.3-5* 
Follow-up diagnosis 
Biopsy-proven 
invasive breast 
cancer 
ZB040 NICE DB: 
The routine use of magnetic resonance imaging (MRI) of the breast 
is not recommended in the preoperative assessment of patients with 
biopsy-proven invasive breast cancer or ductal carcinoma in situ 
(DCIS). 
MRI indicated for 
staging proven 
breast cancer after 
mammography, US. 
I.11* 
Ductal 
carcinoma in 
situ 
ZB040 ACR AC: 
Ductal carcinoma in situ: Breast MRI prior to definitive surgery; 
rated 2 
NICE DB: 
The routine use of magnetic resonance imaging (MRI) of the breast 
is not recommended in the preoperative assessment of patients with 
biopsy-proven invasive breast cancer or ductal carcinoma in situ 
(DCIS). 
MRI indicated as 
follow-up for 
suspected Paget 
disease. 
I.7* 
Screening 
Breast cancer  
in average-risk 
women 
ZB040 ACR AC: 
Breast cancer screening: MRI breast without and with contrast for 
average-risk women, breasts not dense; rated 3 
MRI indicated as 
follow-up after 
unclear 
mammography, US. 
I.3-5* 
Breast cancer  
in intermediate-
risk and high-risk 
women 
ZB040 Breast cancer screening: MRI breast without contrast for 
intermediate and high risk; rated 1 
Comment: MRI breast with contrast indicated. 
MRI indicated as 
initial diagnosis in 
women with 
familial breast 
cancer history. 
I.2* 
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Surveillance 
Breast cancer ZB040 NICE DB: 
Do not offer MRI to women:  
 of any age at moderate risk of breast cancer  
 of any age at high risk of breast cancer but with a 30% or lower 
probability of being a BRCA or TP53 carrier  
 aged 20 to 29 years who have not had genetic testing but have  
a greater than 30% probability of being a BRCA carrier – aged 20 
to 29 years with a known BRCA1 or BRCA2 mutation  
 aged 50 to 69 years who have not had genetic testing but have a 
greater than 30% probability of being a BRCA or a TP53 carrier, 
unless mammography has shown a dense breast pattern  
 aged 50 to 69 years with a known BRCA1 or BRCA2 mutation, 
unless mammography has shown a dense breast pattern.  
MRI indicated as 
initial diagnosis in 
women with 
familial breast 
cancer history. 
I.2* 
Breast cancer: 
women aged  
50 years and 
over  
ZB040 NICE DB: 
Do not offer MRI surveillance to any women aged 50 years and  
over without a TP53 mutation unless mammography has shown a 
dense breast pattern. 
MRI indicated as 
follow-up when 
mammography  
and US are non-
conclusive.  
US recommended 
for dense breast. 
I.4/5* 
Early invasive 
breast cancer  
or ductal 
carcinoma in 
situ (DCIS), 
post-treatment 
ZB040 NICE DB: 
Do not offer magnetic resonance imaging (MRI) for routine post-
treatment surveillance in patients who have been treated for early 
invasive breast cancer or ductal carcinoma in situ (DCIS). 
MRI indicated as 
post-treatment 
follow-up care after 
breast cancer, when 
recurrence is 
suspected. 
I.12* 
Ratings 1, 2 and 3 represent ‘usually not appropriate’; grey marking refers to overlapping recommendations 
* refers to the respective chapter number in the OGR 
1 OGR usually does not specify MRI technique as contrast application, angiographic, functional or spectroscopic imaging. 
 
